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91.  Introduction and outline of the thesis
The red blood cell in health and disease
The red blood cell: structure and function
Red blood cells (RBCs), or erythrocytes, are by far the most numerous blood 
cells. A microliter of human blood contains 4 to 6 million RBCs and in total there 
are roughly 25 trillion RBCs in the five liters of blood of our human body. Their 
main function is the transport of oxygen (O2) from the lungs to the organs and to 
carry carbon dioxide (CO2) from the organs to the lungs. 
The RBC presents an intricate relationship between cell structure and func-
tion. Its oxygen transport function depends on rapid and efficient diffusion of 
oxygen across the red cell’s plasma membrane. The lack of organelles creates 
more space for hemoglobin. Furthermore, the biconcave shape makes the RBC 
more flexible when traveling through the narrow microcapillaries and the change 
to a bullet shape in the microcapillaries creates a large surface that is ideal for gas 
exchange. The absence of mitochondria results in the absence of a need to use 
the oxygen that RBCs transport for energy production. Instead, RBCs produce 
all their ATP via anaerobic glycolysis. 
The membrane-cytoskeleton complex
Every time the RBC passes through a capillary, it undergoes extensive defor-
mation and must resist fragmentation. During its life, an RBC squeezes roughly 
160,000 times through capillaries of a third of its diameter (4, 248). Therefore, 
the RBC must have a highly deformable and yet stable membrane. This is possible 
because of its unique membrane-cytoskeleton complex. Unlike other cell types, 
the cytoskeleton of the RBC consists of spectrin filaments, which are linked to 
the membrane in two different protein-complexes: the band 3 or ankyrin complex 
and the junctional complex, also known as the 4.1R complex (Figure 1.1). 
The two isoforms of spectrin, alpha (260 kDa) and beta (225 kDa), form a loosely 
wound helix. Two alpha-beta helices are linked end-to-end to form a single 
tetramer, which has binding sites for several other proteins, including other spec-
trin molecules. In this way, spectrin forms an irregular hexagonal network of poly-
meric molecules, tied together by actin (Figure 1.2). 
Because the spectrin-actin interaction by itself is weak, it is stabilized by the 
formation of a ternary complex with protein 4.1. This complex, together with 
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many other proteins, is bound to the membrane in the junctional complexes. At 
the self-association side, spectrin binds to ankyrin, which in its turn binds to band 
3, the anion (Cl-/HCO3
-) exchanger AE1 (see Figure 1.1).
In order for the membrane to deform, the cytoskeletal network must be able 
to undergo rearrangement. Disruption of the protein-protein interactions 
has a markedly negative effect on membrane stability. Therefore, deforma-
tion is achieved mainly by folding and unfolding of spectrin molecules. Chasis 
and Mohandas proposed that reversible deformation occurs with a change in 
geometric shape, at a constant surface area (50). In a biconcave shape, spec-
trin molecules are in a folded confirmation. With increased shear stress, the 
membrane becomes increasingly extended because some spectrin molecules 
uncoil while others assume a more compressed and folded form (Figure 1.3).
Gas exchange
The hemoglobin (Hb) molecules inside the RBC bind oxygen reversibly, loading 
oxygen in the lungs and unloading it in other parts of the body (Figure 1.4). The 
FIGURE 1.1 The membrane-cytoskeleton complex. The 4.1R complex is also known as the junc-
tional complex. (216) CAII, Carbonic anhydrase II; GAPDH, Glyceraldehyde-3-phosphate dehydroge-
nase; GPA, Glycophorin A; GPC, Glycophorin C; LW, Landsteiner-Wiener; PFK, Phosphofructokinase; Rh, 
Rhesus; RhAG, Rhesus associated glycoprotein
11
1.  Introduction and outline of the thesis
FIGURE 1.2 Visualization of the hexagonal lattice in the RBC membrane skeleton. (A) The structural 
model of a hexagonal lattice composed of spectrin is supported by high-resolution electron micrographs 
of isolated membranes. (B) The putative location of the structural elements is shown schematically. (161) 
FIGURE 1.3 Model of the reversible deformation of the RBC membrane. (A) The nondeformed 
membrane. With increased shear stress, the membrane becomes increasingly extended (B) and (C). 
Further extension of the membrane beyond that shown in c would result in an increase in surface area 
and the breaking of junction points. This is the stage at which membrane fragmentation occurs. , 
protein 4.1, actin, and spectrin association points; O, spectrin-spectrin association points; linear coils, 
spectrin dimer. (50) 
A
A B
B
C
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affinity of Hb for oxygen depends on several factors: the oxygen concentration 
in the surrounding tissue, the pH of the blood, and the CO2 concentration. In the 
lungs, the environmental circumstances (high pO2, low pCO2 and increased pH) 
lead to the binding of oxygen to Hb. In the tissues, an increase in pCO2 leads to 
a decrease in pH and thereby to a conformational change of Hb resulting in the 
release of oxygen and a binding of CO2, a process called the Bohr effect (47). The 
conformation of deoxyHb, called the tense state or T-state, enables the binding 
of 2,3-DPG. The latter stabilizes the T-state and thereby reduces the affinity for 
oxygen even more (169).
The conformational change of Hb does not only affect its affinity for oxygen 
and CO2, but also its affinity for band 3. In the T-state, deoxyHb binds with a 
high affinity to the N-terminal domain of band 3, which increases the membrane 
rigidity (51, 87). In contrast, in the relaxed state (R-state), oxyHb is released from 
band 3 and the cell becomes more flexible. This is another example of the sophis-
ticated relationship between RBC structure and function; the increased deform-
ability makes the RBC more able to withstand the high shear forces it encounters 
in the arteries and while squeezing through the narrow microcapillary bed.
H2O + CO2
H2CO3
H+      
Band 3
Cl-
 CO2
C.A.
O2
CO2
 Hb.O2 O2 +   
H2O + CO2
H2CO3
H+      
Band 3
Cl- C.A.
O2
 Hb.O2
CO2
HCO3
  + O2
 CO2
LUNGSTISSUE
HHb
HHb
FIGURE 1.4  Gas exchange in the tissues and the lungs. HHb, deoxyHb; Hb.O2, oxyHb; CA, 
carbonic anhydrase. CA II is bound to the C-terminal domain of Band 3. Along with band 3, CA contrib-
utes to pulmonary gas exchange by catalyzing the hydration of CO2 to produce carbonic acid and bicar-
bonate ions. At the lungs, the same enzyme catalyzes the conversion of bicarbonate ions back to carbon 
dioxide (244). 
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Red blood cell metabolism
Glucose is used in the RBC in a constant trade-off between two metabolic path-
ways: the glycolysis and the pentose-phosphate pathway (PPP). The distribution 
between these pathways is coordinated by the reversible binding of hemoglobin 
to band 3 (178). The glycolysis is essential for red cell energy production, while 
the PPP has a function in the protection of the RBC to oxidative damage through 
the production of NADPH (87). The high oxygen tension and the generation of 
superoxide anion during binding and release of oxygen to hemoglobin constitute 
a high degree of oxidative stress, making the PPP important for survival.
The N-terminal domain of band 3 contains binding sites for key enzymes of the 
glycolysis, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), aldo-
lase and phosphofructokinase (52). Binding of these enzymes to band 3 inhibits 
their function and thereby shifts the glucose consumption to the PPP. These 
enzymes compete with deoxyHb for binding to the N-terminal domain of band 
3. Therefore, during deoxygenation, the glycolytic enzymes are released, which 
favors the use of glucose for the production of ATP (51). Through this mecha-
nism, the cell can balance its metabolite flow between both pathways, depending 
on its needs. In circumstances with high oxygen levels, the cell has to be able 
to protect itself from an increase in reactive oxygen species (ROS) and needs 
therefore high levels of the reducing agent NADPH. Once the cell has released 
its oxygen in the tissues, the oxidative stress decreases, and the cell can invest 
more of its glucose in energy production.
 
The life of a red blood cell 
RBCs originate in the bone marrow in the process called erythropoiesis. During 
erythropoiesis, a stem cell differentiates via several steps into a reticulocyte, 
which is then released into the bloodstream where it matures into an RBC within 
a few days. During its passage through the circulation, RBCs encounter severe 
physiological conditions consisting of mechanical stress, oxidative damage and 
fast changes in ionic and osmotic conditions. Yet, RBCs live for approximately 120 
days before they are removed from the circulation (228) (Figure 1.5). In vivo, RBC 
aging is regulated by several pathways resulting finally in the controlled exposure 
of molecules that cause binding and phagocytosis by the immune and reticuloen-
dothelial systems (168). RBC removal mainly takes place by macrophages in the 
liver and to some extent in the spleen (12, 223).
14
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Since the red cell lacks organelles and thereby the proper machinery to repair 
damage by replacement of damaged molecules, the RBC relies on vesiculation 
to survive. RBCs shed vesicles that are enriched in non-functional proteins and 
autoantigens, which would lead to untimely removal of cells from the circula-
tion (253). This process leads to the loss of approximately 20 percent of the cell 
surface and 30 percent of their volume in the course of the RBC life span (24, 
250). Old RBCs have a reduced deformability as a consequence of the increased 
hemoglobin concentration, together with a decreased surface/volume ratio, and 
an increased membrane stiffness (25, 126). This change in deformation capacity 
FIGURE 1.5 Erythrocyte birth, ageing and removal. PC, Phosphatidylcholine; PS, Phosphati-
dylserine; PE, Phosphatidylethanolamine; PI, Phosphatidylinositol; SM, Sphingomyelin. Adapted from 
Dinkla (81) and Coltel (56) 
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presumably stimulates the removal of old cells, by trapping them in the spleen 
where they can be recognized as old cells by macrophages (214). So far, three 
molecules have been identified as likely to play a role in recognition and phago-
cytosis of aged RBCs: band 3, phosphatidylserine (PS) and CD47 (28, 45, 147).
Next to its main functions in anion exchange, membrane-cytoskeleton organi-
zation and metabolism (see above), band 3 is important for RBC removal as well. 
Band 3 modifications accumulate during physiological RBC aging, probably due to 
oxidative insults. Conformational changes in band 3 eventually transform it into a 
senescent neoantigen that is recognized by autologous IgG (28, 138). These same 
conformational changes may induce loss of binding sites between the cytoskel-
eton and lipid bilayer resulting in the formation of vesicles (37).
CD47, also known as the integrin-associated protein, may function as a marker 
of self on RBCs. It normally inhibits phagocytosis through interaction with the 
inhibitory immunoreceptor SIRPa, which is highly expressed by red pulp macro-
phages in the spleen (45, 193). Conformational changes in CD47 may turn it from 
a “do-not-eat-me” signal into an “eat-me” signal (45). 
Next to these two membrane proteins, components of the lipid bilayer have been 
postulated to play a role in RBC removal. The plasma membrane has a well-con-
trolled phospholipid asymmetry, with phosphatidylserine (PS) and phosphatidy-
lethanolamine (PE) mostly at the inside, and phosphatidylcholine (PC) and sphin-
gomyelin (SM) mainly in the outer leaflet of the lipid bilayer (194). During ageing, 
the mechanisms controlling this lipid distribution may become disrupted, leading 
to the exposure of PS on the outside of the membrane. PS is recognized by 
macrophages as a removal signal, which may stimulate phagocytosis (147).
The RBC in disease
Storage/Transfusion-associated pathologies
Blood transfusion is a medical treatment that was used for the first time already 
in the beginning of the 1800’s. It has been a successful life-saving treatment in 
the last decades for patients with blood loss because of trauma or during surgery, 
but also for anemic patients. In the Netherlands, yearly 250,000 people undergo 
at least one blood transfusion (221).
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Since the beginning of blood banking, the legal requirements for blood storage 
have developed extensively. During storage, RBCs undergo various metabolic, 
structural and morphological changes, the so-called storage lesions (20, 140, 
167). The acceptable extent of the metabolic changes, such as the decrease in 
2,3-DPG, ATP, and pH, together with hemolysis, forms the major part of the 
current blood bank quality guidelines. Hemolysis and survival rate can also be used 
as quality parameters and seem to be more directly related to transfusion-related 
pathologies caused by the storage lesions, such as iron accumulation, endothelial 
damage, inflammation, and formation of alloantibodies (31). Especially for transfu-
sion-dependent patients, these side effects become critical over time. 
Transfused RBCs have been shown to have an overall good survival with a 
maximum of 135 days after transfusion (165). Nevertheless, survival studies show 
the disappearance of 5 - 10% within the first 24 hours after transfusion. This 
percentage increases up to 30% after the maximal storage time (167, 209). This 
suggests that, during blood bank storage, a specific population of RBCs becomes 
vulnerable for quick disappearance from the circulation. It has been proposed 
that this fraction of vulnerable RBCs is the main cause of the side effects of 
transfusion (31). The results of several studies have shown that six factors are the 
main determinants of RBC recovery after storage: 1) the duration of storage, 2) 
the type of plasticizer in the bag, 3) the composition of the suspending solution 
in the bag, 4), the volume of the suspending solution in the bag, 5) the quality 
of leukoreduction, and 6) as yet imperfectly understood interdonor variability 
(121). Nevertheless, it is still unknown which storage-associated alterations at the 
molecular level makes these RBCs more prone to clearance after transfusion.
In the last years, an increasing number of studies have focused on understanding 
the molecular changes causing these side effects, in order to improve storage 
conditions and transfusion (28, 38, 61, 144)  The current blood bank quality 
guidelines are determined mainly by the extent of metabolic changes, such as 
indicated by changes in 2,3-DPG, ATP, and pH, as well as hemolysis. However, 
the reversibility of these metabolic changes in vivo make it unlikely that they are 
responsible for most transfusion side effects. Alterations in membrane struc-
ture, as indicated by morphological changes, are more likely to cause a decrease 
in transfusion efficacy (20). Data on storage-related exposure of removal signals, 
such as band 3-derived senescent neoantigens and PS, support the theory that 
physiological aging-related changes in the membrane are functionally relevant 
17
1.  Introduction and outline of the thesis
FIGURE 1.6  Most common morphological shapes of (abnormal) RBCs.
      Discocyte                           Spherocyte                               Stomatocyte                      Echinocyte
      Ovalocyte                          Elliptocyte                                     Sickle cell                       Acanthocyte
determinants of the quality of RBC concentrates (29). It would be desirable if 
blood bank guidelines, especially for transfusion-dependent patients, would be 
extended with these physiologically relevant parameters.
RBC-associated pathologies
There is a broad range of hereditary red cell pathologies, which can be divided 
into two groups: the hemoglobinopathies and the membranopathies. As their 
name already implies, they are characterized by respectively alterations in the 
hemoglobin structure or in the membrane-cytoskeleton complex. Well-known 
hemoglobinopathies are sickle cell anemia and thalassemia. Inherited abnor-
malities of the red cell membrane involve a range of disorders, varying from 
abnormalities of RBC shape in asymptomatic patients to hemolysis and anemia 
of varying degrees of severity in clinically affected patients. Spherocytosis and 
elliptocytosis are the most common examples of membranopathies. These RBC 
pathologies are all characterized by misshapen red cells and associated with 
decreased red cell function. Diagnosis of these diseases relies on the presence 
of malformed RBCs in a blood smear (Figure 1.6). 
This thesis focuses on changes in the RBC membrane-cytoskeleton complex 
and their effects on cell function. From that perspective, the membranopathies 
constitute an interesting starting point for understanding the effects of molec-
ular defects on each protein and on the resulting changes in the structure and 
function of the red cell membrane.
18
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Hereditary spherocytosis (HS) is the most common form of congenital hemolytic 
anemia, with an incidence of 1 in 2000 among Causasians. This group of hetero-
geneous disorders is characterized by sphere-shaped RBCs, that are mechani-
cally unstable and have an increased osmotic fragility (76). Spherocytosis is char-
acterized clinically by anemia, jaundice, and splenomegaly, with variable severity.  
The severity of the disease differs from hardly any clinical expression to death in 
utero in the most extreme form (75). HS can be caused by a mutation in several 
genes encoding various proteins of the red cell membrane (100) (Table 1.1). 
Hereditary elliptocytosis (HE) is the second most common hereditary hemo-
lytic anemia, with an incidence of 1 in 5,000 to 10,000 among Caucasians, which 
may be significantly higher in other populations. HE is characterized by ellipti-
cally shaped RBCs, which have a decreased mechanical stability resulting in a 
variable degree of hemolytic anemia. The clinical features resemble those of HS, 
although they are usually milder (75, 76). Elliptocytosis is caused by mutations in 
various RBC membrane proteins (100) (Table 1.1).
In literature, the interactions in the membrane-cytoskeleton complex are divided 
into two types: vertical interactions between the membrane skeleton and the lipid 
bilayer, and horizontal interactions among components that form the membrane 
skeleton meshwork. 
It has been suggested that mutations in proteins involved in vertical interactions, 
such as the binding of the spectrin cytoskeleton to the band 3-ankyrin 
complex, induce vesiculation-associated membrane loss and the appearance of 
spherocytes. Mutations in membrane proteins that affect horizontal interactions, 
such as the spectrin dimer-dimer structure and the spectrin-actin-protein 4.1R 
interactions, are thought to lead to membrane fragmentation and elliptocytosis 
(182, 239).
Patients with typical HE are often asymptomatic and are diagnosed incidentally 
when tested for unrelated conditions. On the other hand, most HS patients have 
incompletely compensated hemolysis and mild to moderate anemia. In HS, the 
defect in one of the membrane proteins results in increased membrane fragility, 
which then leads to increased membrane vesiculation. As a result of this vesicula-
tion, the surface-area-to-volume changes, causing the spheroidal shape of these 
RBCs and a decreased deformability. This makes these cells more vulnerable 
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to entrapment in the hostile environment of the spleen. Destruction of these 
abnormal RBCs in the spleen is the principal cause of hemolysis (100).
Neuroacanthocytosis
Also other diseases can display abnormal RBC morphologies. Neuroacantho-
cytosis (NA) is a family of rare hereditary neurodegenerative disorders, which 
includes chorea-acanthocytosis (ChAc), McLeod syndrome (MLS), Huntington’ s 
disease-like 2 (HDL2) and panthothenate kinase-associated neurodegeneration 
(PKAN) (135, 204). Patients affected by these progressive and fatal disorders 
suffer from devastating movement disorders as well as a variety of other symp-
toms (135). NA shares considerable similarities with Huntington s´ disease (HD). 
As in HD, the basal ganglia are preferentially affected by neurodegeneration. In 
contrast to HD, a key to the understanding of underlying mechanisms may be 
found in the easily accessible RBCs of NA patients. Although the clinical symp-
toms of NA all seem to be caused by neurodegeneration, the presence of acan-
thocytes in the blood stream constitutes a characteristic feature of NA. Acan-
thocytes are misshapen, spiky red blood cells (Figure 1.6). These cells are the 
TABLE 1.1 Membrane protein mutations in HS and HE as listed in the Online Mendelian 
   Inheritance in Man. 
GENE AFFECTED PROTEIN PHENOTYPE
ANK1 Ankyrin Spherocytosis, type 1
EPB42 Protein 4.2 Spherocytosis, type 5
EPB41 Protein 4.1 Elliptocytosis 1
SPTB Beta-spectrin Spherocytosis, type 2
Elliptocytosis 3
SPTA1 Alpha-spectrin Spherocytosis, type 3
Elliptocytosis 2
SLC4A1 Band 3 Spherocytosis, type 4
Ovalocytosis, SA type (Elliptocytosis 4)
The estimated frequencies of mutations in different membrane proteins in HS and HE are divided as 
follows: hereditary spherocytosis is caused ~20% of the cases by mutation in band 3; ~5% by mutation 
in protein 4.2; ~45% by mutation in ankyrin; ~30% by mutation in ß spectrin. Hereditary elliptocytosis is 
caused ~5% of the cases by mutation in ß spectrin; ~80% by mutation in α spectrin; ~15% by mutation in 
protein 4.1 (239). 
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origin of the term neuroacanthocytosis, denoting the association of neurological 
findings and acanthocytes. During the last years, RBCs from NA patients have 
been used to gain more insight into the mechanisms underlying the pathophysi-
ology of the NA disorders (11, 13, 32, 70, 71, 96, 232). 
Although the genetic basis for the NA disorders is known, the molecular mech-
anisms underlying both the neurodegeneration and the formation of acantho-
cytes remain elusive. The affected genes encode the Kell protein-associated XK 
protein in MLS, VPS13A (vacuolar protein sorting 13A, also known as chorein) 
in ChAc, JPH3 (junctophilin 3) in HDL2 and PANK2 (pantothenate kinase 2) in 
PKAN (124, 173, 240, 259). JPH3 and PANK2 are not present in mature RBCs, 
and the function of XK and chorein are not known, which does not provide any 
obvious clues to the mechanism resulting in the typical acanthocytic shape. 
The occurrence of acanthocytes may be caused by distinct primary causes 
in each syndrome, depending on the respective gene defects. It has been 
suggested that each mutation affects a common pathway in erythropoiesis 
and/or red cell membrane homeostasis, thereby leading to the same pheno-
type (204). Furthermore, this pathway might not only be responsible for the 
aberrant RBC shape, but also for the neurodegeneration. An improved under-
standing of the alterations that arise in the, relatively easy accessible, patients’ 
RBCs may therefore help to understand the molecular basis for the neurolog-
ical phenomena in NA.
Since RBC shape changes are often the result of changes in membrane struc-
ture, it is to be expected that the membrane-cytoskeleton is disturbed in acan-
thocytes. The membrane complexes are formed during erythropoiesis and 
remodeled during reticulocyte maturation (159). Deficiencies in protein sorting 
during erythropoiesis lead to aberrant RBC morphology (215). Therefore, it is 
suggested that acanthocytes are the result of an unbalanced distribution of 
membrane proteins and/or cytoskeleton during erythropoiesis (204). VPS13A 
has been proposed to control one or more steps in protein trafficking (204), 
and may  affect the protein distribution of the main components of the RBC 
membrane-cytoskeleton complex during erythropoiesis. Furthermore, VPS13A 
may be involved in autophagy (131, 220). Autophagy is known to play an important 
role both in various forms of neurodegeneration and in late stages of erythropoi-
esis, by removing aggregated proteins and non-functional organelles in neurons 
and in erythroid precursor cells (18, 152). Loss of autophagy has been associated 
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with impaired erythropoiesis (184), and therefore may play a role in the forma-
tion of acanthocytes. The Kx/Kell complex is part of the junctional complex, 
so absence of a functional XK protein may very well lead to shape changes in 
patients with MLS. At present, there are no clues to a possible mechanism of 
acanthocyte formation in patients with HDL2 and PKAN.
Aims and outline of the thesis
In the course of our studies on the molecular cause of neuroacanthocytosis, we 
were confronted with a lack of molecular knowledge on the relation between 
RBC structural and functional characteristics. The aim of this thesis is to gain 
a better understanding of the structural features that determine the func-
tion and morphology of the red blood cell. These insights can contribute to the 
fundamental understanding of the structure/function relationship of cellular 
membranes in general, as well as help in a better understanding of RBC-related 
diseases. Furthermore it can contribute to the improvement of RBC transfusion.
Under normal conditions in vivo, or during blood bank storage, RBCs undergo 
several age-related structural changes. In the last decades, most research on 
RBC aging in vivo and in vitro has been focused on detailed analyses of the molec-
ular changes in the plasma membrane. So far, relatively little attention has been 
devoted to the changes in deformability and the consequences of those changes 
on the cell’s function. In chapter 2, we review the available data on aging-as-
sociated and storage-associated alterations in RBC deformability. The data we 
acquired in the course of a preliminary study served as the starting point for an 
inventory of the data on alterations in RBC deformability during storage, the 
putative consequences, and the proteomic and metabolomics indications for the 
underlying molecular mechanisms.
While various techniques have been used to investigate the rheological proper-
ties of stored RBCs, the clinical significance of those data is controversial. We 
developed a microfluidic approach for evaluating RBC deformability in physio-
logically meaningful and clinically significant conditions. In chapter 3, we describe 
the use of this approach to determine the effect of blood bank storage on the 
deformability capacity of RBCs. Our data indicate that the capacity of the cells 
to deform and relax is not affected during storage in the blood bank. Further-
22
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more, altered cell morphology by itself does not necessarily affect deformability. 
The exposure of phosphatidylserine (PS), a potent removal signal, is considered 
to be an indication of the structural changes RBCs undergo during blood bank 
storage. In chapter 4 we postulate that, during blood bank storage, the suscep-
tibility to stress-induced PS exposure increases, thereby rendering a consider-
able fraction of the RBCs susceptible to rapid removal after transfusion. There-
fore, RBCs of different storage times were exposed to various near-physiological 
stress conditions, after which PS exposure was measured. Our findings show 
that, during storage under blood bank conditions, RBCs become increasingly 
susceptible to loss of phospholipid asymmetry induced by hyperosmotic shock 
and energy depletion. This is associated with the appearance of an aging pheno-
type. These findings could be an explanation for the rapid disappearance of up to 
25 percent of RBCs during the first 24 hours after transfusion, which is particu-
larly a problem for blood bank units after longer storage time. 
Microvesicles are fragments that are shed from the plasma membrane of stimu-
lated or apoptotic cells. They are associated with various physiological processes 
involving intercellular communication, hemostasis, and immunity. Classically, the 
RBC has been used as a model for the mechanism of vesicle formation. In the 
last few years, the interest in the ins and outs of RBC vesiculation has increased, 
since vesiculation plays a role in all stages of the RBC life, constitutes one of 
the RBC storage lesions, and also plays a role in RBC-associated pathologies. In 
chapter 5, we present the recent data on RBC vesicle composition, and discuss 
these in the light of the molecular mechanisms that have been postulated on 
the vesicle generation process. Furthermore, we combine these insights into a 
new model, and propose some experimental approaches that could falsify and/
or refine this theory. 
Band 3 is a central player in RBC homeostasis because of its interactions with 
several membrane and cytoskeletal proteins, as well as key enzymes of various 
metabolic pathways. These interactions are controlled by a signaling network 
acting via phosphorylation of band 3, and by the binding of deoxyhemoglobin to 
band 3. In chapter 6 we show that band 3-centered manipulation of the interac-
tion between the lipid bilayer and the cytoskeleton using various treatments has 
diverse effects on morphology, membrane organization, membrane lipid organi-
zation, deformability and metabolic activity.
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1.  Introduction and outline of the thesis
Panthothenate kinase-associated neurodegeneration (PKAN) is one of the 
neuroacanthocytosis syndromes. In comparison with ChAc and MLS, even less 
data are available on the characteristics of the RBCs of PKAN patients. In chapter 
7, we describe for the first time a qualitative and semi-quantitative morpholog-
ical, structural and functional analysis of the RBCs from PKAN patients and their 
relatives. Our results show the presence of morphological, structural and func-
tional changes in RBCs not only of patients, but also in the RBCs of some of their 
relatives.
In chapter 8, the findings are summarized and future directions are provided.
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Storage
During storage, RBCs undergo various metabolic, structural and morphological 
changes, the so-called storage lesions (120). The acceptable extent of the meta-
bolic changes forms a major part of the blood bank quality guidelines. However, 
the consequences of these changes for RBC survival after transfusion are mostly 
unknown. Strikingly, it still has not been determined which events in the blood 
bank are responsible for the disappearance of up to 30 percent of the transfused 
RBCs within the first hours after transfusion in the patient (167). Also, the rela-
tionship between RBC survival after transfusion and the occurrence of transfu-
sion-related pathologies such as iron accumulation, inflammation, and formation 
of anti-RBC antibodies is far from understood.
Since the changes in most metabolic parameters such as 2,3-DPG, ATP, and pH 
are rapidly reversible, the metabolic events underlying these parameters are 
not likely to contribute to most adverse transfusion effects. The storage-asso-
ciated morphological changes, namely the partially reversible transition from 
a discoid to an echinocyte/stomatocyte, and finally to an irreversible sphero-
cyte-like morphology (59, 120), suggest that alterations in membrane structure 
are more likely to cause a decrease in transfusion efficacy and an increase in 
harmful effects. The last few years have witnessed a strong increase in proteomic 
and biochemical data on RBC biology during blood bank storage (9, 28, 29, 38, 
59, 61, 144, 145, 177). Especially the data on storage-related exposure of removal 
signals such as phosphatidylserine (PS) and band 3-derived senescent cell anti-
gens, support the theory that physiological aging-related changes in the RBC 
membrane are major, functionally relevant quality determinants of RBC concen-
trates (29).
In the context of membrane alterations, in contrast to detailed analyses of 
the molecular constituents, relatively little attention has been devoted to the 
changes in deformability that accompany aging in vivo and in vitro. Here, we 
review the available data on aging- associated and storage-associated alterations 
in RBC deformability. Some relevant, preliminary data from our own laboratory 
will serve as the starting points for an inventory of the data on alterations in RBC 
deformability during storage, the putative consequences, and the proteomic and 
metabolomic indications for the underlying molecular mechanisms.
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Deformability
The capacity of RBCs to adapt their shape to the dynamic flow conditions, 
both in the capillaries and - in extremis - in the spleen, is essential for a proper 
functioning, i.e. flow through the microcirculatory bed. RBC deformability is a 
major determinant of RBC survival, as deduced from the association between 
abnormal RBC shape, anemia, and splenic sequestration (78, 180, 202). Deform-
ability is determined by the mechanical properties of the RBC membrane, the 
viscosity of the cytoplasm - which is mainly determined by the mean cellular 
hemoglobin concentration (MCHC) -, and the surface area-to-volume ratio 
(S/V). Both an increase and a decrease in S/V, an increase in MCHC, and a 
decrease in membrane elasticity may all lead to a decrease in deformability. Thus, 
membrane loss by vesiculation and altered transport of ions and water across the 
membrane, such as occur during storage, both affect deformability. The speed 
and degree of relaxation, i.e. return to the normal cell shape after deformation, 
have been attributed to the elastic properties of the cytoskeleton (195), as well 
as to the viscosity of the cytoplasm (103). Deformability can be measured using 
RBC filtration, aspiration through a micropipette, and light scattering in a rheom-
eter or a flow chamber (14). A decrease in deformability, as measured by ektacy-
tometry, occurs during physiological RBC aging in vivo (25). Again, the relative 
contributions of the aging-associated decrease in S/V ratio and of the increase 
in MCHC are not clear.
Changes in the MCHC occur during storage in SAGM, as the RBC volume starts 
to increase in the first week of storage (166). Also, proteomic and biochemical 
data suggest oxidation as well as breakdown of structural proteins already in the 
first weeks of storage (38, 61, 144). These changes may be responsible for the 
decreased capacity to maintain membrane organization, as deduced from the 
increased susceptibility to osmotic stress- induced PS exposure, and to band 
3 crosslinking-induced binding of autologous IgG (29, 36). Since alterations in 
MCHC and membrane organization affect deformability, and since deforma-
bility is associated with RBC survival (180, 202), storage-associated changes in 
deformability may contribute to the fast removal of a considerable fraction of 
the transfused RBC2. Unraveling the details of the role of deformability in RBC 
removal, the underlying molecular changes, and thereby the putative mecha-
nism(s), is the main reason for our interest in this topic.
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Storage and deformability
In general, most older data suggest that cold storage induces a reduction of 
the deformability, as measured with various techniques (14, 17), and this reduc-
tion has not only been associated with morphological changes (17, 20), but also 
with the post-transfusional survival (5). Interestingly, our recent data, obtained 
by automated ektacytometry using the Laser-assisted Optical Rotational Cell 
Analyzer (LORCA), did not indicate that the deformability of SAGM-stored 
RBCs decreases with storage time, not even after the maximal storage period of 
five weeks (Figure 2.1A). It is possible that in the final weeks the decrease in S/V 
resulting from vesiculation, which would lead to a decrease in deformability, is 
compensated by a decrease in MCHC and an increase in deformability. 
These data are in accordance with recent data using the same technique, 
suggesting that deformability of leukoreduced, SAGM-stored RBCs is not signifi-
cantly reduced up to five weeks of storage (92, 119). In contrast, a comparison of 
fresh RBCs isolated directly from whole blood with RBCs in their first week in the 
blood bag, strongly suggests that deformability does already decrease during 
the three days of processing from blood to blood bag in the blood bank (Figure 
2.1A). The same conclusion can be drawn from the LORCA data obtained from 
the RBCs that were processed and stored in different media (16). On one hand, 
this decrease in deformability may be caused by the same changes in membrane 
organization that underlie the increased PS exposure of one week-old blood 
bank RBCs compared with fresh RBCs (36). On the other hand, hyperosmotic 
stress, which induces a strong increase in PS exposure especially upon prolonged 
storage (36), does not seem to affect deformability (Figure 2.1B), suggesting 
that decreased deformability and increased PS exposure are not causally related. 
Thus, at this time it is not clear if increased PS exposure induces a decrease in 
membrane elasticity or if they share a common cause.
Neither the LORCA measurements, nor the osmotic gradient ektacytometry 
data indicate the occurrence of storage-associated differences in deformability, 
be it a decrease in the maximal elongation index (EI) in the first weeks of storage, 
or a shift in the hyperbolic part of the osmoscan in the last weeks of storage 
(Figure 2.2). The major changes seem to occur during the processing of the RBC 
in the blood bank, with no further, detectable changes after the first week. In 
fresh as well as in stored RBC, hyperosmotic stress does not result in any addi-
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FIGURE 2.1 Effect of storage time and osmotic stress on deformation. RBC deformability was 
monitored using a laser-assisted optical rotational cell analyzer (LORCA, Mechatronics, Hoorn, the 
Netherlands) as previously described (116). RBCs suspended in a viscous solution of polyvinylpyrro-
lidone are subjected to increasing shear stress. The resulting laser diffraction pattern, changing from 
circular (rest) to elliptical (high shear) are expressed by the Elongation Index (EI), calculated from the 
major (a) and minor (b) ellipse axis as (a-b)/(a+b). More deformable RBCs are more elongated and 
produce a higher EI. (A) Shear stress EI curves for fresh RBCs and after 1, 3  and 5 weeks of storage. (B) 
Shear stress EI curves for fresh RBCs and after 2 and 5 weeks of storage after overnight incubation in 
normal Ringer or hyperosmotic Ringer at 370C as described before (36).
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tional changes in the osmoscans (Figure 2.2). From a comparable study on freshly 
isolated RBC fractions with various cell volumes and densities, it was concluded 
that the shape of the hyperbolic part of the osmoscan is largely dependent on the 
MCHC (25). Whereas in RBCs aged in vivo, the shift is towards the left, indicating 
an increase in MCHC that is associated with a decrease in osmotic resistance 
(25, 245), in blood bank RBCs the shift towards the right (Figure 2.2) suggests a 
decrease in MCHC and an opposite effect on osmotic resistance.
Short-term storage is already accompanied by a decrease in deformability as 
measured by rotational ektacytometry, and also may give rise to RBCs that are 
retained in the spleen more than fresh RBCs. When RBCs were passed through a 
recently developed spleen-mimicking device (78), the percentage of RBCs that 
did not pass the device was increased with storage time (Figure 2.3). The differ-
ence between week 2 and week 4 may be explained by the loss of damaged RBCs. 
Curiously, these pilot data suggest that hyperosmotic stress may actually facili-
tate trafficking through the spleen, which would induce spleen-dependent vesic-
ulation and/or phagocytosis (252). A similar function has been postulated for the 
ligation of complement receptor 1-initiated increase in deformability (103).
Phosphatidylserine is widely recognized as a signal for macrophage recognition 
and RBC removal (147). Although increased PS exposure by itself may not be 
sufficient for removal, it may induce adherence of RBCs to other cells, such as 
the blood vessel endothelium, and thereby facilitate the induction of phagocy-
tosis. We found that a hyperosmotic stress- induced increase in PS exposure was 
associated with an increase in antibody-induced phagocytosis of stored RBCs 
by human monocyte-like THP1 cells (Table 2.1). Thus, a stress-induced alteration 
in passage through the spleen may be functionally associated with increased 
phagocytosis. 
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FIGURE 2.2 Effect of storage time and stress on osmotic fragility as measured with osmotic 
gradient ektacytometry. Osmotic gradient ektacytometry, i.e. RBC deformability measured during a 
gradient of increasing osmolality (osmoscan) was performed using a the new LORCA MaxSis (see also 
the legend to Figure 2.1). Osmoscans of fresh RBCs, RBCs with a storage time of 2 weeks and RBCs with 
a storage time of 5 weeks were acquired after overnight incubation in normal Ringer (control) or hyper-
osmotic Ringer (stress) at 37°C (36, 245).  
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TABLE 2.1 The effect of osmotic stress on antibody-induced phagocytosis.
ANTI-RH D ANTIBODY % PHAGOCYTOSIS
control stress
0 0.0 0.0
1:25 3.7 5.9
1:5 11.6 17.2
1:1 21.7 30.5
RBCs (2x106) that had been incubated in iso-osmotic (control) or hyperosmotic medium (stress) were 
opsonized without (0) or with anti-Rhesus D antiserum in various dilutions (1:1, 1:5, 1:25), labeled with 
CFSE and co-incubated with THP1 cells (1x105) at 37oC in a 5% CO2-incubator for three hours. After 
removal of the non-phagocytized RBCs with NH4-lysis buffer and washing at 4
oC, Fc receptors were 
blocked with PBS containing one percent pooled human serum. The percentage of THP1 cells that had 
phagocytized RBCs was determined by flow cytometry. Anti-CD235a antibody staining was used to 
discriminate between RBC adhesion and uptake. CFSE+ CD235a- events were considered to be THP1 cells 
that had phagocytized RBCs.
FIGURE 2.3 Perfusion of stored RBCs through a spleen-mimicking device. RBCs were obtained 
from whole blood or from blood bags stored for two and four weeks. A suspension consisting of approx-
imately 5% CFSE-labeled RBCs incubated overnight in normal Ringer (control) or hyperosmotic Ringer 
(stress) and 95% untreated/unlabeled RBCs was passed through a bead-sorting device at a flow rate 
of 60 mL/h (78). Flow cytometry was used to determine the percentage of labeled cells in the initial 
upstream sample, in the sample retrieved from in between the beads, and in the downstream fractions. 
The percentage of CFSE-labeled cells in the upstream samples was set at 5% and the retained and down-
stream samples were corrected accordingly.
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Storage, deformability, proteomics 
and metabolomics 
The presently available data, confirmed and extended by our own preliminary 
data using the spleen-mimicking device and osmoscan, suggest that the most 
pronounced effect of the changes RBCs undergo during blood bank storage may 
not only be a decreased deformability in the circulation, but also a decreased 
capacity to pass through the spleen. Since the spleen facilitates vesiculation 
and thereby possibly the removal of damaged membrane patches enriched in 
removal signals (252, 253), this may result in accelerated removal of stored RBCs. 
Also, a comparison of the osmoscan (Figure 2.2) and spleen-mimicking device 
data (Figure 2.3) indicates that the decrease in MCHC during the first weeks of 
storage, that by itself would result in an increase in deformability, is not a major 
determinant of changes in deformability of transfused RBCs in all relevant phys-
iological conditions.
Therefore, identification of the storage-associated alterations in the interaction 
between the cytoskeleton and the lipid bilayer that determine membrane elas-
ticity, may be instrumental in identifying the processes that trigger deformabili-
ty-linked removal of transfused RBCs. In most recent theories on the function-
ally relevant changes in the membrane composition of stored RBCs, alterations 
in band 3 occupy a central position. Storage-associated breakdown as well as 
aggregation of band 3 have been observed by biochemical and immunochemical 
analysis (9, 28, 33, 144, 177). Together with proteomic data, these analyses show 
that breakdown of band 3, ankyrin and spectrin, and membrane accumulation 
of hemoglobin occur mainly after three weeks of storage, but that the effect of 
these processes are already detectable within the first two weeks of storage (38, 
59, 177). The proteomic data also emphasize the importance of the 'repair and 
destroy' proteins that protect against oxidative stress and unfolding (104), and 
warrant a closer, experimental look at the changes in membrane-bound chap-
erone proteins, proteasome components, and small G proteins already observed 
in the first weeks of storage (38).
Already during the first days of storage, signs of oxidation are observed in the 
cytoskeletal proteins 4.2 and 4.1, spectrin, and in band 3. These are followed 
by breakdown of actin, GAPDH, band 4.9 and ankyrin, as well as crosslinking 
of spectrin (61). These data indicate that oxidative damage of membrane and 
membrane-associated proteins may precede proteolysis.
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Thus, an oxidation-induced alteration of the linkage between membrane and 
cytoskeleton is a possible molecular mechanism causing the observed changes 
in deformability as revealed by the osmoscan and spleen-mimicking device data 
that warrants further investigation. Oxidation may influence the phosphoryla-
tion status of band 3, and thereby affect the interaction between membrane and 
cytoskeleton (196, 197). Recent research on signaling in RBCs strongly suggests 
that a change in the interaction between integral membrane and cytoskeleton 
proteins, possibly caused by decreased phosphorylation, is the most likely reason 
for the early storage-associated susceptibility to the osmotic stress-induced 
decrease in deformability. Casein kinase II-catalyzed phosphorylation of beta 
spectrin and protein kinase C-catalyzed phosphorylation of protein 4.1 are asso-
ciated with a complement receptor-mediated increase in deformability (103). 
These data confirm the involvement of serine phosphorylation of spectrin in the 
mechanical properties of the RBC membrane (172). Phosphorylation of band 4.1 
promotes dissociation of actin from the cytoskeleton, also contributing to an 
increase in deformability (74, 171). Also, Lyn and/or Syk-catalyzed tyrosine phos-
phorylation of the cytoplasmic domain of band 3 is associated with a decreased 
binding of the band 3 with the cytoskeleton, and with a 'vesiculating' morphology 
(95). Syk has a high preference for oxidized band 3 (197), which may be rele-
vant in view of the early oxidation events during storage (61). Recent (phospho)
proteomic-inspired data show an association between Lyn signaling and altered 
cytoskeleton-membrane interaction, resulting in an abnormal cell shape (71).
Also, altered phosphorylation may be responsible for the metabolic changes, 
such as the recently described increase in glycolytic intermediates within the first 
two weeks of storage (59, 102). The rate of glycolysis is influenced by the stor-
age-associated decrease in pH and NAD+, but we postulate that the metabolic 
changes are mainly due to alterations in band 3 structure and function. The cyto-
plasmic domain of band 3 has a high affinity for key enzymes of the glycolysis, and 
binding is regulated by phosphorylation (46, 163).
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Conclusions and perspectives
The published data together with our results presented here support the theory 
that phosphorylation-driven changes in the RBC membrane during blood bank 
processing and especially in the first two weeks of storage are responsible for 
the accompanying changes in deformability. After 14 to 21 days of storage, func-
tionally relevant molecular changes are likely to become irreversible, since they 
comprise progressive proteolysis and vesicle formation. Uncovering the trig-
gering events and the underlying signaling pathways will be instrumental in under-
standing and preventing the untimely disappearance of a considerable fraction 
of the transfused RBCs within the first hours after transfusion.
In our perspective, the most fruitful approach to elucidate the basis for reduced 
RBC survival after transfusion starts with investigating the effects of signal-
ing-based manipulation of RBCs in vitro on functionally relevant parameters. 
These parameters should be informative on the activation of, and recognition 
and removal by the immune system, on deformability in the capillaries and in 
the spleen, and on the susceptibility to osmotic stress, as may be critical during 
passage of transfused RBCs through the kidneys (36, 149). Proteomics and 
metabolomics will be instrumental in analyzing the accompanying changes in 
membrane structure. The main challenge is the development of biologically rele-
vant read-out systems, and the transition of blood bank research from quality 
control in the blood bag to quality control in the patient.
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Abstract 
Red blood cells (RBCs) undergo extensive deformation when travelling through 
the microcapillaries. Deformability, the combined result of properties of the 
membrane-cytoskeleton complex, the surface area-to-volume ratio and the 
hemoglobin content, is a critical determinant of capillary blood flow. During 
blood bank storage and in many pathophysiological conditions, RBC morphology 
changes, which has been suggested to be associated with decreased deforma-
bility and removal of RBC. While various techniques provide information on the 
rheological properties of stored RBCs, their clinical significance is controversial. 
We developed a microfluidic approach for evaluating RBC deformability in a phys-
iologically meaningful and clinically significant manner. Unlike other techniques, 
our method enables a high-throughput determination of changes in deforma-
tion capacity to provide statistically significant data, while providing morpho-
logical information at the single cell level. Our data show that, under conditions 
that closely mimic capillary dimensions and flow, the capacity to deform and to 
relax are not affected during storage in the blood bank. Our data also show that 
altered cell morphology by itself does not necessarily affect deformability.  
41
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Introduction
During its life span of approximately 120 days, a red blood cell (RBC) makes about 
160,000 round-trips between the lungs and the tissues (110). Its high flexibility 
enables passage through microcapillaries, some of which have a diameter smaller 
than the RBCs themselves, thereby ensuring transport of oxygen and carbon 
dioxide throughout the body. Within the microcapillaries, RBCs repeatedly 
change from a discocyte shape to an axisymmetric bullet-like shape, depending 
on the flow properties and microcapillary diameter, and back to a discocyte 
shape within the venules (234). This extensive deformation and relaxation, which 
is a critical parameter of the blood flow, is the combined result of the elastic 
properties of the membrane-cytoskeleton complex, the surface area-to-volume 
ratio and the viscosity as determined by the hemoglobin content (183).
During storage in the blood bank, RBCs undergo several structural and func-
tional changes (120). Some of these changes are likely to induce the clearance 
of up to 30% of the transfused RBCs from the circulation within 24 hours after 
transfusion (167). One possible explanation for this disappearance may be a crit-
ical decrease in deformability during storage (54, 98), which could lead to a 
decrease in the capacity to pass the narrow inter-endothelial slits in the spleen, 
and a concomitant increase in susceptibility to phagocytosis (66). Also, various 
RBC-centered pathophysiological conditions that are associated with micro-
vascular disorders are associated with altered RBC deformabilty (48, 181, 186). 
However, little is known on the underlying molecular mechanisms.
A number of techniques have been developed to quantify RBC deformability. 
The available methods can be divided into two categories: single-cell tech-
niques, such as micropipette aspiration and optical tweezers, and measurement 
on whole blood or diluted RBC suspensions, such as filtration and ektacytometry 
(190). Single-cell techniques, while precise, make it difficult to obtain statistically 
significant data, whereas the RBC suspension techniques impose flow geome-
tries that are far from those actually experienced by RBCs in human capillaries. 
Also, these techniques are only able to measure flow behavior of populations 
or endpoint results. Because of these limitations, these techniques have yielded 
confusing and sometimes even conflicting results (5, 117, 119, 183). The perfusion 
of RBCs through microcapillaries provides an alternative and more direct means 
to address RBC deformability (151, 237). Most work in this area so far has focused 
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on understanding the physical rather than the biological aspects of RBC deform-
ability (40, 236, 237, 257). Therefore, we developed a microfluidic system for the 
study of red blood cell flow behavior in a microcirculation-mimicking network. 
In addition to assessing deformation in microchannels with dimensions similar to 
those of microcapillaries, we also monitored relaxation to the discocyte shape. 
Using high-temporal resolution imaging, we could record time-lapse videos of 
RBCs in the narrow channels and the relaxation zones. Deformation and relax-
ation were analyzed by automated image processing that provides statistically 
significant data. This approach enables to address the effect of heterogeneity 
within the RBC population. The visual aspect of our approach makes it possible 
to relate the relaxed morphology to the deformed state on the single cell level. 
These characteristics make our microfluidic system useful not only for identifi-
cation of the molecular determinants of RBC deformability, but also for evalua-
tion of the effect of RBC pathology (abnormal hemoglobins, membranopathies 
and enzyme deficiencies) on the microcirculation, and of the consequences of 
pathological conditions such as systemic inflammation or cardiovascular disease 
on RBC deformability. 
After establishing the conditions to measure RBC deformability in a physio-
logically meaningful and clinically significant manner, we studied the associa-
tion between blood bank storage and deformability, since this could serve as a 
possible explanation for the considerable loss of RBCs shortly after transfusion, 
and for the mostly unknown relationship between blood bank quality parameters 
and RBC function and behavior after transfusion (120, 167).
                             
Materials and methods 
Ethics statement
All procedures followed were in accordance with the ethical standards of the 
committee on human experimentation (CMO NL nr.: 45934.091.13). Written 
informed consent was obtained from all blood donors participating in this study. 
RBC sample preparation
Experiments were performed with RBCs from five transfusion units that had been 
collected, processed and stored following standard Dutch blood bank proce-
dures, including removal of buffy coat, leukoreduction and storage in saline-ade-
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nine-glucose-mannitol. RBCs were washed to remove medium, plasma, and vesi-
cles using Ringer solution (125 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgSO4, 2.5 
mmol/L CaCl2, 5 mmol/L glucose, 32 mmol/L HEPES/NaOH, pH 7.4) by repeated 
centrifugation (5 min, 1550g). Fresh RBCs were isolated from 5 ml whole blood 
(EDTA), donated by healthy volunteers. RBC fractionation according to cell 
density was performed using a discontinuous Percoll gradient consisting of six 
layers ranging from 40% Percoll to 80% Percoll as described previously (24). 
The RBCs were combined into four fractions: fraction 1, 61% Percoll + 64.5% 
Percoll; fraction 2, 67.5% Percoll; fraction 3, 71% Percoll; fraction 4, 80% Percoll. 
All deformability analyses were performed in Ringer containing 1% bovine serum 
albumin (BSA, Sigma-Aldrich, St. Louis MO, USA).
Treatment of RBCs
In order to investigate the contribution of the various cell components to the 
deformability in our microfluidic system, RBCs were incubated for 20 min at 
room temperature with 0.05% glutaraldehyde (GA), obtained by dilution of a 
25% GA-stock solution (Sigma-Aldrich, St. Louis MO, USA) with Ringer. Alter-
natively, treatment with lysophosphatidylcholine (LPC) (Sigma-Aldrich, St. Louis 
MO, USA) consisted of incubation at room temperature at 10% hematocrit for 
five minutes with 5 to 10 uM LPC in Ringer.
Phosphatidylserine measurements
The percentage of phosphatidylserine (PS)-exposing RBCs, a physiological indi-
cation for the possibly damaging effect of the stress that the RBCs may have 
experienced, was determined as described before (36). In short, RBCs were incu-
bated for 30 min at room temperature in the dark in Ringer with Annexin-V-
FLUOS (1:25, Roche, Basel, Switzerland) to label PS-exposing cells. The RBCs 
were analyzed with a flow cytometer (FACScan, Becton Dickinson, Franklin 
Lakes, NJ), using its accompanying software (CELLQUEST, Becton Dickinson). 
The data were analyzed with Summit 4.3. Results are expressed as percentages 
of Annexin V–positive RBCs.
Microchannel fabrication
Soft lithographic techniques were used to fabricate a microcapillary network of 
10 µm deep channels (Figure 3.1; (255, 256)). The microfluidic device was molded 
against an SU-8 photoresist structure on a  silicon  wafer using a commercially 
available poly(dimethylsiloxane) (PDMS)  silicone  elastomer (Sylgard 184, Dow 
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Corning, USA). The surface of the Sylgard 184 devices was OH-terminated by 
exposure to plasma (Diener electronic, Germany), and was sealed with another 
plasma-treated glass cover slide to yield closed microchannels. The liquids were 
dispensed from plastic syringes (Becton Dickinson), which were connected to 
the microfluidic device by polytetrafluoroethylene tubing (Novodirect, Kehl, 
Germany). 
FIGURE 3.1 Microcapillary network design. (A) Schematic of the whole microfluidic device. (B) Micro-
channel region selected to image RBC deformation and relaxation. Numbers indicate the different spots/
regions of interest within the channel that were used for the analysis of RBC shape change. Scalebar: 
50 µm.
1 2 3 4 5 6 7 8
relaxationdeformation
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Experimental setup and data analysis
For monitoring RBCs in microfluidic flow, cells were diluted to a concentra-
tion corresponding to a hematocrit of 2%. The cells were perfused through 
the microfluidic channels with computer-controlled syringe pumps (neMESYS, 
Cetoni, Germany) to enable accurate, constant volumetric flow rates. Images of 
the field-of-view were recorded (with up to 1250 frames per second) for quan-
titative image processing. Flow of cells was observed through a 100X oil immer-
sion objective (Olympus UPLFLN 100X, N.A. 1.30) using an optical microscope 
(IX71, Olympus B.V., The Netherlands), equipped with a high speed CMOS camera 
(Phantom high speed camera, Vision Research, UK). High quality snapshots of 
RBCs were obtained using a short exposure time down to 10 µs.  In each run, a 
sequence of images of approximately 20,000 was recorded. The videos were 
manually pre-processed with Image J to divide them into separate video files 
for the various regions of interest (ROIs; Figure 3.1B). Hereafter, RBC detec-
tion and DI calculation were performed fully automatically with a custom-written 
MATLAB code. The grey scale video files from Image J are used as input, and the 
output consists of DI values for all detected RBCs in the input files. The auto-
matic RBC detection and DI calculation are split up in seven steps. Each of the 
following steps was performed for each video file individually. First, a subset of 
frames (20 percent) was taken for analysis. Second, background filtering was 
performed on the subset of frames by subtracting an averaged image, based on 
multiple frames. This procedure eliminates static objects, such as the microfluidic 
channels. Third, the grey scale frame images were transformed into binary black-
white images, based on a pre-set grey intensity threshold. Fourth, RBCs were 
detected per frame as white pixel clusters in the black-white images. Fifth, pixel 
clusters representing aggregated RBCs and incomplete RBCs on the edge of the 
field, were excluded automatically from the data set. Sixth, the length, width and 
area were automatically determined for each included RBC (white pixel cluster). 
Seventh, the deformation index (DI), defined as the ratio between the sides (DI = 
length/width) was calculated for each individual RBC.
Statistical analysis
Data analysis was performed using PASW Statistics 18 (IBM, New York, USA). 
All DI values are mean values, calculated from at least 800 events per sample 
(represented by 200-300 cells). A p-value less than 0.05 was considered statis-
tically significant. Differences between the mean values were evaluated using 
one-way ANOVA, followed by least significant difference correction for multiple 
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comparisons. In a first approximation, it was assumed that repeated measure-
ments did not influence the results. Linear regression was applied to verify that 
DI remained constant within the channels. In all cases, the t-test for individual 
regression coefficients showed that the slope did not contribute significantly to 
the linear model and hence could be omitted, leaving a constant value. 
Results
We aimed to measure RBC flexibility in a clinical context and under physiologi-
cally relevant conditions. Therefore, next to assessing the capacity of RBCs to 
deform in narrow channels, we also addressed relaxation upon exit from these 
channels. Furthermore, given the heterogeneity in RBC populations from one 
donor (83, 123), we also aimed to obtain data at a single cell level. In order to 
meet these requirements, we established a microfluidic system with high-speed 
image acquisition and quantitative image analysis (Figure 3.1). The parallel array of 
microfluidic channels not only enhances throughput, but also enables collection 
of sufficient numbers of RBCs for biochemical analysis.
To establish the physiologically relevant conditions for quantitatively assessing 
RBC deformation in flow through narrow microchannels, we examined the effect 
of length and width of the channels, and the flow velocities along these channels. 
A channel length of 1000 µm was selected because at that length all RBCs exhib-
ited the axisymmetric bullet-like shape found in the microcirculation in vivo. The 
deformation channels open into a wider region to allow the cells to relax back 
to their original shape (Figure 3.1). Analysis of the flexibility was performed at 
the exit of the deformation channels, enabling a simultaneous detection of the 
deformation and relaxation of a single RBC.
The RBCs exhibited a bullet-like shape in the deformation part (Figure 3.2). This 
RBC deformation in the narrow channels is expressed as the Deformation Index 
(DI), which is defined as the ratio between the length (A) and width (B) of the 
RBC during flow within this channel (Figure 3.2). In order to mimic flow condi-
tions in vivo, the width of the microchannels was varied. In the smallest channel 
with a width of 7 µm, at a flow rate of 25 µl/h and a flow velocity of 0.63 cm/s in 
the narrow part of the channel, all RBCs showed the typical axisymmetric bullet-
like shape (Figure 3.3) as described in vivo (234). Under these conditions, the flow 
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FIGURE 3.2 Flow of RBCs in microchannels. (A) RBCs flowing inside and just outside microchannels. The 
arrow indicates the direction of the flow. Scalebar: 15 µm. (B) Deformation of the cell is determined in a 
virtual box with length (a) and width (b) and is expressed by the deformation index (DI), that is, the ratio 
between the length and width (a/b). Dots indicate the parabolic flow profile within the microfluidic chan-
nels. (C) Deformed single RBC flowing within the 7 µm channel showing a bullet-like shape. Scalebar: 3 µm.
profile was parabolic and mimicked the normal blood flow in the human circula-
tory system (136, 234) The corresponding shear stress (τ) was calculated using 
the Weissenberg-Rabinowitsch equation: τ = 6Qµ/nWH2 (where Q is the total flow 
rate in µl/h, µ is the viscosity in Pa.sec, W is the width of the channels in µm, H is 
the height of the channels in µm and n is the number of channels. This rheometric 
equation gives the unique relation between the channel wall shear stress and the 
total flow rate for non-Newtonian fluids within rectangular channels (10, 146). 
The shear stress was calculated to be 2.98 Pa, which is in the same range of that in 
human microcapillaries (143, 211). In channels wider than 7 µm, most of the RBCs 
exhibited tumbling behaviors at a flow rate of 25 µl/h (Figure 3.3). 
Deformation of RBCs was also analyzed at flow rates of 50 and 100 µl/h, 
resulting in flow velocities of 1.36 cm/s and 2.51 cm/s in the deformation zone, 
in 7 µm deformation channels. Asymmetric shape deformations were observed 
A
B C
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FIGURE 3.3 Deformation of RBCs exposed to various flow parameters. (A) Channels with widths 
of 7, 10, and 15 µm and a syringe pump flow rate of 25 µL/h, resulting in a flow velocity in the narrow 
channels of 0.63 µL/h, 0.47 µL/h, and 0.29 µL/h, respectively, and in different cell shapes. (B) Behavior 
of cells at higher flow velocities of 1.36 cm/s and 2.51 cm/s (corresponding to pump flow rates of 50 
µL/h and 100 µL/h).
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in channels for flow velocities above 0.63 cm/sec (Figure 3.3), resulting from 
out-of-axis cell position. The behavior of RBCs in 7 µm channels at a flow velocity 
of 0.63 cm/s closely resembled that in the microcirculation in vivo (143, 211, 234). 
Therefore, these conditions were used in further analyses. 
RBCs were analyzed in Ringer solution instead of autologous plasma for ease of 
RBC preparation, and because plasma has a higher risk of clogging the channels; 
this did not lead to significant diffe rences in the deformation index and relax-
ation (DI 1.63 ± 0.29 in Ringer vs. 1.61 ± 0.10 in plasma).
The microfluidic device enables the collection of RBCs for off-line analyses after 
passage through the device. The parallel array of microfluidic channels and a flow 
rate of 25 µl/h enable  the collection of 10 million cells within 20-30 minutes for 
off-chip analysis. PS exposure on the outer membrane is a stress signal which 
facilitates recognition and removal by macrophages (36, 147). We used the 
possibility to collect RBCs after passage through the microchannels in order to 
evaluate any putative artifacts that would hamper the translation of our in vitro 
data to RBC behavior in vivo. Cells were collected at the end of the device and 
stained with Annexin-V. Flow cytometric analysis showed that any mechanical 
stress within the microfluidic device did not cause PS exposure (2.46 +/- 0.01 % 
PS-exposing cells before the passage through channels, compared to 2.24 +/- 
0.01 % after passage). This observation supports the suitability of our set-up in 
mimicking the conditions experienced in vivo.
Using our microfluidics setup, we investigated the effect of storage time in blood 
bank units on deformability and relaxation in a microcapillary-simulating environ-
ment. After transfusion, up to 30% of the transfused RBCs are cleared from the 
circulation within 24 hours, and changes in deformation may contribute to this 
phenomenon (98, 167). RBCs of different storage times were perfused through 
the microfluidic device. In order to compare deformability, the DI of the cells was 
calculated at different locations within the device, in the microchannels as well 
as in the relaxation zone. Our data showed that storage in blood bank conditions 
for up to five weeks (the maximal storage time in the Netherlands) did not lead to 
a significant decrease in the capacity to deform to a bullet shape or to relax to a 
discoid shape afterwards (Figure 3.4). There were no indications for loss of RBCs 
or hemolysis in any of the samples, indicating the absence of a selection bias. 
The relatively large standard deviation suggests a large variation in deformation 
capacity of RBCs from different donors. This was confirmed by frequency distri-
bution analysis of the DI values (Figure 3.5).
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FIGURE 3.4 Deformation and relaxation of RBCs stored for different periods of time. (A) Defor-
mation index of RBCs within the deformation channels (spot 5 in Figure 3.1) and relaxation regions 
(spots 6, 7, and 8 in Figure 3.1). For reasons of legibility the standard deviation, which varied between 
15 and 20%, is not shown. There was no significant change in DI with storage time (P < 0.05). (B) Relax-
ation of RBCs stored under blood bank conditions for different periods of time. The relaxation capacity 
of RBCs is expressed as the ΔDI, that is, the difference in DI in the deformation channel (spot 5 in Figure 
3.1) and in the relaxation region (spot 6 in Figure 3.1). All data are the mean of five different blood bags.
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3.  Microfluidic analysis of RBC deformability
Since the standard deviation within the individual samples also suggested a 
heterogeneous deformation capacity, we postulated that this might be associ-
ated with an heterogeneity in cell morphology. It is known that storage is asso-
ciated with both a decrease in RBC density and an increase in abnormal cell 
morphology (20, 120). Therefore, we measured the deformation behavior of 
RBCs of various densities as obtained by Percoll density separation. Although the 
stored RBCs in the various Percoll fractions had distinct morphologies, with the 
more aberrant cell shapes in the more dense fractions as has also been described 
by others (20), the mean DI of the RBCs did not differ significantly between the 
fractions (data not shown). These data indicate that a non-discocyte morphology 
is not necessarily associated with decreased deformability as measured in capil-
lary-mimicking conditions. 
FIGURE 3.5 Donor heterogeneity in RBC deformability of RBCs. Given is the frequency distribu-
tion of DI for the RBCs from freshly drawn blood from two different donors. Per sample 250–350 events 
are measured.
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Deformability is determined by the elastic properties of the membrane-cytoskel-
eton complex, the surface area-to-volume ratio and the cellular viscosity, mostly 
determined by the hemoglobin concentration. In order to identify the contri-
bution of these factors, we analyzed the deformation of RBCs that had been 
altered with glutaraldehyde or with LPC. Treatment with the fixative glutaralde-
hyde, which diminishes the elasticity of the membrane-cytoskeleton complex, 
has been described to impair RBC filterability (229), whereas incubation with LPC, 
which leads to a decrease in the surface-to-volume ratio, has been described to 
induce an increase in splenic retention ex vivo (214). Most glutaraldehyde-treated 
RBCs kept their fixed morphology in the narrow channels, leading to a deforma-
tion index that was significantly (p < 0.05) different from that of untreated cells 
(Figure 3.6). Control cells relaxed back to their discocyte shape within maximally 
40 ms after exiting from the narrow channels into the wider region of the device, 
while the glutaraldehyde-treated RBCs kept the same fixed morphology also in 
this relaxation zone. The difference in DI for the glutaraldehyde-treated RBCs 
measured in the narrow channel and in the relaxation region is probably caused 
by of the tumbling behavior the cells exert in the relaxation area, where there are 
no physical restrictions. Treatment of RBCs with LPC did not show any signifi-
cant effects on deformation index or relaxation (data not shown), indicating that 
changes in membrane stiffness as induced by glutaraldehyde fixation affect the 
deformation index in the 7 um width microcapillaries, while moderate changes in 
the surface-to-volume ratio do not.
Discussion
Here we demonstrate that high temporal resolution imaging of RBCs at the exit 
zone of narrow channels within a microfluidic device provides comprehensive infor-
mation on their capacity to deform and subsequently relax to a discoid shape. Using 
single-cell imaging, high throughput for statistically significant data was obtained 
by virtue of fully automated image processing. Furthermore, by parallelization of 
several microchannels, sufficient throughput can be generated for off-line anal-
ysis, e.g. using flow cytometry. In addition, the visual aspect of this method makes it 
possible to study subpopulations within one sample, making it an attractive method 
to study red cell pathologies. By analyzing cells at the exit zone of the narrow chan-
nels, a simultaneous detection of a deformed and relaxing RBC can be performed, 
thereby correlating deformation behavior to specific morphology of RBCs in rest.
53
3.  Microfluidic analysis of RBC deformability
It has been postulated that the rapid clearance of up to 30% of transfused RBCs 
might be associated with a blood bank storage-associated reduction in deform-
ability (98, 167). This association would make deformability a valuable param-
eter, not only for evaluating blood bank quality but also to clarify the relationship 
between various clinical conditions and RBC removal. Data on storage-associ-
ated RBC deformability obtained by ektacytometry, filtration and micropipette 
aspiration have yielded conflicting results (5, 16, 17, 92, 117, 119, 183). In contrast 
to these techniques, microfluidics analyzes deformation under conditions that 
mimic microcapillary flow conditions much more closely. The data we obtained 
with our microfluidic analysis strongly suggest that storage in blood bank condi-
FIGURE 3.6 The effect of treatment with glutaraldehyde on deformability and relaxation 
capacity. (A) The deformation capacity of control and glutaraldehyde- (GA-) treated RBC samples as 
measured by the DI. For reasons of legibility the standard deviation, which varied around 15%, is not 
shown. At all spots, the DI of the GA-treated RBCs was significantly different from that of control RBCs 
(P< 0.01); (B) typical cell shapes in control and GA-treated samples in region of interest 5 (deformation) 
and region of interest 8 (relaxation).
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tions is not associated with alterations in deformability capacity of RBCs during 
their passage through the capillary system. Recent microfluidic data obtained 
with a comparable system also showed no significant effect of blood bank storage 
time on deformability, but a decrease in relaxation capacity (258). Interestingly, 
the latter was associated with an increase in the circularity distribution width, indi-
cating that the relaxation capacity is more strongly associated with changes to a 
more spherical cell shape than the deformation index. Also, the data of the glutar-
aldehyde-treated RBCs indicated that an increase in membrane stiffness leads 
to a decreased deformability in the narrow channels. It has been suggested that 
membrane loss by storage-associated vesiculation could be the main factor for a 
decreased deformability of red cells from transfusion units (98). However, the lack 
of an effect of LPC-induced increase in surface-to-volume ratio on the deforma-
tion index or the relaxation index, indicates that moderate changes in surface-
to-volume ratio by itself do not induce any aberrant behavior in microcapillaries. 
This is in line with our observations on the normal behavior of the most dense 
RBCs as obtained by separation on Percoll gradients. Nevertheless, more exten-
sive changes in the surface-to-volume ratio could have an effect in conditions of 
more severe mechanical stress, as experienced by RBCs in the spleen (214). 
Thus, all available data using a capillary-mimicking microfluidic approach suggest 
that the storage lesions, including the altered cell morphology, do not affect 
RBC behavior in the microcapillaries. However, an increased membrane rigidity 
in combination with an increased intracellular viscosity may be responsible for 
decreased capacity to pass through the spleen. These changes may be the effect 
of a vesiculation-induced increase in cellular hemoglobin concentration, and a 
concomitant loss of functional membrane-cytoskeletal anchorage proteins 
during aging in vivo and in vitro (34, 35). The loss of capacity to pass through the 
spleen may be detectable with the - more physically demanding - methods such 
as ektacytometry or the recently described spleen-mimicking device (78). Our 
data strengthen the hypothesis that removal of transfused RBCs is mainly caused 
by the appearance of removal signals.
In conclusion, we show that microfluidics, when geared to flow conditions in 
capillaries, can yield substantial information on RBC deformability. We expect 
this approach to become a valuable tool for providing insights into RBC behavior 
in transfusion and hematological research. Our microfluidic analysis may be 
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especially useful in the elucidation of the biologically relevant factors that are 
responsible for the large variation in the quality of RBC concentrates. In addition, 
our setup may be useful in evaluating the effects of disorders such as cardiovas-
cular disease or systemic inflammation on red blood cell function. 
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Abstract
Background 
During storage of red blood cell (RBCs) before transfusion, RBCs undergo a 
series of structural and functional changes that include the exposure of phos-
phatidylserine (PS), a potent removal signal. It was postulated that, during blood 
bank storage, the susceptibility to stress-induced PS exposure increases, thereby 
rendering a considerable fraction of the RBCs susceptible to rapid removal after 
transfusion.
Study design and methods
RBCs were processed and stored following standard Dutch blood bank proce-
dures. Samples were taken every week for up to 6 weeks and exposed to various 
stress conditions, such as hyperosmotic shock and energy depletion. The effect 
of these treatments on PS exposure was measured by flow cytometric analysis 
of annexin V binding. The same analyses were performed on RBCs that had been 
separated according to density using discontinuous Percoll gradients.
Results 
During storage under blood bank conditions, RBCs become increasingly suscep-
tible to loss of phospholipid asymmetry induced by hyperosmotic shock and 
energy depletion. Especially the RBCs of higher densities, that have a smaller 
volume and an increased HbA1c content as is typical of aged RBCs, become 
increasingly susceptible with storage time.
Conclusions 
During storage, RBCs develop an increased susceptibility to stress-induced loss 
of phospholipid asymmetry that is especially associated with an aging phenotype. 
This increased susceptibility may be responsible for the rapid disappearance of 
a considerable fraction of the RBCs during the first 24 hours after transfusion.
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Introduction
During storage of red blood cells (RBCs) before transfusion, RBCs undergo 
a series of structural and functional changes. These include the loss of discoid 
morphology, changes   in membrane organization as deduced from quantitative 
and qualitative data on membrane protein composition, decreases in the concen-
tration of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate acid, vesicle 
formation, and eventually lysis (29, 35, 122, 125). Although most of these changes 
are reversible in vitro, a considerable number of RBCs disappear from the circula-
tion within the first hours after transfusion, even after less than 1 week of storage, 
during which these “storage lesions” are barely detectable (137). Thus, it has 
been postulated that RBCs undergo more subtle damage during processing and 
storage, such as glycation or oxidative damage to proteins and lipids, resulting in 
the exposure of efficient removal signals. These may be neoantigens that are iden-
tical or related to physiological aging antigens on the integral membrane protein 
Band 3 and that are responsible for physiological immune recognition and removal 
of old RBCs in vivo (167). Alternatively, storage-associated loss of phospholipid 
asymmetry may result in exposure of phosphatidylserine (PS), an effective signal 
contributing to the recognition and phagocytosis of apoptotic cells and cell frag-
ments (91). PS exposure has been implicated in removal of damaged RBCs (147).
Indications for both processes have been described in various blood bank storage 
conditions. However, a significant increase in binding of autologous antibodies and 
PS exposure was detectable only after prolonged storage periods and on much 
smaller cell numbers than the up to 25% that are removed from the circulation 
within the first 24 hours after transfusion (29, 35, 243). Thus, we postulate that 
blood processing and/or storage induce an increased susceptibility to the gener-
ation or exposure of these removal signals after transfusion. Numerous data have 
been presented indicating a signaling complex leading to exposure of PS by RBCs 
subsequent to various forms of stress, such as hyperosmotic shock, oxidation, or 
energy depletion in vitro (149). Some of these “near-physiological” stress condi-
tions, such as an increase in the osmotic value of the surrounding medium, are 
likely to be experienced by RBCs in vivo during their passage through the kidney 
(149). Therefore, we investigated the susceptibility of RBCs to stress-induced PS 
exposure during their storage in blood bank conditions. We also investigated the 
association of PS exposure during storage with other variables of RBC aging in 
vivo, such as cell density, cell volume, and HbA1c content.
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Material and methods
Experiments were performed with RBCs from five RBC units of blood group 
A, Rhesus-positive donors that had been collected and processed according to 
standard Dutch blood bank protocols, including leukoreduction and storage in 
saline-adenine-glucose-mannitol. The concentrates were sampled every week. 
Samples of 2 to 5 mL were taken aseptically, and RBCs were washed to remove 
medium, plasma, and vesicles using Ringer’s solution  (125 mmol/L  NaCl,  5 
mmol/L  KCl,  1 mmol/L   MgSO4, 2.5 mmol/L CaCl2, 5 mmol/L glucose, 32 mmol/L 
HEPES/ NaOH, pH 7.4) by repeated centrifugation (5 min, 1550 x g, 4°C). All 
experiments were performed in Ringer’s solution. Where indicated, osmolarity 
was increased by adding 400 mmol/L sucrose; extracellular Cl- was removed by 
replacing NaCl, KCl, and CaCl2 with Na-gluconate, K-gluconate, and Ca-gluco-
nate, respectively; for energy depletion, glucose was omitted from the buffer.
RBC fractionation according to cell density was performed using a discontin-
uous Percoll gradient consisting of six layers ranging from 40% Percoll (1.060 
g/mL) to 80% Percoll (1.096 g/mL) as described previously (24). The RBCs were 
combined into four fractions: Fraction 1, 61% Percoll + 64.5% Percoll; Fraction 2, 
67.5% Percoll; Fraction 3, 71% Percoll; and Fraction 4, 80% Percoll (Figure 4.1).
The relative content of the hemoglobin (Hb) subfractions was determined by 
means of ion-exchange high- performance liquid chromatography, after lysis of 
100 mL of RBCs in 10 mmol/L malonic acid, 1 mmol/L NaCN, 15 mmol/L NaNO3, 
and 0.1% saponin for 30 minutes at 37°C and removal of cell debris by centrifu-
gation for 30 minutes at 10,000 x g (251).
The stress treatments consisted of incubation of the RBCs at 4% hematocrit in 
a 96-well plate (U-form, Greiner Bio-One, Frickenhausen, Germany) in 200 mL 
of Ringer’s solution with or without 400 mmol/L sucrose or without glucose or 
chloride (see above) for 24 hours at 37°C in a humidified incubator. After this 
incubation, the RBCs were resuspended by gentle pipetting and 20 mL of the 
cell suspension was washed in 1 mL of Ringer’s solution by centrifugation (5 
minutes, 1550 x g, 4°C). The RBC pellet was resuspended in 100 mL of Ringer’s 
and incubated for 30 to 60 minutes at room temperature in the dark with fluo-
rescein isothiocyanate–labeled annexin V (1:25, Roche, Indianapolis, IN) to label 
exposed PS, with phycoerythrin-labeled CD235a (mouse IgG1, Clone 11E4B-7-6, 
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1:25, Beckman Coulter, Brea, CA) to label RBCs and with CD41-PC5 (Clone HIP8, 
1:10, BioLegend, San Diego, CA) to label platelets (PLTs). As a positive control for 
annexin V binding, RBCs were incubated with the calcium ionophore A23187 (2.5 
mmol/L) for 45 minutes at 37°C. After being washed, the RBCs were analyzed 
with a flow cytometer (FACScan, Becton Dickinson, Franklink Lakes, NJ) and 
with its accompanying software (CELLQUEST, Becton Dickinson). Results are 
expressed as percentages of annexin V–positive RBCs.
Results
The percentage of PS-exposing RBCs may not only be a measure of the extent 
of cell damage during storage, but also be an indication for the propensity of the 
RBCs to be phagocytosed after transfusion (147, 149). During storage of RBC 
concentrates under blood bank conditions, the percent- age of PS-exposing 
RBCs increased from 0.16% to 5.32% after 6 weeks (Figure 4.2), confirming 
previous data obtained with human RBCs in various storage media (65, 101, 243). 
This increase was not caused by a putative increase in the number of aggregating 
RBCs, as only  events  within the RBC size range were gated (Figure 4.3A). In addi-
A B
FIGURE 4.1 Percoll fractionation of stored RBCs. RBCs from 1-week-old (A) and 6-week-old (B) 
RBCs were fractionated by discontinuous Percoll gradients and Fractions 1 (61% + 64.5% Percoll), 2 
(67.5% Percoll), 3 (71% Percoll), and 4 (80% Percoll) were combined.
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tion, the PS-exposing RBCs were slightly smaller than those without PS (median 
forward scatter, 480 vs. 529; Figure 4.3A). Furthermore, PLTs were excluded as 
a source of annexin V–positive events (Figure 4.3B). Also, these numbers were 
not significantly altered after rejuvenation of the RBCs by incubation of up to 
24 hours in autologous plasma or Ringer’s solution (data not shown). However, 
with increasing storage time, maintenance of phospholipid asymmetry became 
much more susceptible to hyperosmotic shock, especially after 3 weeks of 
storage (Figures 4.2 and 4.3). The flow cytometry plots indicate that the effect 
of hyperosmotic shock on PS exposure is similar to that of an artificial increase in 
the intracellular calcium concentration (Figures 4.3E and 4.3F), as has been used 
to induce RBC death in vitro (149). Hyperosmotic shock induced more PS expo-
sure than energy depletion, whereas removal of chloride barely had any effect 
(Figure 4.2). Notably, the absence of chloride protected 3-week-old RBCs against 
the PS-exposing effect of hyperosmotic stress, but not RBCs of shorter storage 
times (data not shown). After the fourth week, the susceptibility to osmotic stress 
continued to increase, whereas the susceptibility to energy depletion did not 
increase any further (Figure 4.2). In all stress conditions, the maximal PS expres-
sion was reached after 18 hours of incubation and was completely reversible upon 
incubation of the RBCs with normal Ringer’s for 4 hours at 37°C (data not shown).
FIGURE 4.2 RBC susceptibility to stress-induced exposure of PS during storage in blood bank 
conditions. RBCs were stored using standard Dutch blood bank conditions, and their PS exposure was 
determined by flow cytometry using fluorescently labeled annexin V before and after stress. Each point 
represents the mean percentage annexin V–positive RBCs from five different transfusion units ± SD. 
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FIGURE 4.3 Flow cytometry analysis of PS exposure on stored RBCs. RBCs were stored for 4 weeks 
and examined by flow cytometry as described under Materials and Methods and in the legend to Figure 
4.2. (A) Side scatter (SSC) versus forward scatter (FSC) plot showing the gate used for fluorescence 
analysis; (B) double labeling with anti-CD235a and anti-CD41 showing the virtual absence of PLTs; (C) 
negative control; (D) annexin V binding to untreated RBCs; (E) annexin V binding after treatment with 
calcium ionophore A23187; (F) annexin V binding after hyperosmotic stress. Annexin V-positive RBCs 
are shown in red. AV-F = annexin V-FITC; PE = phycoerythrin.
A
C
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Since the enzymes and transport systems involved in maintenance of phospho-
lipid asymmetry may be differentially affected by pH (243), we determined the 
effect of pH on the stress susceptibility of PS exposure. After all storage periods, 
a pH of 6.5 - which is the pH after prolonged storage (219) - led to an increase 
in the number of PS-exposing RBCs before and after osmotic stress, whereas a 
pH of 8.2 protected against stress-induced PS exposure, especially after the first 
week of storage (Figure 4.4). The PS-exposing effect of pH 6.5 increased during 
the first 3 to 4 weeks of storage and decreased again in the fourth and fifth 
weeks (Figure 4.4). Identical effects of pH were observed after energy depletion 
(data not shown).
The RBC population in a blood bag consists of cells of all ages, including RBCs 
that have exceeded their maximal life span in vivo, and this heterogeneity may 
be responsible for the variability in many storage-associated biochemical and 
biologic changes. Fractions enriched in RBCs of various ages can be obtained 
by Percoll density separation (24). Therefore, we separated RBCs of various 
storage periods according to cell density and combined these into four  fractions 
(see   Materials   and   Methods).  In RBCs of all storage periods, increased cell 
density was associated with a decreased mean corpuscular volume (MCV) and an 
increased HbA1c content (Table 4.1). Semi-quantitative image analysis indicates 
a storage-associated, gradual decrease in cell numbers of approximately 20% in 
Fractions 1 and 2 with a concomitant increase in Fractions 3 and 4 (Figure 4.1). 
Also, the HbA1c content of all fractions increased with storage time (Table 4.1). PS 
expression increased with increasing cell density especially after osmotic stress 
and to a lesser extent after energy depletion (Figure 4.5). Longitudinal experi-
ments showed that all fractions became more susceptible to stress-induced PS 
expression during the first 2 to 4 weeks of storage, but maximal PS exposure was 
reached sooner in the more dense fractions (Figure 4.6).
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FIGURE 4.4 Effect of pH on RBC susceptibility to osmotic shock–induced PS exposure during 
storage. The effect of pH on the susceptibility to hyperosmotic stress–induced PS exposure (stress) was 
determined by performing the stress treatment in medium of pH 6.5, pH 7.4, and pH 8.2, respectively. 
The effect of pH 7.4, the standard pH, is shown in Figure 4.2. Each point represents the mean percentage 
annexin V–positive RBCs from five different RBC units ± SD. 
FIGURE 4.5 Susceptibility to stress-induced PS exposure of stored RBCs of various densities. 
RBCs from five RBC units that had been stored for 3 weeks were separated according to density into 
four fractions, and the susceptibility of each fraction to stress-induced PS exposure was determined as 
described under Materials and Methods section.
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TABLE 4.1  Characteristics of the Percoll fractions
Fraction
HBA1C (%)
MCV (fL) 1 week 5 weeks
1 83 4.2 5.1
2 81 4.7 5.4
3 79 5.0 5.9
4 75 5.2 5.8
RBCs from 5-week-old RBCs were fractionated by discontinuous Percoll gradients, and MCV and 
glycated Hb (HbA1c; expressed as percentage of the total Hb content) were determined as described 
before (251).
FIGURE 4.6 Storage time–associated and cellular density–related changes in susceptibility to 
stress-induced PS exposure. During storage, RBCs from five RBC units were separated according to 
density into four fractions each week, and the susceptibility of each fraction to stress-induced PS expo-
sure was determined as a function of storage time. Data are shown as the mean ± SD of the percentage
annexin V–positive RBCs in each fraction. For the sake of clarity, only the data of fraction 2 and frac-
tion 3 are presented. The kinetics of the RBCs of fraction 1 were comparable to those of fraction 2, and
the kinetics of the RBCs of fraction 4 were similar to those of fraction 3. 
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Discussion
The data presented here show that, during storage under blood bank conditions, 
some RBCs lose the capacity to maintain an asymmetric phospholipid distri-
bution in their plasma membrane, as indicated by a storage period–associated 
increase in the percentage of RBCs that expose PS. This is probably due to a small 
but reversible decrease in aminophospholid translocase activity during storage, 
in combination with a virtually absent scramblase activity (243).  This percentage 
does not exceed 5% of the total number of RBCs, even after 1 week beyond the 
maximal storage periods. Furthermore, restoration of ATP levels did not affect 
these numbers, but increased pH did (Figure 4.2 and 4.4), confirming earlier 
data (243). Thus, not only during aging in vivo (253), but also during storage, the 
majority of the RBCs are very proficient in preventing the accumulation of PS, 
even in circumstances in which the “storage lesions” become quite severe (122, 
125, 243). 
There is a conspicuous discrepancy between the apparently severe morphologic 
lesions and the low content of removal signals, such as PS, on the one hand, 
and the fast removal of up to 30% of the RBCs after transfusion on the other 
hand (137). The data we present here show that, during storage in routine blood 
bank conditions, RBCs become increasingly susceptible especially to hyperos-
motic shock–induced PS exposure. Preliminary data suggest that this increase 
in susceptibility starts early during blood processing, either due to the biochem-
ical stress upon the transfer of RBCs from plasma to the storage medium and/
or due to the mechanical stress during the separation of the blood components. 
The PS-inducing effect of glucose depletion, which results in a rapid decrease 
in ATP concentration (243), was much less effective than hyperosmotic shock, 
and removal of extracellular chloride even resulted in a decrease in PS exposure 
(Figure 4.2). This is in contrast to the approximately equal effects of these treat-
ments on freshly isolated RBCs (149), which implies that energy depletion and 
osmotic stress–induced shrinkage initiate parallel, not sequential mechanisms. 
The adaptation of RBC ion and water transport to the storage medium may 
expose this divergence. It has been shown that the activity of aminophospholipid 
translocase, one of the enzymes involved in PS transport across the membrane, 
decreases with decreasing pH (243). The PS-exposing effect of low pH, in combi-
nation with the protective effect of a higher pH on stress-induced PS expression 
(Figure 4.4), suggests that especially this enzyme may become inactivated by 
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hyperosmotic conditions. The decrease in the effect of low pH after 4 weeks of 
storage (Figure 4.4) may be caused by storage-associated changes in the char-
acteristics of aminophospholipid translocase. 
During aging in vivo, RBCs discard damaged membrane patches enriched in 
removal signals in the form of vesicles, which is postulated to prevent untimely 
removal of otherwise functional cells (253). The same process may occur during 
storage, since the vesicles that accumulate in transfusion units almost all expose 
PS, contain IgG, and are enriched in senescent cell antigen-related Band 3 
epitopes (29, 38). The kinetics of the susceptibility to energy depletion, chloride 
removal, and pH all suggest that RBCs undergo crucial changes after 3 weeks 
of storage. Around the same time, the protein composition and immunologic 
activity of the RBC membrane undergo major changes, and vesicle production 
increases (29, 35, 38, 144, 219). Thus, the storage-related and density-associated 
changes in the susceptibility to PS exposure may be associated with the capacity 
to generate PS-enriched vesicles. 
The cause of the disappearance of up to 25% of the RBCs from the circulation 
within the first 24 hours after transfusion is unknown. Our present data suggest 
that the increase in susceptibility of RBCs to stress-induced PS exposure during 
blood bank storage may contribute to this fast removal. During its passage 
through the circulation, the RBC encounters deformation-associated mechanical 
stress in capillaries and spleen and osmotic stress during its passage through the 
kidney. Thus, incubation in a hyperosmotic medium in vitro may indeed be charac-
terized as “near-physiological stress” (149). However, in view of its relatively slow 
kinetics, the increased PS expression observed upon hyperosmotic treatment in 
vitro may by itself not be relevant to removal in vivo, but rather expose a flaw in 
membrane organization that has been acquired during storage. The pathological 
situation in the recipient’s circulation may contribute to an increased PS expo-
sure. Increased plasma sphingomyelinase concentrations that are associated with 
many inflammatory conditions may enhance PS exposure (150). Also, the transi-
tion from a highly artificial storage medium to the blood may represent a major 
stress event. 
Removal-prone RBCs may originate from the oldest cells present at the time of 
blood collection. In vivo, RBC aging is associated with a decrease in cell volume 
and an increase in cell density and in HbA1c (24, 251, 253). Increased PS expo-
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sure has been described before in the RBCs with the highest densities, and RBCs 
become more dense with storage time (57, 231, 243). In transfusion units, the most 
dense RBCs do not only have an increased PS exposure, but also an increased 
susceptibility to osmotic stress-triggered PS exposure (Figure 4.5). Also, higher 
cell density is associated with an increased rate of susceptibility during storage 
(Figure 4.6). It is not likely that the increase in susceptibility affects only the very 
old RBCs, since the fraction of RBCs that is removed within 24 hours after trans-
fusion is   much larger than the fraction of the most dense cells. Therefore, we 
conclude that during blood processing and storage in the blood bank, a consider-
able fraction of the RBCs that are not yet physiologically old becomes damaged 
and thereby acquires an increased susceptibility to stress-induced PS exposure. 
The RBCs that are rapidly cleared from the circulation after transfusion are the 
most likely cause of unwanted transfusion reactions, especially in patients who 
are dependent on frequent transfusions. Elucidation of the molecular cause of 
their increased susceptibility to PS exposure and removal may lead to the devel-
opment of methods to prevent their generation or to remove them from the 
blood bag before transfusion.
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Abstract  
The erythrocyte cytoskeleton is composed of a two-dimensional network of 
flexible proteins that is anchored to the cell membrane, and determines cell 
shape. The cytoskeleton also affects the diffusion and distribution of membrane 
proteins and lipids through direct interactions and steric effects. Here, we present 
a unified model which describes how the coupling of the local interactions of the 
cytoskeleton with the bilayer exerts control over the process of membrane vesic-
ulation. In this model, a disturbance of the band 3-ankyrin anchoring complexes 
leads to increased compression and rigidity of the spectrin cytoskeleton, leading 
to buckling of the phospholipid bilayer, resulting in vesicle formation. The predic-
tions of this model on size and protein composition of vesicles are confirmed by 
the available data, especially data of vesicles that are generated during aging in 
vivo and in blood bank storage conditions. Finally, we suggest some future theo-
retical elaborations of this model, as well as the experimental approaches for 
testing it.
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Introduction
Microvesicles, also referred to as microparticles, are fragments that are shed 
from the plasma membrane of stimulated or apoptotic cells. They are associ-
ated with various physiological processes involving intercellular communica-
tion, hemostasis, and immunity. Variations in their number and/or characteristics 
are observed in pathophysiological circumstances. High shear stress, oxida-
tive stress, inflammatory or procoagulant stimulation, and apoptosis all stimu-
late vesicle generation (99, 127, 174). Stimulation leads to a redistribution of lipids 
and proteins in and associated with the cell membrane, leading to changes in 
(the kinetics of) microdomain organization, changes in phospholipid asymmetry, 
cytoskeleton reorganization, and vesicle release. Controlled inclusion or exclusion 
of specific molecule species into these microdomains results in vesicles with a 
particular membrane composition and content (127). This explains how microves-
icles of the same cellular origin may have different protein and lipid compositions, 
be involved in the maintenance of homeostasis under physiological conditions, 
or initiate a deleterious process in case of excess or when carrying pathogenic 
constituents (99, 127). 
Thus, vesicles constitute a disseminated storage pool of bioactive effectors. For 
example, antigen-presenting cells secrete MHC-carrying vesicles that stimu-
late proliferation of T cells (77, 127). Microvesicles that are shed from activated 
platelets expose phosphatidylserine (PS), thereby providing a catalytic surface 
promoting the assembly of the enzyme complexes of the coagulation cascade. 
Furthermore, vesiculation is thought to represent a mechanism to eliminate cell 
waste products. This plays an important role in the problems around the immunity 
of cancer cells, as vesicles may be instrumental in the elimination of membrane 
proteins that are recognized by the immune system, and thereby facilitate escape 
and promote survival. Also, cancer cells may use vesicles to get rid of toxic drugs, 
accounting in part for the resistance to chemotherapy (127). 
Classically, the erythrocyte has always been an important subject in research on 
the structure/function relationship of the plasma membrane, including vesicle 
formation (141). In the last few years, the interest in the ins and outs of eryth-
rocyte vesiculation has increased, since vesiculation plays a role in all stages of 
the erythrocyte life. During erythropoiesis, iron is transported into the eryth-
roblast for hemoglobin synthesis by receptor-mediated endocytosis of vesicles 
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containing complexes of transferrin receptor, transferrin, and iron. At a later 
point in erythroid terminal differentiation, vesiculation plays a crucial role in 
remodeling of the reticulocyte membrane, when a number of integral membrane 
proteins, including the transferrin receptor, are removed from the cell surface 
by exocytosis. Finally, vesiculation of the mature erythrocyte plasma membrane 
is not only an integral part of the physiological erythrocyte aging process but 
also constitutes one of the erythrocyte storage lesions in the blood bank, 
and also plays a role in the pathology of hemoglobinopathies and erythrocyte 
membranopathies (35).
In this chapter, we will present the recent data on erythrocyte microvesicle 
composition, and discuss these in the light of the mechanisms that have been 
postulated on the vesicle generation process. We will try to combine these into 
a new model, and will propose some experimental approaches that could falsify 
and/or refine this theory. In this model, we propose that a crucial role in the 
process of membrane vesiculation is played by the erythrocyte cytoskeleton. 
The erythrocyte cytoskeleton is composed of a two-dimensional network of flex-
ible proteins that is anchored to the cell membrane, and determines the overall 
mechanical properties of the cell (15, 50, 181). On the cell level, this network plays 
a crucial role in determining the overall cell shape (156), by modifying the force 
balance (tension) at the membrane (105, 108). On a more local level, the cyto-
skeleton affects the diffusion and distribution of membrane proteins and lipids 
through direct interactions and steric effects (‘membrane corrals’) (42, 73, 105, 
108, 157). Here, we present a unified model, which describes how the coupling 
of the local interactions of the cytoskeleton with the bilayer can drive and exert 
some control over the process of membrane vesiculation.
The membrane/cytoskeleton model of the 
erythrocyte
During its life, the erythrocyte is squeezed through capillaries that are roughly 
one-third of its diameter, for approximately 100,000 times (170). Therefore, 
the erythrocyte must have a highly deformable as well as stable membrane. 
Membrane deformability gives the erythrocyte the capacity to deal with the 
shear forces in the circulation, and membrane stability provides the capacity 
to circulate without fragmentation. The ability of the erythrocyte membrane 
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to store energy during brief periods of deformation and to return to its orig-
inal shape is associated with the maximal duration of its lifespan of 120 days in 
the human circulation (15, 50). The well-described biochemical characteristics 
of the erythrocyte membrane underlying these unique functional requirements 
have long been instrumental for the development of models of the generic cell 
membrane. 
Phosphatidylcholine (PC) and sphingomyelin (SM) are the dominant lipid compo-
nents of the outer leaflet of the lipid bilayer, and PS and phosphatidylethanol-
amine (PE) are mainly found in the inner leaflet. This asymmetry is under control 
of a flippase, an inward-directed pump specific for PS and PE, an outward-di-
rected pump referred to as floppase, and a lipid scramblase, which catalyzes 
unspecific, bidirectional redistribution of phospholipids across the bilayer. The 
asymmetry may be involved in erythrocyte homeostasis, as PS binds to the cyto-
skeletal components spectrin and protein 4.1 (170). Also, erythrocyte stimulation 
accompanied by a significant, sustained increase in the cytosolic Ca2+ concentra-
tion may lead to a collapse of the membrane asymmetry, with the most prom-
inent change being the surface exposure of PS. PS is a recognition signal for 
macrophages, thereby promoting erythrocyte removal (147).
It was thought for a long time that the plasma membrane is a two- dimensional 
‘fluid mosaic’, and that the membrane proteins are uniformly dispersed in the 
lipid solvent (233). However, in recent years, the existence of other lipid bilayer 
organization states, ‘liquid-ordered’ membranes, became clear (41, 89). These 
regions, also called rafts, are enriched in cholesterol and sphingolipids, making 
them more ordered, less fluid, and more resistant to solubilization by detergents 
than the bulk plasma membrane (89). Rafts are also distinguished by a specific 
assortment of proteins that are anchored by a glycosylphosphatidylinositol (GPI) 
anchor to the outer leaflet, such as acetylcholinesterase (227). Also, at the cyto-
solic side, the proteins stomatin, flotillin-1, and flotillin-2 are concentrated in 
rafts (218). Rafts of different sizes are formed continuously, and their stability is 
a function of size, capture by raft-stabilizing protein, and protein–protein inter-
actions (6, 114).
The main integral membrane protein is band 3, which constitutes 15–20% of the 
total membrane protein, and is present in a monomer/dimer/tetramer equilib-
rium (7). The band 3 molecule consists of three dissimilar, functionally distinct 
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domains. The N-terminal, cytoplasmic domain binds with a variety of peripheral 
membrane and cytoplasmic proteins including some key glycolytic enzymes, 
peripheral proteins ankyrin, protein 4.2, and hemoglobin. The hydrophobic 
transmembrane domain functions as the chloride/bicarbonate exchanger, and 
forms a complex with other integral membrane proteins such as the Rhesus and 
Rhesus-associated proteins, and the glucose transporter. The C-terminal domain 
has a binding site for carbonic anhydrase II. Band 3 is crucial for a proper linking 
of the lipid bilayer to the membrane skeleton, through its interaction with ankyrin 
and binding to protein 4.2. Also, glycophorin C (GPC) functions as a bilayer–
skeleton tethering point via its interaction with protein 4.1 within the junctional 
complex (see below), while glycophorin A (GPA) is partially associated with band 
3 (7, 181).
The cytoskeleton is a filamentous network of peripheral proteins that is composed 
of three principal components: spectrin, actin, and protein 4.1. The cytoskeleton 
consists mainly of polymeric spectrin molecules, which are tied together by actin, 
protein 4.1 at nodes called junctional complexes. The skeleton is highly flexible 
and compressible (181). Spectrin, the main component of the skeleton, is a flex-
ible, filamentous molecule and constitutes 20–25% of the mass of proteins that 
can be extracted from the membrane. Spectrin is composed of two non-iden-
tical subunits (a and ß) intertwined side by side to form a heterodimer. Spectrin 
heterodimers self-associate at one end of the molecule to form tetramers. These 
self-associating heterodimers dominate in the cytoskeleton. At opposite ends, 
the tails of the dimers are associated with short oligomers of actin. The spec-
trin–actin interactions are stabilized by the formation of a ternary complex with 
protein 4.1. Each actin oligomer can bind to six spectrin tetramer ends, thereby 
creating an approximately hexagonal lattice (181).
The structural model of a hexagonal lattice is supported by high-resolution elec-
tron micrographs of isolated membranes (86). In order for the membrane to 
deform in the microcirculation, the skeletal network must be able to undergo 
rearrangement. In one model, deformation occurs with a change in geometric 
shape, but at a constant surface area. In the non-deformed state, the spectrin 
molecules exist in a folded confirmation, but with increased shear stress the 
membrane becomes increasingly extended as some spectrin molecules become 
uncoiled while others assume a more compressed and folded form. When the 
spectrin molecules attain their maximal extension, the limit of reversible deform-
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ability is obtained. Further extension would result in an increase in surface area 
and the breaking of junction points and of the tetramers (8), at which stage 
membrane fragmentation is thought to occur (86).
Mechanical properties of the 
membrane/cytoskeleton of the erythrocyte  
The filamentous spectrin proteins that compose the cytoskeletal net- work each 
have elastic spring-like properties (21, 22, 85, 106). Under moderate extension, 
these molecules behave as soft elastic spring (their elasticity is controlled by 
thermal fluctuations), giving the cytoskeleton network an elastic shear modulus: 
μ ≈ kBT
 / 4rg
2 ≈ 2 x 10-6 J m -2, where kBT is thermal energy and rg
2
 ≈
 13 nm is the esti-
mated radius of gyration of a spectrin tetramer filament in water (85). This shear 
modulus of the erythrocyte depends on the entropic spring constant of each 
filament, and the average connectivity of the whole network. The entropic spring 
constant of each filament is given by: k ≈ 3kBT
 / 4rg
2.  Under normal conditions, the 
spectrin filaments have their ends anchored to the membrane at a distance of 
2r ≈ 80nm on average. This distance is larger than 2rg, and the filaments are under 
extension, experiencing a tensile force: F
cyto
 ≈ ( kBT/rg
 ) ( r / rg-
 1 ). This force of the 
individual filaments, which acts to stretch the spectrin filaments, is acting equally 
to compress the membrane bilayer, until the two components globally balance 
each other (108, 225). Note that there may be also an overall osmotic pressure 
difference across the cell membrane, which stretches both the bilayer and spec-
trin network.
On a local scale, the membrane may slightly bend to balance the compres-
sion force applied on it by the cytoskeleton. Over the whole cell, this compres-
sion means that the cytoskeleton is pulling the membrane inwards, while the 
finite membrane area counteracts this inward-directed force (108). The overall 
compression applied by the cytoskeleton on the membrane is, therefore, a 
function of the proportion of connected filaments, and their average spring 
constant. The bending of the membrane caused by this inward compression can 
be described on the level of the whole cell as an induced spontaneous curvature, 
or equivalently an area difference between the inner and outer leaflets (156). We 
have shown, for example, that the calculated increase in cytoskeletal compres-
sion of the bilayer when adenosine triphosphate (ATP) is depleted, is indeed large 
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enough to drive the discocyte–echinocyte shape transition observed under 
these conditions (22, 108). The effects of the cytoskeleton-induced compression 
of the bilayer on the local scale, where it may affect the vesiculation process, are 
discussed in the following sections.
Various factors can modify the entropic elasticity (spring constant) of the 
individual spectrin filaments: (i) adding or removing a band 3-ankyrin binding 
complex at the filament midpoints results in lowering or, respectively, increasing 
the entropic spring constant (42); (ii) unfolding of the spectrin protein under 
stretching of the cell (such as in shear flow) results in an increase of the molecular 
length (increase of rg
 ) and, therefore, lower tension (86, 134, 153); (iii) complete 
breakup of the spectrin tetramer into two dimers (8), or dissociation of the 
bound spectrin filament ends from the attachments at the actin–band 4.1 anchor 
complex, both result in a vanishing of the elasticity for that filament, since the 
mechanical linkage is broken. In addition to the main anchoring points at the fila-
ment ends (actin–band 4.1 complex) and midpoints (band 3-ankyrin complex), 
the spectrin filaments have interactions with a variety of membrane compo-
nents, that may give rise to further attachment points of the filament to the 
bilayer, of various strength. Examples of such interactions are between spectrin 
and PS, and a variety of raft components such as stomatin (218). Furthermore, 
the close association of lipids with band 3 and spectrin suggests that the lipid 
composition may also affect the stability of the anchoring complexes.
Vesiculation 
In vivo
During the lifespan of the mature erythrocyte, volume and hemoglobin content 
decrease by 30% and 20%, respectively (245). Also, the surface area and lipid 
content decrease by 20%, mainly by the release of hemoglobin- containing 
vesicles. This process occurs throughout the lifespan, but is accelerated in the 
second half, if a functional spleen is present (252). Vesicles are rapidly removed 
by the mononuclear phagocyte system, especially by Kupffer cells in the liver. 
This removal, which occurs very rapidly, is mediated by PS-binding scavenger 
receptors, and probably by autoantibodies as well (254). The presence of the 
latter on vesicles has been postulated to be caused by binding of autologous IgG 
to band 3-derived senescent cell antigens (253). Vesicle formation may serve as 
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a means to dispose of ‘bad’ membrane patches, thereby getting rid of nonfunc-
tional proteins and potentially damaging autoantigens, and simultaneously saving 
an otherwise functional erythrocyte from an untimely death (253). From data 
obtained from patients who had undergone splenectomy, it is clear that the 
spleen plays an important role in vesicle formation, but the mechanism of this 
process is obscure (252).
In transfusion units
Also, vesiculation takes place during storage, resulting in the accumulation of vesi-
cles in erythrocyte concentrates for transfusion, and contributing to irreversible 
cell shape change and membrane changes. The resulting dense, poorly deformable 
spherocytes are presumed to be quickly removed from the circulation after trans-
fusion (179). The lipid component of vesicles might be the stimulus for the activa-
tion of inflammatory genes in leukocytes in the recipient, possibly contributing to 
transfusion-related multiple organ failure (90). Also, removal signals on the most 
damaged erythrocytes and on storage vesicles may lead to an overload of the 
reticulo-endothelial system, and thereby to a depression of the immune defenses 
(125). In addition, a concentration of structurally altered membrane proteins such 
as band 3 on the vesicles in transfusion units could generate non-physiological 
neoantigens that may activate the recipient’s immune system to generate allo-
antibodies and/or autoantibodies, and thereby lead to autoimmune hemolytic 
anemia, especially in transfusion-dependent patients (35).
In vitro
Shedding of vesicles is also observed under other conditions that trigger the 
transition from a discocyte into an echinocyte shape in vitro, such as ATP deple-
tion and Ca2+ loading (1, 3, 189). In these conditions, shedding of vesicles has 
been described to occur at the tip of membrane spicules (112). Also, numerous 
membrane-active compounds, such as detergents, that disturb the lipid organi-
zation of the membrane or agents that affect ion transport across the membrane 
induce vesicle formation (109) .
In patients
Altered vesicle formation has been associated with various abnormal erythro-
cyte morphologies. Spherocytosis is one of the inherited erythrocyte disor-
ders that result from mutations in various membrane and cytoskeletal proteins. 
The affected proteins are mainly ankyrin, spectrin, and band 3, and occasionally 
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protein 4.2 and the Rh protein. These proteins are all part of one of the complexes 
by which the cytoskeleton is anchored to the lipid bilayer (181). Hereditary ellipto-
cytosis is caused mainly by mutations in the spectrins and protein 4.1, leading 
to decreased spectrin self-association and/or weakened junctional complexes, 
thereby decreasing the mechanical stability. Ovalocytosis is caused by a deletion 
in band 3, and is associated with increased membrane rigidity (132). One form of 
acanthocytosis has been linked with a mutation in band 3 (139). Finally, stomato-
cytosis has been thought to result from defects in cell volume regulation, prob-
ably by mutations in as yet unidentified cation transport systems (182). A decrease 
in the capacity to regulate erythrocyte water content and thereby volume and 
morphology has also been implicated in the pathophysiology of hemoglobinop-
athies such as sickle cell disease and thalassemia. In these patients, the blood 
content of erythrocyte-derived vesicles was found to be increased, and related 
to the plasma hemoglobin concentrations (246). Electron micro- graphs show 
that vesicles are formed during spherocyte formation in patients with hered-
itary spherocytosis (88). Also, the erythrocytes of trans- genic mice lacking 
band 3 have a spherocyte morphology, and show prominent vesicle production 
(203). Similarly, mutations leading to defects in the band 4.2 protein also lead to 
breakage of the band 3-ankyrin anchors of the spectrin filaments, and give rise 
to hereditary spherocytosis and vesicle shedding (88, 182). It has been suggested 
that, in patients with spherocytosis, an acceleration of vesicle formation leads to 
a membrane loss that cannot be compensated for by uptake of lipids from plasma 
proteins. The erythrocytes become more and more microspherocytic, and are 
thought to be hemolysed principally by the spleen, a serious anemia being the 
consequence (35, 245). A special case is constituted by patients with neuroacan-
thocytosis. In all manifestations of this syndrome of basal ganglia degeneration, 
structural changes in band 3 are central in acanthocyte formation (27).
Vesicle composition
In vivo
Erythrocyte-derived (i.e., GPA-positive) vesicles obtained from the freshly drawn 
plasma of healthy donors are variable in size (200–800 nm), predominantly right-
side-out, and contain all hemoglobin components in a pattern similar to that 
of old erythrocytes, that is, enriched in modified hemoglobins such as HbA1c 
(252). All the vesicles are positive for the complement- regulating, GPI-anchored 
81
5.  Cytoskeletal control of red blood cell shape 
proteins CD55 and CD59, approximately 40% contain IgG, and 50–70% expose 
PS (252–254). Based on immunoblot analysis suggesting altered band 3 struc-
tures in these vesicles, it was speculated that the IgG is bound to band 3-derived 
senescent cell-specific antigens (253). These data are all confirmed by proteomic 
analysis (Bosman et al., in preparation). Thus, vesicles contain aged cytoplasmic 
hemoglobin as well as aged membrane band 3. The presence of removal signals 
such as senescent cell antigens and PS are likely to be responsible for their very 
fast removal (179, 253). As yet, no data are available on the lipid composition of 
these vesicles.
In transfusion units
In contrast to the scarcity of information on erythrocyte-derived vesicles in vivo, 
many data are available on vesicles that are generated during storage (109). Very 
recently, a combination of proteomic and immunochemical investigations have 
provided an updated structural and functional inventory of the vesicles that orig-
inate during processing and storage of erythrocyte concentrates under blood 
bank conditions (38, 144, 213, 219). These analyses partially confirm earlier data, 
such as a storage-associated increase in (aggregated) hemoglobin in the vesi-
cles, and in aggregated and degraded band 3 in vesicle membranes. The size of 
the vesicles may vary with storage time and storage medium, but most vesicles 
have a diameter of 80–200 nm (144, 219). Vesicles contain hardly any of the 
major integral membrane proteins and cytoskeletal proteins, with the exception 
of band 3 and protein 4.1 (38). The concentration of carbonyl groups in vesicles 
increases with storage time relative to that in erythrocyte membrane fractions, 
indicating the accumulation of oxidized proteins, some of which could be iden-
tified as band 3, actin, and stomatin (38, 144). Storage vesicles have also been 
described to contain proteins that are part of an apoptosis signaling cascade, 
such as Fas and caspase 3 (111). Storage vesicles are enriched in the raft protein 
stomatin, but contain less of the other raft proteins flotillin-1 and flotillin-2 (38, 
219). Storage vesicles expose PS, and contain IgG. Reliable, detailed data on the 
phospholipid composition of vesicles generated in transfusion units are lacking 
(109), but the available data suggest that the phospholipid organization of the 
vesicle membrane is different from that of the erythrocyte, and that it varies 
depending on storage medium and storage time (111) (Bosman et al., unpublished 
observations). Immunoblot analysis of the vesicular proteins that are resistant to 
solubilization by Triton X-100 shows that most of the stomatin and almost all of 
the flotillins are associated with rafts. Also, the GPI-linked proteins acetylcho-
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linesterase and CD55 in vesicles are associated with the vesicle rafts. Band 3 
and the Duffy antigen, previously shown to be present in rafts from erythrocyte 
membranes, were absent from the vesicle rafts (213, 219).
In vitro
Upon an increase of the intracellular calcium concentration by treatment with 
the cation ionophore A23187, a shape change from discocyte to echinocyte 
occurs. Furthermore, microvesicles bud off from the microvillous-like projec-
tions of the echinocytes. Calcium-induced vesicles are depleted of PC, spectrin, 
actin, and glycophorin, while band 3 and  acetylcholinesterase are retained (109). 
Vesicle formation is associated with activation of a calcium-dependent phospho-
lipase C producing 1,2-diacylglycerol, and with translocation to the membrane 
and activation of the protease calpain. There is a significant negative correla-
tion between erythrocyte ATP content and vesicle amount (219). ATP depletion 
induces the same morphological changes as calcium loading, but the protein 
compositions of the vesicles induced by ATP depletion, calcium loading, and 
storage differ (109). The spectrin-free vesicles induced by nutrient deprivation 
bind IgG in much higher quantities than the erythrocytes they are derived from, 
suggesting a selective enrichment of autoantigens in vesicles (188). The raft 
proteins stomatin, acetylcholinesterase, and CD55 are enriched in calcium-in-
duced vesicles, but other raft proteins such as flotillin-1 and flotillin-2 are absent 
(217, 219). Together with the differences in protein and phospholipid composi-
tion as well as in size and shape of vesicles induced by various membrane- active 
compounds such as amphiphiles or lysophosphatidic acid (113, 129), these in vitro 
data emphasize an earlier conclusion that the composition of vesicles differs 
depending on the manner by which they were produced (109). These data also 
support and highlight the theory that multiple pathways are likely to be involved 
in the mechanism of vesicle generation.
In patients
Many data are available on the differences in membrane protein composition 
and/or organization between pathological and healthy erythrocytes, but only 
scarce data are available on the composition of erythrocyte-derived vesicles 
from the blood of inpatients with membranopathies and hemoglobinopathies 
described earlier. These vesicles contain hemoglobin and 50% of these vesicles 
express PS at their surface as do the vesicles in healthy controls. PS exposure 
is associated with a promotion of thrombin generation (219). Erythrocytes with 
83
5.  Cytoskeletal control of red blood cell shape 
sickle cell hemoglobin shed vesicles upon unsickling in vitro. Such vesicles are 
devoid of spectrin, ankyrin, and protein 4.1, and their membranes contain exten-
sive regions of non-bilayer phase regions (2, 247).
Mechanism(s)
A summary of the presently available data on the composition of vesicles as 
compiled above may serve as the framework for our present theory on the 
mechanism by which erythrocytes generate vesicles in health and (erythrocyte) 
disease, and during storage under blood bank conditions. The main character-
istic of all vesicles is the virtual absence of spectrin and ankyrin, the main compo-
nents of the erythrocyte cytoskeleton, and of an intact cytoskeletal spectrin–
actin network. The observation that vesicle membranes are highly enriched in a 
variety of proteins, compared to their concentration in the intact erythrocyte 
membrane, suggests that there is a relationship between their protein composi-
tion and the vesiculation process.
Generically, membrane vesiculation can be achieved either by an asymmetry in 
the membrane leaflet composition that favor membrane curvature, or by the 
generation of forces (e.g. from the cytoskeleton). While the lipid composition of 
the plasma membrane of cells is always asymmetric, the increase of this asym-
metry, for instance under the action of proteins such as flippase, can increase 
steric torques within the bilayer and trigger the formation of vesicles (80, 224).
The cytoskeleton is likely to play an important role in erythrocyte vesiculation. By 
segregating the erythrocyte membrane into ‘‘corrals,’’ the cytoskeleton affects 
both the rate of diffusion of the membrane components, and the physical extent 
of free membrane patches. The spectrin filaments affect membrane proteins 
by steric repulsion, which tends to segregate some proteins away from the fila-
ments, and by attractive interactions with other membrane components, which 
therefore aggregate near the filaments. The result is a mosaic of membrane 
compositions (155), which reflects the network geometry of the cytoskeleton, 
and the chemical affinities of the membrane components (Figure 5.1A). 
The most obvious process driving vesicle formation is the aggregation of 
membrane proteins of specific types that have mutual affinity, forming membrane 
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domains. Membrane domains of a large enough size will spontaneously bud and 
detach as a vesicle when above some critical size, driven by the minimization of 
the line tension along the domain perimeter. The radius of the formed vesicles 
is roughly equal to the spontaneous curvature of the domain components. For 
domains and vesicles of sizes that are very small compared to the typical size of 
the cytoskeleton units, that is, for diameters d « 2r
 ≈ 60-100 nm, the aggrega-
tion-driven vesiculation process can proceed without being necessarily affected 
by the cytoskeleton. This process may result in nanovesicles of a diameter of 
order ˜25 nm (212, 226, 238). In this case, we expect that the domains (and 
resulting vesicles) will have compositions, which differ according to the vesicle 
size, corresponding to the spontaneous curvature of each membrane compo-
nent that tends to form domains. This would explain why vesicles of different sizes 
have very different membrane compositions (38, 217) (Figure 5.1B).
The formation of larger (micro)vesicles, with diameters in the range of 60–300 
nm, most likely involves a local deformation of the spectrin cytoskeleton. The 
challenge is to provide a unified model for the interplay between the process of 
membrane domains aggregation and the bilayer interaction with the erythro-
cyte cytoskeleton. The effects of the cytoskeleton on the bilayer can be divided 
into two types: the chemical binding of the spectrin filaments to the integral 
membrane components and the compressive force that the cytoskeletal network 
exerts on the bilayer. These two effects are coupled to each other, as we discuss 
below.
All vesicles contain band 3, but apparently in a condition that makes it incapable 
of functioning as an anchorage site for the cytoskeleton. Thus, the central event 
in vesicle formation seems to be the breakage of the link between band 3 and 
the spectrin network, the so-called vertical linkage, rather than in the horizontal 
interactions in the spectrin–actin–protein 4.1 ternary complex. The processes 
that lead to a disruption of this linkage may differ, for example, the breakdown 
of band 3 and/or ankyrin by the calcium-activated proteases calpain or caspases, 
triggered by aging-related, apoptosis-like processes (39, 149), or mutation-re-
lated, specific alterations in the structure of band 3, ankyrin, spectrin, or other 
components of the band 3 complex (249). Since the cytoplasmic domain of band 
3 has high-affinity binding sites not only for ankyrin but also for denatured hemo-
globin and for key enzymes of the glycolysis, the oxidation status as well as the 
energy content of the erythrocyte may also affect binding of ankyrin to band 3. 
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FIGURE 5.1 Vesicle formation. (A) Schematic illustration of the erythrocyte cytoskeleton and 
membrane. Black ovals: spectrin end-points anchoring complex of actin-band 4; light-gray ovals: 
midpoint anchoring complex of band 3-ankyrin; black solid lines: spectrin filaments (intact tetramers); 
gray ovals: various membrane proteins and charged lipids that are attracted to the cytoskeleton; gray 
ovals with thick rim: membrane proteins that are repelled from the cytoskeleton. (B) Mobile components 
may aggregate and form domains which leave as nanovesicles of uniform composition and radius, deter-
mined by their spontaneous curvature. (C) Breakage of the midpoint band 3-ankyrin anchors releases 
mobile proteins to form an aggregate, which together with the increased tension leads to budding and 
eventual vesicle detachment (driven by the aggregate line tension) of vesicles that are larger and more 
heterogeneous compared to (B). White ovals: degraded band-3 proteins from the broken anchor point, 
which are mobile and free to aggregate.
Binding and activity of glycolytic enzymes is regulated by phosphatases and 
kinases (46), indicating that signal transduction by intracellular as well as extra-
cellular triggers may influence lipid bilayer–cytoskeleton interaction.
Whatever the cause of the decrease in interaction may be, it has been proposed 
that the degradation of band 3-ankyrin anchoring complexes leads to increased 
compression and rigidity of the cytoskeleton, leading to buckling of the bilayer 
and resulting in vesicle formation (106, 225). These vesicles will bud from the 
free membrane patches that are constrained by the cytoskeletal network (Figure 
5.1C), and therefore have a more heterogeneous composition compared to the 
nanovesicles that form due to a pure aggregation process (Figure 5.1B). Release 
of the spectrin–bilayer anchoring also diminishes the direct chemical interac-
tion between the spectrin filaments and the membrane components, making 
them more mobile and free to aggregate (Figure 5.1C). We therefore propose 
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that both an increased cytoskeleton rigidity and the release of mobile membrane 
components drive the formation of microvesicles in response to degradation of 
the spectrin–bilayer anchoring through the band 3-ankyrin complex.
We start with the relationship between the elastic rigidity of the spectrin fila-
ments and the removal of the midpoint anchoring (Figures 5.1C and 5.2). The 
effect of the latter can be understood as a direct manifestation of the entropic 
nature of the elasticity of the spectrin filaments; the larger the configu-
rational entropy of the flexible proteins, the larger the spring constant of 
this filament, and therefore decreasing this configurational entropy by the addi-
tion of midpoint anchoring leads to a lower elasticity. The increased cytoskele-
ton-induced tension when the midpoint anchoring is removed can be demon-
strated by the following estimate of this force; F
cyto
 ≈ ( kBT/rg
 ) ( r / rg-
 1 ). When the 
midpoint anchor is present, the effective r becomes half that of the end-points, 
and similarly rg is reduced by a factor of ˜ √2  (for pure Gaussian chains). If we 
use the values for r and rg given above for the spectrin network of the erythro-
cyte, the reduction in the tension can be estimated to be of order 2. Another 
demonstration of the effect of anchoring on the spring constant of the filament 
is by considering the theoretical limit of many anchoring points, such that the 
filament becomes effectively two- dimensional, moving only in the plane of the 
bilayer (Figure 5.2C). Using the description of a Gaussian chain in 2D, we find that 
the effective spring constant is smaller compared to 3D (no midpoint anchors) 
by a factor of k2D
 = (2/3) k3D. This is the maximal softening that we can get, and 
this is a weaker effect than for fixed attachment points, since the conformational 
entropy of the anchor points inside the bilayer plane is maintained.
It is important to note the opposite effects on the cytoskeleton stiffness of the 
band 3–ankyrin and actin–band 4 anchoring complexes; the removal of the first 
kind increases the stiffness of the spectrin bond, while removal of the second kind 
results in a vanishing of the stiffness of the bond, since the mechanical linkage is 
broken. Some agents may affect both types of complexes, in opposite manners; 
calcium loading seems to lead to band 3-ankyrin breakage as described earlier, 
while it strengthens the spectrin–actin–band 4 anchoring complexes (158) .Both 
these modifications result in a stiffer cytoskeleton, which we propose to play a 
role in the overall shape transitions of the cell (discocyte to echinocyte) and in 
increased vesiculation. 
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Next, we describe how the local compressive forces applied by the cytoskel-
eton on the fluid membrane can drive a local bilayer buckling and budding of 
a membrane blister, which afterwards detaches as a free vesicle. This process 
occurs when the local compressive force increases beyond a critical threshold 
where the barrier for membrane budding becomes small enough (or even 
vanishes). The mathematical details of this analysis have been presented before 
(225), and we will here give a description of the basic physical mechanisms.
The local force balance between the compressed bilayer and the stretched cyto-
skeleton is schematically shown in Figure 5.3. There are three energies in this 
system, which we considered, all depending on the local shape and area of the 
membrane. (i) First, there is the membrane tension energy, which arises from the 
thermal fluctuations of the bilayer. This energy is minimized when the bilayer area 
is larger than the projected local area, such that there is excess area ‘‘stored’’ in 
the thermal undulations of the bilayer. The cytoskeleton anchoring introduces a 
constraint on the bilayer undulations, and the simplest way to analyze this local 
FIGURE 5.2 Vesicle formation and spectrin–bilayer anchorage. (A) Schematic illustration of the 
erythrocyte cytoskeleton and membrane. Black ovals: spectrin end-points anchoring complex of actin–
band 4; gray ovals: midpoint anchoring complex of band 3-ankyrin; black solid lines: spectrin filaments 
(intact tetramers). The dashed circles denote the configurations of the spectrin filament that contribute 
to the entropic elasticity. (B) When the midpoint band 3-ankyrin anchors are degraded, the configura-
tional entropy of the spectrin filaments increases, leading to stiffer entropic spring constant. (C) In the 
limit of many spectrin–bilayer attachments (grey circles), the filament can only have 2D conformations 
inside the plane of the membrane (black arrow and dashed line), and a low entropic elasticity.
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coupling of the bilayer and cytoskeleton is to assume that the bilayer within each 
membrane patch that is defined by a closed cytoskeletal unit has independent 
thermal fluctuations (Figure 5.3A). Using this assumption, the bilayer tension 
energy, therefore, acts to keep the bilayer area within each cytoskeleton unit 
at the optimal value determined by the local thermal fluctuations. (ii) Second, 
there is the curvature energy of the bilayer. We assume for simplicity that the 
bilayer has an average of zero spontaneous curvature, so that this energy is zero 
when the membrane is flat. As the membrane buckles and forms a curved bud, 
this energy increases. Note that if the bud contains membrane components that 
have a convex spontaneous curvature, then the curvature energy cost of forming 
the bud (and vesicle) is reduced.(iii) Finally, there is the elastic stretching energy 
of the cytoskeleton unit, which defines the perimeter of the membrane unit.
Minimizing these energies, we find the following behavior as a function of 
the bilayer area (Figure 5.3B): as the bilayer area within the cytoskeleton unit 
increases, the cytoskeleton is at first stretched, but eventually the system prefers 
FIGURE 5.3 Schematic description of the force balance at the erythrocyte membrane. (A) The 
cytoskeleton units apply a compressive pressure on the bilayer (thin black arrows), which is balanced by 
the bilayer thermal fluctuations, undulations modes within each cytoskeleton units (dashed lines). Large 
black circles represent the actin– band 4.1 complex anchoring the ends of the spectrin filaments (thick 
black lines), while the small gray circles represent the ankyrin–band 3 anchoring complex. (B) Beyond a 
critical compression in the cytoskeleton (thin black arrows, left image), the bilayer within the cytoskel-
eton unit buckles to form a curved bud, which can then form a vesicle, and releases the tension in the 
cytoskeleton unit (right image). (C) In an array of stretched cytoskeleton units, the system can overcome 
the energy barrier to form a growing vesicle at one of the units, which then grows due to flow of bilayer 
from the surrounding units (gray arrows). When the vesicle detaches the whole array is relaxed slightly, 
until the next event of vesicle nucleation.
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to release the cytoskeleton tension at the cost of membrane bending energy, 
and the membrane buckles. The instability from flat to buckled bilayer occurs 
as the area mismatch between the bilayer and unstretched cytoskeleton unit is 
increased, or as the cytoskeleton stiffness increases. Alternatively, decreasing 
the bilayer bending modulus or increasing its spontaneous curvature, also gives 
rise to a buckling instability.
The behavior we have just described can now be implemented for an array of 
identical units, where we consider a transition from all units being flat, to one unit 
that buckles and relieves the tension throughout the array (Figure 5.3C). The fluid 
bilayer can easily flow between the cytoskeleton units, so that the entire excess 
area can be (theoretically) concentrated at one unit, which buds and vesiculates. 
This picture allows us to calculate the equilibrium configuration of such a system, 
and find the critical area mismatch leading to vesiculation.
In reality, this process of membrane flow and vesicle growth leads to formation 
of vesicles with some size distribution, with typical diameters 80–300 nm, and of 
both spherical and cylindrical shapes. This observation indicates that as the vesi-
cles grow there are various forces that destabilize the growing vesicle, leading to 
its detachment. The most dominant force leading to vesicle pinching and detach-
ment arises from line tension due to the different composition of the bilayer at 
the growing bud as compared to the surrounding membrane (Figure 5.1C) (128). 
Note that the bending modulus of the bilayer in the growing bud is lowered due 
to the aggregation of membrane proteins (97), further lowering the energy cost 
of vesicle formation. In vivo, the vesicles may furthermore be detached from the 
cell due to the forces of the shear flow.
The location of the growing vesicle in the array may be random, as nucleation 
is driven by thermal fluctuation over an energy barrier. The local shape of the 
membrane does play a role, as there is evidence that vesicle is shed preferentially 
from highly curved regions such as the tips of spicules (97, 129, 154, 160, 207). 
The high curvature of the membrane at the tips of spicules lowers the energy 
cost to form a vesicle, making these regions have a lower energy barrier and 
increased vesicle nucleation rate.
The rate of vesicle formation depends on the slowest process, which drives 
their formation. The two processes that determine the vesicle growth when it 
is driven by the cytoskeleton compression are (i) the rate of increase of stiff-
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ness, which determines the rate of vesicle nucleation and (ii) the rate of vesicle 
growth, which is limited by the flow of membrane to the budded unit from the 
surrounding units. For example, during the natural aging process of the cell, 
the observed rate of membrane shedding is 20% of the area in 100 days, which 
translates to about one 100-nm-sized vesicle an hour. We can give a rough esti-
mate of the rate at which membrane can flow in order to concentrate enough 
material at the budded unit to form a vesicle of this size; the number of units 
needed to be ‘‘drained’’ in order to form a vesicle of diameter of 100 nm is Nv ≈ 
SV / δs, where SV ≈5S0 is the area of the vesicle and δs ≈
 S0 /10 is the excess area 
per unit cytoskeleton–membrane (S0 is the equilibrium area of the unstretched 
cytoskeleton units). The time it takes to concentrate the bilayer at the growing 
bud can therefore be estimated as: tv ≈ Nv /v  where the flow velocity of the 
bilayer can be estimated as: v≈∆F/γ S0  where ∆F ≈10kBT is the energy barrier 
for the vesicle formation and γ is an effective friction coefficient of the bilayer 
as it flows past the cytoskeleton anchors (proportional to the membrane 
viscosity).  Putting all these numbers together we get that the flow time-scale is 
tv≈ Nv S0
3/2 ŋm/
 ∆F≈ 0.1 - 1s, where ŋm is the membrane viscosity. The slowest time-
scale giving rise to one vesicle per hour during normal aging is therefore the rate 
of stiffness increase. Note that this estimation, based on dimensional analysis, 
only gives the approximate time-scale for the vesicle rate of formation.
In experiments where the stiffness increases more rapidly, for example, due to 
calcium loading, or by changing the membrane fluidity of the whole erythrocyte 
(e.g., through the cholesterol content) so that the flow time- scale increases, the 
two timescales may be closer and both affect the rate of vesiculation.
The model we present here predicts that membrane vesicles are effectively 
‘‘extruded’’ in between the filaments of the cytoskeletal network, and are there-
fore free of any spectrin cytoskeleton components. The sizes of such vesicles 
are also predicted to be of order 80–200 nm, corresponding to the range of 
sizes of network compartments in the erythrocyte cytoskeleton. Both these 
predictions are in agreement with the observed properties of these vesicles, as 
described earlier.
Integrating the models presented earlier we now suggest the following chain of 
events that lead to the shedding of membrane vesicles when components of the 
band 3-ankyrin anchors are modified and/or degraded in the erythrocyte:
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i) Degraded or otherwise aging-modified proteins of the anchor complex, such 
as band 3 and band 4.2, loose the ability to bind ankyrin and spectrin, which 
releases the midpoint anchoring of the spectrin filament.
ii) The increased tension lowers the energy barrier for local membrane budding. 
Note that the estimated increase in local stiffness of an individual spectrin 
filament is by a factor of 1.5–2, which is much larger than the overall 50% 
increase in stiffness of the whole network observed in the senescent eryth-
rocyte. This indicates that the overall network connectivity also decreases, 
through dissociation of the spectrin tetramers.
iii) The modified, released band 3 molecules are free to diffuse in the membrane, 
and to aggregate at regions that are far from the spectrin filaments, that is, 
at the middle of the membrane patch. The degraded band 3 can be linked by 
oxidatively damaged hemoglobin; denatured hemoglobin has a high affinity 
for the cytoplasmic domain of band 3, and aggregation of damaged hemo-
globin leads to aggregation of band 3. This leads to conformational changes in 
band 3 that are antigenic. Binding of damaged hemoglobin to band 3 further 
leads to conformational changes in both the cytoplasmic and membrane 
domains, leading to increased sensitivity to proteases and thereby to aggre-
gation and senescent cell antigen activity.
iv) Furthermore, the degraded proteins aggregated at the free membrane 
patch in the budding unit may further drive the vesicle formation due to an 
emergent convex spontaneous curvature. This may arise from the formation 
of an aggregate with strong asymmetry between the proteins at the inner 
and outer bilayer leaflets (see step iii). Molecules such as IgG, found in high 
concentrations on vesicles, may also induce spontaneous curvature due to 
their asymmetric form. A convex spontaneous curvature further lowers the 
energy barrier toward local budding and vesicle growth.
v) Finally, the aggregated proteins and lipids at the growing bud drive the pinching 
of the bud and its detachment as a free vesicle, due to the line tension that 
forms along the perimeter of the domain aggregate.
Thus, we have described an interesting self-regulating system in which the 
process of aging-related modification and/or degradation of some key proteins 
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such as band 3 initiate the physical process of membrane vesiculation, which 
allows the cell to shed defective components.
Also, the asymmetric lipid composition of the erythrocyte bilayer may play an 
additional role in vesicle formation. In the normal cell, PS is biased toward the 
inner leaflet of the plasma membrane due to the activity of various enzymes and 
to their attractive interactions with the spectrin filaments. Similar to the role 
played by the band 3-ankyrin anchors, the negatively charged PS on the inner 
leaflet of the bilayer increases the attraction between the spectrin filaments and 
the bilayer. Releasing these attractive interactions through the flip-flop of PS 
will have an effect that is similar to the breakage of the band 3-ankyrin anchors, 
that is, an increase in cytoskeleton stiffness and compression. Furthermore, as 
the spectrin anchors break and the filaments become, on average, more distant 
from the bilayer their interaction with the charged lipids weakens, lowering the 
local asymmetry between the leaflets further. Indeed, the lipid asymmetry in 
vesicles is lower than in the membrane of the healthy, intact erythrocyte. The 
distinct protein and lipid composition of the bilayer at the growing bud and 
consequent vesicle may be instrumental in driving the vesicle detachment, as 
discussed earlier. 
Conclusions 
The model described above has  several  biological  implications: (i) vesicle forma-
tion is a relevant biomarker for erythrocyte homeostasis, both in vivo and in vitro; 
(ii) manipulation of the lipid composition of the erythrocyte membrane may 
be instrumental in improving erythrocyte quality, for example, in blood bank 
conditions; (iii) manipulation of protein modification, including but possibly not 
restricted to prevention of oxidation and/or proteolysis, may result in a more 
robust erythrocyte; (iv) more detailed, molecular elucidation of the vesicle 
composition is necessary to falsify our hypotheses. 
The physicochemical mechanisms that we have proposed to drive the vesicula-
tion process in the eythrocyte can be tested experimentally. For example, to test 
our proposal that the compressive force of the cytoskeleton on the bilayer can 
drive the vesicle formation, one could apply calcium loading which drives vesic-
ulation, while balancing it by swelling the cell through osmotic pressure. If there 
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is an osmotic swelling that cancels the effect of the increased calcium concen-
tration, this will show that indeed the force balance at the membrane plays a 
crucial role in driving the vesicle formation. The relationship between the rate 
of compression increase at the membrane and the rate of vesicle shedding has 
not been well studied so far, and can also be compared to the theoretical calcu-
lations.
From a theoretical point of view, the challenges that remain for a complete 
description of the complex dynamics of the erythrocyte membrane are 
numerous. Regarding the vesiculation processes we discussed here, we can chart 
the following tentative directions for future theoretical progress. On a micro-
scopic scale, future numerical simulations that describe the individual spectrin 
filaments as worm-like chains can be extended to include the fluid and flexible 
nature of the bilayer. These simulations will then allow a detailed testing of the 
coarse-grained models we presented here for the cytoskeleton-induced budding 
and vesicle formation. These models can then be further elaborated by including 
the complex composition of the bilayer, allowing for the segregation and aggre-
gation of membrane domains, and the consequences these have on the vesicu-
lation process.
At the coarse-grained level, one could combine the models that we presented 
into a single model that describes the stiffness of the spectrin filaments by their 
anchoring state, together with the bilayer deformation. The local membrane 
composition is then added using standard Ginzburg–Landau formalism to capture 
the phase separation of the bilayer components into domains, and to describe 
how these domains are coupled to the local bilayer shape. These combined models 
can then be used to chart the equilibrium states of the system, or dynamically 
using a linear stability analysis, and using simulations for the full nonlinear evolu-
tion. As one elaborates the theoretical models of this system, either through 
detailed molecular-scale simulations or using coarse-grained descriptions, there 
will be a need for detailed experimental data to supply the necessary values for 
the parameters appearing in the models. The validity of such models will have to 
be tested experimentally, and they will hopefully provide us with a comprehen-
sive understanding of the key mechanisms that dominate the evolution of this 
complex biological system.
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Abstract
During their passage through the circulation, red blood cells (RBCs) encounter 
severe physiological conditions consisting of mechanical stress, oxidative damage 
and fast changes in ionic and osmotic conditions. In order to survive for 120 days, 
RBCs adapt to their surroundings by subtle regulation of membrane organization 
and metabolism. RBC homeostasis depends on interactions between the integral 
membrane protein band 3 with other membrane and cytoskeletal proteins, and 
with key enzymes of various metabolic pathways. These interactions are regu-
lated by the binding of deoxyhemoglobin to band 3, and by a signaling network 
revolving around Lyn kinase and Syk kinase-mediated phosphorylation of band 
3. Here we show that band 3-centered manipulation of the interaction between 
the lipid bilayer and the cytoskeleton, using various treatments that interfere 
with tyrosine phosphorylation, has various effects on: (1) morphology, as shown 
by high resolution microscopy and quantitative image analysis; (2) organization 
of membrane proteins, as indicated by immunofluorescence confocal micros-
copy and quantitative as well as qualitative analysis of vesicle generation; (3) 
membrane lipid organization, as indicated by flow cytometric analysis of phos-
phatidylserine exposure; (4) deformability, as assessed in capillary-mimicking 
circumstances using a microfluidics system; (5) deformability as determined 
using a spleen-mimicking device; (6) metabolic activity as indicated by metab-
olomics. Our data show that there is a complex relationship between red cell 
morphology, membrane organization and deformability. Also, our data show that 
red blood cells have a relatively high resistance to disturbance of membrane 
organization in vitro, which may reflect their capacity to withstand mechanical, 
oxidative and osmotic stress in vivo. 
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Introduction
Despite constant exposure to oxidative and mechanical stress and fast changes 
in ionic and osmotic conditions, red blood cells survive for approximately 120 
days in the circulation. In healthy individuals, physiological wear and tear leads to 
the appearance of immune recognition and removal signals, resulting in phago-
cytosis. This physiological aging process is disturbed by mutations in hemoglobin, 
membrane proteins or metabolic enzymes (26, 62, 142), and by various multifac-
torial, systemic pathological conditions such as inflammation (84). 
RBC homeostasis is regulated by interactions between proteins in and associ-
ated with the plasma membrane. These interactions revolve around band 3. As 
the main component of the two complexes that link the cytoskeleton to the 
lipid bilayer (the ‘ankyrin complex’ and the ‘junctional complex’), band 3 plays a 
central role in the control of cell morphology and deformability. Also, as a binding 
partner of both deoxyhemoglobin and key enzymes of the glycolysis, band 3 is 
the link between the oxygen-dependent, metabolic tradeoff between the use 
of glucose either in glycolysis for production of ATP or in the pentose phos-
phate pathway for protection against oxidation by production of NADPH (87). 
A signaling network revolving around Lyn and Syk kinase-mediated phosphory-
lation of band 3 is involved in the regulation of many, if not all these processes. 
Activation of Syk is the initial signal of this pathway and leads to tyrosine phos-
phorylation of band 3. Consecutively, Lyn is activated and translocates to the 
membrane where it phosphorylates its target residues on band 3 (46, 95).
Mutations in the main RBC proteins are associated with altered morphology, 
decreased stability, and/or increased removal, many of which result in anemia 
(182). It has been proposed that mutations in membrane proteins that affect 
horizontal or lateral interactions, such as the spectrin dimer-dimer structure 
and the spectrin-actin-protein 4.1R junctional complex, lead to elliptocytosis 
and membrane fragmentation. Mutations in proteins involved in vertical inter-
actions, such as the binding of the spectrin cytoskeleton to the band 3-ankyrin 
complex, are thought to induce vesiculation-associated membrane loss, and the 
concomitant appearance of spherocytes (182, 239). However, there is no clear 
association, not even for a protein as central in membrane organization as band 3, 
between genotype, RBC morphology and clinical phenotype. Also, there is only a 
limited number of data on the effect of a disturbance of membrane protein inter-
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actions on RBC metabolism. Thus, there is an unmet need for a molecular frame-
work that explains the effect of alterations in one protein on the interaction with 
its partners and the concomitant effects on RBC morphology and function. Such 
a framework would be of great benefit for understanding the causes of anemia, 
including the role of vesiculation and the spleen (252).
It was the aim of this study to improve our understanding of the structure-func-
tion relationship of the RBC membrane morphology by treating RBCs with 
agents that disturb the organization of the RBC cytoskeleton-membrane 
complex through their effect on band 3. DIDS is an inhibitor of band 3-cata-
lyzed anion exchange that, upon binding to its membrane domain, reduces the 
linkage between the lipid bilayer and the cytoskeleton, resulting in an echinocyte 
cell shape (242). Treatment of RBCs with the thiol-alkylating reagent N-ethyl-
maleimide (NEM) modifies thiol groups in the N-terminal cytoplasmic domain of 
band 3, and thereby disturbs the ankyrin-band 3 interaction (19, 115). NEM also 
affects the phosphorylation status of band 3, by acting as a protein phospha-
tase inhibitor (23). Finally, phosphorylation of band 3 was manipulated by treating 
RBCs with the phosphatase inhibitor orthovanadate and the Src family kinase-in-
hibitor PP2, both affecting the association of band 3 with the cytoskeleton (43, 
44, 95, 162, 197).  
We compared the morphological, structural and functional effects of these 
treatments. Even for interventions that all affect the band 3 complex, a diver-
sity of structural and functional changes was observed. Our data show that the 
main current theories, in which changes in cell morphology are directly linked to 
disturbances in horizontal linkage within the lipid bilayer, or to vertical linkages 
between the lipid bilayer and the cytoskeleton, do not have sufficient heuristic 
power to explain all the structural and functional changes. 
Materials and methods 
Sample collection and ethical issues 
Fresh RBCs were isolated from five ml whole blood (EDTA) from healthy volun-
teers. RBCs were washed using Ringer solution (125 mmol/L NaCl, 5 mmol/L 
KCl, 1 mmol/L MgSO4, 2.5 mmol/L CaCl2, 5 mmol/L glucose, 32 mmol/L HEPES/
NaOH, pH7.4) by repeated centrifugation (5 min, 1550 x g). Written informed 
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consent was obtained from all donors participating in this study. The study was 
performed following the guidelines of the local medical ethical committee and in 
accordance with the declaration of Helsinki. 
Treatments of the RBCs  
RBCs (2% hematocrit) were incubated for 30 min at 37°C in Ringer solu-
tion containing 100 µM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS, 
Sigma-Aldrich, St. Louis MO, USA) or 50 µM N-ethylmaleimide (NEM, Sigma-Al-
drich, St. Louis MO, USA).  Phosphorylation was manipulated by incubation 
with 100 µM orthovanadate (Sigma-Aldrich, St. Louis MO, USA) or 20 µM PP2 
(Sigma-Aldrich, St. Louis MO, USA). PP2 was solved in DMSO and then diluted in 
Ringer to a solution with a final concentration of 0.1% DMSO. After treatment, 
the RBCs were washed twice in Ringer solution by centrifugation (3 minutes, 
400 x g) before analysis.
Cell classification 
Cells were resuspended in Ringer solution, poured into Lab-Tek chambered cover-
glass (Thermo Fisher Scientific, Rochester NY, USA) and random field pictures 
were taken for morphological classification. Microscopy was performed on a 
TCS SP5 confocal laser scanning microscope (Leica Microsystems, Mannheim, 
Germany) equipped with an HCX Plan-Apochromat 63X/N.A. 1.2 water immer-
sion lens. Image J version 1.45j (U. S. National Institutes of Health, Bethesda MD, 
USA, http://imagej.nih.gov/ij/) was used for image analyses. 
Immunofluorescence 
After treatment, the RBCs were fixated and stained as described before (175). 
1% BSA was used instead of fish skin gelatin for blocking purposes. Primary 
antibodies and relative dilutions were: mouse anti-stomatin (GARP-50, kindly 
provided by Rainer Prohaska, University of Vienna, Austria) at 1:200, mouse 
anti-band 3 N-terminal domain (B3-136, Sigma-Aldrich, St. Louis MO, USA) at 
1:100 and mouse anti-band 3 C-terminal domain (IVF12, Developmental Studies 
Hybridoma Bank, Iowa City, IA, USA) at 1:100. The secondary antibody was goat 
anti-mouse Alexa-488 (Invitrogen, Carlsbad CA, USA) at 1:1000 dilution. Image 
analysis and single cell fluorescence determination were carried out using ImageJ 
version 1.45J.
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Phosphatidylserine exposure 
After treatment, two million RBCs were resuspended in 25 µL of Ringer and 
incubated for 45 minutes at room temperature in the dark with Fluos–labeled 
annexin V (1:25, Roche, Indianapolis, IN) to label exposed phosphatidylserine (PS). 
After washing, the RBCs were analyzed with a flow cytometer (FACSCalibur, BD 
Biosciences, Franklin Lakes NJ, USA) and Cellquest Pro software version 6.0 (BD 
Biosciences, Franklin Lakes NJ, USA) was used. Data analysis was performed with 
Cyan Summit software v4.3 (Beckman-Coulter, Fullerton CA, USA). Results are 
expressed as percentages of annexin V–positive RBCs.
Measurement of acetylcholinesterase activity 
Acetylcholinesterase (AChE) activity was measured using Ellman’s method (217), 
using 2x106 cells or, for vesicle measurements, the supernatant of 2x107 cells.
Microfluidics 
RBC deformation within the microcapillaries was simulated with a microfluidic 
device as described before (53). Cells were diluted to a hematocrit of 2% in Ringer 
solution with 1% BSA. Perfusion of the cell suspension through the microfluidic 
channels was done with computer-controlled syringe pumps (neMESYS, Cetoni, 
Germany) for accurate adjustment of the flow rates. In all experiments a constant 
volumetric flow rate of 25 µl/h was used, which corresponds to a flow velocity 
of 0.63 cm/s in the narrow channel. Images of up to 1250 frames per second of 
the field-of-view were recorded for quantitative image processing. Cell flow was 
observed through a 100X oil immersion objective (Olympus UPLFLN 100X, N.A. 
1.30) using an optical microscope (IX71, Olympus B.V., The Netherlands) equipped 
with a high speed CMOS camera (Phantom high speed camera, Vision Research, 
UK). Snapshots of RBC shape were obtained using a short exposure time of 10 
µs. A sequence of images of 20,000 in each run was recorded.  The RBCs in 
these images were analyzed using the length and width of a rectangular box 
enclosing the deformed RBC measured by a macro developed for automated 
image processing using ImageJ. With these values, the deformation index (DI), 
defined as the ratio between the sides (DI=length/width) was calculated.
 
Bead-sorting device 
RBC deformability was assessed using a bead-sorting device that mimics the 
mechanical deformation that RBCs experience in the spleen (78). RBCs were 
treated as described above, after which the RBCs (1x108) were labeled with 
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CFSE diacetate (Thermo Fisher Scientific). A 2% hematocrit suspension(600 μl) 
consisting of 5% treated/labeled and 95% untreated/unlabeled RBCs in Ringer 
with 1% BSA was passed through the bead-sorting device at a flow rate of 60 ml/h. 
The untreated/unlabeled RBCs acted as both facilitators of steady perfusion of 
the cells of interest, and as an internal control for deformability. The percentages 
of CFSE-positive cells in the various samples were determined by flow cytometry 
(100,000 cells), and the percentages in the retained and downstream fractions 
were normalized to the labeled cells in the upstream samples.
Phospho-immunoblotting 
Membrane fractions from control and treated red cells were prepared as previ-
ously reported (71, 72, 130). Proteins were separated by 1D-electrophoresis, 
transferred to membranes, and probed with the following specific antibodies: 
anti-Lyn antibody (2732, Cell Signaling, USA), anti-phospho-Lyn (P-Lyn; Cell 
Signaling, USA), anti-Syk (Cell Signaling; USA) and anti-phospho-Syk (P-Syk; Cell 
Signaling; USA); anti-SH-PTP1 (SantaCruz; USA); Phospho-Tyr 564 SH-PTP1 
(anti-P-SH-PTP1 564; Cell Signaling, USA). Densitometric analysis of band inten-
sities was carried out by Quantity One analysis software (Bio-Rad, Hercules, CA, 
USA) (69, 71, 164, 201). 
Metabolomic analysis 
Metabolomes were charted as described before (60). In short, packed RBCs 
were lysed, extracted with chloroform/methanol, and treated with acetonitrile 
to precipitate proteins. Metabolites in the lysate were separated on an Ulti-
mate 3000 Rapid Resolution HPLC system with a Reprosil C18 column. MS 
analysis was performed, both at downstream negative and positive ion mode, 
on an electrospray hybrid quadropole time-of-flight mass spectrometer Micro-
TOF-Q (Bruker-Daltonik, Germany) equipped with an ESI-ion source. Data were 
acquired with a stored mass range of m/z 50-1200. The SmartFormula3D TM 
software (Bruker Daltonics) was used to calculate molecular formulae based on 
the isotopic and fragmentation patterns.
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Results
Cell morphology and membrane organization
To better define the structure-activity relationship of band 3 and RBC morphology, 
we subjected RBCs to a series of treatments known to interfere with band 3 
function. Remarkably, in spite of this restriction in the choice of compounds, very 
different effects were observed. Incubation with DIDS at concentrations known 
to induce band 3 crosslinking as well as the loss of low and high affinity ankyrin-
binding sites, induced the formation of stable echinocytes, as described before 
(95, 187, 242). In contrast, NEM, that affects the conformation of the cyto-
plasmic domain did not have a distinct effect on morphology (Figure 6.1A), which 
is in agreement with previous observations (19).  An overall increase in phosphor-
ylation status induced by the phosphatase inhibitor orthovanadate resulted in the 
appearance of echinocytes as well as spherocytes (95). Inhibition of Src-family 
kinase activity by PP2 did not show an effect on cell morphology (Figure 6.1A).
In order to assess the effect of these treatments on the interactions of band 
3 with its partners in the membrane-cytoskeleton complex, we investigated 
concomitant changes in protein and lipid organization using immunofluores-
cence confocal microscopy. Remarkably, membrane organization was changed 
at the molecular level also after treatments that did not have a visible effect on 
cell morphology. Staining with an antibody against the N-terminal domain of 
band 3 shows a punctuated pattern in control cells, that, upon treatment with 
NEM, becomes much more diffuse (Figure 6.1). Treatment with DIDS, which had a 
profound impact on morphology, induced a similar pattern, at least in some cells. 
In contrast, the actin antibody stains the control cells, but not the NEM-treated 
or some of the DIDS-treated RBCs (Figure 6.1B).
Lipid distribution can also be influenced by changes in the membrane-cytoskel-
eton complex organization, with phospatidylserine (PS) exposure on the outside 
of the cell membrane being the most prominent change, and associated with 
vesiculation and aging (147). However, only orthovanadate led to an increase in PS 
exposure, indicating that the disruption of the organization of band 3 complexes 
had no dramatic effect on phospholipid asymmetry (Figure 6.1C).
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FIGURE 6.1 Morphological and structural changes after treatment of RBCs. RBCs were treated 
with various reagents and analyzed as described in Materials and Methods. (A) representative RBC 
morphologies after treatment of fresh RBCs from a healthy volunteer; (B) immunofluorescent staining 
of band 3 and actin; (C) PS-positive RBC expressed relative to the control (N=3).
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Phosphorylation
We previously showed that the Syk-Lyn pathway plays a key role in the modulation 
of membrane-cytoskeleton protein-protein and protein-lipid bilayer interactions 
(71, 164, 195). Using cell fractionation and immunoblot analysis, we evaluated the 
effect of various treatments on membrane translocation of phospho-Syk (P-Syk) 
and phospho-Lyn (P-Lyn), the active forms of these kinases  (71). DIDS, NEM and 
orthovanadate led to Syk and Lyn activation (Figure 6.2). In PP2-treated cells we 
found a significant reduction in the membrane association of P-Lyn compared 
to control cells, whereas no differences in membrane association of P-Syk were 
observed (Figure 6.2). This finding is in agreement with previous reports (71, 197). 
We then evaluated the phosphorylation status of SH-protein tyrosine phospha-
tase-1 (SH-PTP1), as this enzyme has been functionally linked to Lyn in various cell 
models (58, 67, 191). Interestingly, we observed a reduction in SH-PTP1 activa-
tion (P-SH-PTP1 Tyr 564) in RBCs treated with the Lyn inhibitor PP2 (Figure 6.2), 
suggesting that Lyn may be a downstream regulator of SH-PTP1 in human RBCs.
Deformability 
Deformability plays a key role in RBC functioning in vivo and is closely related to 
the cytoskeleton-membrane interactions. To further complement the morpho-
logical studies with a dynamic assessment of deformability, we studied changes 
in deformation capacity with two techniques that simulate circulation through 
microcapillaries and passage through the spleen in vivo.
Treatment with DIDS and NEM led to a decrease in deformability in the micro-
channels of a microfluidic device mimicking the microcapillaries (53), as did 
treatment with the Lyn kinase inhibitor PP2 (Figure 6.3A). In contrast, an increase 
in the phosphorylation state upon treatment with orthovanadate resulted in an 
increase in deformability (Figure 6.3A). When RBCs were passed through a bead-
sorting device, mimicking the inter-endothelial slits in the spleen, the capacity to 
deform was significantly impaired after treatment with DIDS, whereas the other 
treatments had no effect (Figure 6.3B).  On the other hand, incubation with 
DIDS was the only treatment that did not impair the capacity of RBCs to elon-
gate under large shear stress in the LORCA ektacytometer or in the ARCA rheo-
scope (data not shown). These findings are similar to those previously reported 
for DIDS and NEM (19, 50, 242). Vesiculation may be an important factor that 
influences deformability by its effects on the surface-to-volume ratio. The latter 
also affects osmotic fragility. Therefore, in order to assess if changes in deform-
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FIGURE 6.2 Phospho-immunoblot analysis of RBC membranes after treatment. (A) Active Lyn 
(phospho(P)-Lyn 396), total Lyn, active Syk (phospho (P)-Syk), total Syk, and active SH-PTP1 (phos-
pho(P)-Tyr 564 SH-PTP1) were evaluated using specific antibodies (see also Materials and Methods). The 
representative experiment shown is one of five similar experiments. Actin was used as loading control. 
(B-C) The panels show the data of a densitometric analysis of the immunoblots; data are shown as means 
±SD (n=5; *P<0.05; **P<0.02 compared to control RBCs).  
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ability where related to changes in surface-to-volume ratio, we determined the 
osmotic fragility of the treated cells.  Almost all treatments led to a decrease in 
osmotic fragility, with the exception of treatment with orthovanadate, which had 
the opposite effect (Figure 6.3C).
Vesicle formation
It has been postulated that changes in membrane structure that disrupt the 
binding of the cytoskeleton to the lipid bilayer induce vesicle formation (62, 182, 
225). Therefore, we measured vesicle number and composition after treatment 
with DIDS and NEM. All treatments – including the control incubation - induced 
vesiculation, but the number of vesicles and the composition differed between 
FIGURE 6.3 Deformability characteristics after treatment of RBCs. RBCs were treated as 
described in Materials and Methods. (A) deformability and relaxation as measured with a microfluidic 
device; (B) deformability and retention as assessed with a spleen- mimicking device; (C) an osmotic 
fragility assay to determine changes in the surface/volume ratio. The values in A are the mean +/- SE 
of at least 200 cells; the values in B are the mean +/- SD of four measurements; the values in C are the 
mean of three measurements with a standard deviation of less than 0.02 absorbance units.
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the control and the treatments. DIDS and NEM treatment both led to a decrease 
in vesicle production (Figure 6.4), but the vesicles that were formed did contain 
more of the integral membrane protein band 3, the lipid-anchored protein CD59, 
and displayed more of phosphatidylserine (PS) than the control vesicles (Figure 
6.4). These observations support previous conclusions from proteomic analyses 
that vesicles may originate by different mechanisms, depending on which molec-
ular linkage in the membrane-protein network is broken (29, 37, 225). To investi-
gate whether treatments led to a breakage of protein contacts with subsequent 
release of specific proteins in vesicles, we used the GPI-anchored acetylcholin-
esterase as an independent, quantitative parameter of vesicle production (217). 
In line with our results for band 3 and CD59, there was a treatment-associated 
effect. RBC acetylcholinesterase activity was decreased 20% for DIDS, 10% for 
NEM and 5% for orthovanadate, with a concomitant increase in the acetylcholin-
esterase activity in the vesicle fractions. 
FIGURE 6.4 Vesicle numbers and composition after DIDS and NEM treatment of RBCs. Cells were 
treated and the resulting vesicles were quantitated and analyzed by flow cytometry and immunofluo-
rescence as described in Materials and Methods. The data presented are the results of a series of pilot 
experiments.
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FIGURE 6.5 The effect of manipulation of phosphorylation on red blood cell metabolism. 
(<< A Page 108); Glycolysis intermediates presented as the means of three donors with standard deviations 
(B) Glycolysis intermediates of three individual donors. For details see Materials and Methods. 
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Metabolism
Next to having an impact on RBC morphology and dynamic behavior, changes 
in band 3 conformation and phosphorylation may affect glycolysis as well as 
the pentose phosphate pathway (PPP) (46, 87, 95). In a series of pilot experi-
ments, we found that incubation of RBCs with DIDS had an inhibitory effect on 
glycolysis (Cluitmans et al., unpublished). In physiological circumstances, i.e. at 
ample glucose supply, a decrease in the rate of the glycolysis is accompanied by 
an increase in the activity of the pentose phosphate pathway (87). In line with 
this mutual interdependence, the same preliminary data indicated that incuba-
tion with DIDS resulted in an increase in NADPH, the primary product of the 
pentose phosphate pathway. In order to explore the underlying, physiological 
signaling mechanisms, we examined the effect of manipulation of phosphory-
lation signaling on the metabolomic profile, using the RBCs of three individuals. 
In contrast to our findings for DIDS, our data did not show significant effects 
of manipulation of phosphorylation on the concentration of glycolysis metab-
olites (Figure 6.5). Orthovanadate increased the concentration of cyclic AMP, 
indicating an overall effect on intracellular signaling, but had no effect on inosi-
tol-1-phosphate and phosphatidylinositol-3,4,5,-trisphosphate levels (Cluitmans 
et al., data not shown). Also, we found no consistent effects of orthovanadate 
or PP2 on the pentose phosphate pathway intermediates, nor on the reduced 
gluthation (GSH)/oxidized gluthation (GSSG) ratios. Incubation with PP2 did 
not result in any significant changes in the concentrations of the glycolysis or 
pentose phoshate pathway intermediates (Figure 6.5). However, our data indi-
cate that there may be considerable inter-individual variability in the suscepti-
bility to such manipulations. This susceptibility extends to the effects of DMSO, 
as a solvent control for PP2 (Figure 6.5).
Discussion
Various mechanisms have been postulated for the generation of abnormally 
shaped RBCs. These theories revolve around a weakening of the linkage between 
the cytoskeleton and the lipid bilayer. After an initial screening of a number of 
compounds, we analyzed the effects of the band 3-directed agents DIDS, NEM, 
PP2 and orthovanadate on various morphological and functional RBC charac-
teristics, protein localization at the plasma membrane and RBC-derived vesicles. 
Overall, our data warrant a critical revision of the current paradigms. 
111
6.  RBC homeostasis, morphology and deformability 
Cell morphology and membrane organization 
A comparison of the cell morphology and confocal immunofluorescence data 
shows that changes in organization of the membrane-cytoskeleton network 
are not always accompanied by changes in cell morphology, and vice versa 
(Figure 6.1). Immunoblot analyses of band 3 and spectrin did not reveal any clear 
concomitant differences in membrane protein composition (data not shown), but 
did show differences in membrane protein phosphorylation state (Figure 6.2). 
The effects of DIDS and NEM on phosphorylation are remarkable, as both treat-
ments do not directly interfere with kinase activity. The absence of a relation 
between structural changes at the membrane protein level and RBC morphology 
has been reported before, most notably in the case of aging-associated changes 
in band 3 conformation (253). 
Measurement of PS exposure indicated that only treatment with orthovanadate 
resulted in a significant disturbance of lipid organization (Figure 6.1C). Again, a 
comparison of PS exposure with cell morphology (Figure 6.1A), showing the same 
echinocytic effect of both DIDS and orthovanadate, indicates the absence of 
a consistent correlation between cell morphology and membrane organization. 
It has been stated that changes in cell morphology are mainly caused by surface 
area loss, due to loss of vertical linkage between the lipid bilayer and the cyto-
skeleton and/or to loss of lateral protein interactions (62).  The results of our 
vesicle analyses suggest that changes in cell morphology may not always be due 
to loss of membrane per se. A combination of quantitative and qualitative vesicle 
analyses strongly indicates that proteins are lost from the cell membrane as a 
result of breaking contacts in the membrane-cytoskeleton complex. Each distur-
bance of membrane organization results in a specific vesicle population, and an 
associated loss of specific proteins. A similar conclusion, that was based on theo-
retical considerations, has been substantiated by a comparison of the vesicles 
generated during aging in vivo with those generated during aging in vitro in blood 
bank storage conditions (29, 37, 107, 225). In addition, comparison of the vesicle 
data with the PS data show that changes in membrane lipid organization may be 
associated with, but are not essential for, vesicle generation. 
112
   Red blood cell homeostasis   
Cell morphology, membrane organization and deformability
There is a notable lack of correlation between morphology and deformability in 
the capillary-mimicking circumstances of the microfluidic device. For example, 
an echinocytic morphology induced by DIDS is associated with a decrease in 
deformability, whereas the deformability of the morphologically indistinguish-
able echinocytes induced by orthovanadate is increased (Figure 6.1A, Figure 
6.3).  It should also be noted that, although DIDS and orthovanadate did not 
induce a shape change in all the cells, deformability was changed for the whole 
cell population. Furthermore, after treatment, misshapen cells behaved the same 
as cells with a normal morphology, suggesting that the effect on deformability 
is the direct result of changes in membrane organization and that shape is not 
a predictor of dynamic RBC behavior. In the data we have obtained so far, no 
consistent correlation can be found for changes in morphology, deformability, 
or PS exposure (54), while the latter parameters are expected to correlate with 
retention in the spleen. The same conclusion was drawn before for the RBCs of 
patients with neuroacanthocytosis. Acanthocytes did not show any differences 
in deformability compared to control cells (55). 
Conclusions on the effect of a change in membrane organization on deforma-
bility are likely to depend on the degree and type of mechanical stress employed. 
All treatments, except for DIDS, decreased deformability when measured under 
high shear stress in an ektacytometer (Cluitmans et al., data not shown), while in 
the spleen-mimicking device only DIDS led to a decrease in deformability. These 
differences trigger the question on the biological relevance of the commonly 
used deformability measurement techniques.  Since the bead-sorting and the 
microfluidic device measure deformability under physiological conditions-mim-
icking circumstances, these techniques seem to be preferable. It remains to be 
established if and how the method of analysis itself contributes to the observed 
effects. For example, high mechanical or osmotic stress may themselves induce 
vesiculation (95), and thereby reduce deformability in susceptible RBCs, that have 
a normal deformability in less stressful conditions. This could explain the strongly 
reduced capacity of the DIDS-treated cells to pass the spleen-mimicking device 
(Figure 6.1), and normal behavior in an ektacytometer. Echinocytes may be more 
susceptible to vesicle formation in these circumstances, which would lead to loss 
of membrane and cell surface and thereby of deformation capacity.
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Cell morphology, membrane organization and metabolomics
Our data show that it is possible to manipulate RBC metabolism by interfering 
with membrane organization in vitro, as has been observed for stomatocy-
tosis and sickle cell disease in vivo (63, 64). Different treatments had different 
effects on the concentrations of intermediates of the glycolysis, of the closely 
associated pentose phosphate pathway and on the glutathione concentration, 
albeit with a strong inter-individual variance. Based on the glycolysis-enhancing 
effect of deoxygenation, which reduces the binding of band 3 to the cytoskel-
etal components ankyrin and/or adducin (87), we postulated that interference 
with this binding in vitro would result in an increase in glycolysis products and 
a concomitant decrease in the pentose phosphate pathway and in the reduced 
glutathione concentration. Indeed, in some individuals, the effect of DIDS 
confirmed the role of band 3 in regulation of the glycolysis, and the concomitant 
effect on production of ATP and on the redox status through the ratio reduced/
oxidized glutathione. The diverse effects of manipulation of the Tyr-phosphor-
ylation status of band 3 on the metabolome indicate an intricate regulation of 
the main energy-producing and redox status-regulating complexes of the red 
blood cell. For example, in some individuals the inhibition of Src-mediated phos-
phorylation of band 3 was associated with an apparent decrease in the rates of 
both the glycolysis and the pentose phosphate pathway (Figure 6.5). Together 
with the asymmetrical effects of inhibition of Src kinase-mediated phosphor-
ylation and inhibition of phosphatase activity (Figure 6.4), our data reveal the 
existence of a phosphorylation-mediated signaling network for regulation of the 
metabolism that involves more than the binding of glycolytic enzymes to band 
3. It is possible that enzymes of the pentose phosphate pathway also bind to 
band 3, and that glycolysis enzymes also bind to other membrane or cytoskel-
eton proteins, such as spectrin (205). The latter associations may be regulated by 
alternative signaling pathways.
Notably, our data suggest large differences in the susceptibility to the treat-
ments between individuals. This may be due to genetic variability in the charac-
teristics of key enzymes in the various metabolomic pathways and/or membrane 
transporters, or to the inter-individual variability in the natural history of the red 
blood cells. 
Together, our metabolomic findings may provide another starting point for iden-
tifying the pathways that regulate RBC metabolism (87, 241). Also, our findings 
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stress the putative value of the RBC as a model for studying regulation of energy 
metabolism, with emphasis on the possibility to study glycolysis as an isolated 
ATP-producing process in situ. 
Conclusions
Our main conclusions are:
1. The main current theories on the linkage between (changes in) red blood 
cell morphology and disturbances in horizontal or vertical associations in the 
membrane/ cytoskeleton complex, require a re-evaluation, since they do not 
explain all the structural and functional observations;
2. Healthy RBCs have a large capacity to withstand disturbance of membrane 
organization before this has functional consequences in vitro; this may very 
well be a consequence of the capacity to function in fast-changing conditions 
in vivo, including mechanical, chemical and osmotic stress;
3. In order to understand the molecular mechanisms underlying RBC-medi-
ated pathology, more physiologically relevant techniques are needed, such 
as spleen-mimicking and capillary-mimicking devices, which reveal functional 
changes even if the morphology is unaffected;
4. Detailed analysis of the composition and organization of RBC-derived vesi-
cles is likely to yield more specific and sensitive information than membrane 
organization-centered research only;
5. Metabolomic analysis may turn out to be an efficient approach for the iden-
tification of the signaling routes that regulate the interaction between the 
RBC and it’s organism-wide environment, both in healthy and in pathological 
circumstances.
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Abstract 
 
Background
Panthothenate kinase-associated neurodegeneration (PKAN) belongs to a group 
of hereditary neurodegenerative disorders known as neuroacanthocytosis (NA). 
This genetically heterogeneous group of diseases is characterized by degenera-
tion of neurons in the basal ganglia and by the presence of deformed red blood 
cells with thorny protrusions, acanthocytes, in the circulation.
Objective
The goal of our study is to elucidate the molecular mechanisms underlying this 
aberrant red cell morphology and the corresponding functional consequences. 
This could shed light on the etiology of the neurodegeneration.
Methods
We performed a qualitative and semi-quantitative morphological, immunofluo-
rescent, biochemical and functional analysis of the red cells of several patients 
with PKAN and, for the first time, of the red cells of their family members. 
Results
We show that the blood of patients with PKAN contains not only variable numbers 
of acanthocytes, but also a wide range of other misshapen red cells. Immunoflu-
orescent and immunoblot analyses suggest an altered membrane organization, 
rather than quantitative changes in protein expression. Strikingly, these changes 
are not limited to the red blood cells of PKAN patients, but are also present in 
the red cells of heterozygous carriers without neurological problems. Further-
more, changes are not only present in acanthocytes, but also in other red cells, 
including discocytes. The patients’ cells, however, are more fragile, as observed 
in a spleen-mimicking device.
Conclusion
These morphological, molecular and functional characteristics of red cells in 
patients with PKAN and their family members offer new tools for diagnosis and 
present a window into the pathophysiology of neuroacanthocytosis. 
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Introduction
Panthothenate kinase-associated neurodegeneration (PKAN) belongs to the 
family of hereditary neurodegenerative disorders known as neuroacanthocy-
tosis (NA), which includes chorea-acanthocytosis (ChAc), McLeod syndrome 
(MLS) and Huntington’s disease-like 2 (HDL2) (135). NA is a genetically heteroge-
neous group of diseases, characterized by neurodegeneration, affecting mainly 
the basal ganglia and leading to progressive movement disorders, with cogni-
tive and psychiatric features (135, 204). PKAN has been recently included in NA 
as a recessive NBIA disorder (neurodegeneration with brain iron accumulation), 
displaying clinical manifestations similar to those of NA, but characterized by the 
accumulation of iron in the basal ganglia (118).
One of the biological hallmarks of NA is the presence of acanthocytes, red blood 
cells (RBCs) with thorny protrusions, in the blood (135, 204). The association of 
acanthocytosis and neurodegeneration of the basal ganglia suggests a common 
pathogenic pathway, which can easily be explored by studying NA red cells. 
Changes in the structure and function of band 3, a key integral protein of the red 
cell membrane, as well as abnormalities in a band 3-regulating signaling network 
occupy a central position in our knowledge on the RBCs from NA patients (27, 
68). However, the relation between the disease-causing mutations, the abnormal 
red cell shape, the structural changes and their effects on the function of the 
acanthocytic red cells remains mainly unknown.
In comparison with ChAc and MLS, only limited data are available on the charac-
teristics of the RBCs of PKAN patients (118). Only recently, a reduced response of 
acanthocytic PKAN RBCs to drug-induced endovesiculation has been described 
to suggest a perturbation of red cell membrane function in patients with PKAN 
(232).
Here, we describe for the first time a qualitative and semi-quantitative morpho-
logical, structural and functional analysis of the RBCs from clinically diagnosed 
PKAN patients and their relatives. Our results show the presence of morpholog-
ical, structural and functional changes in RBCs not only of patients, but also in 
the RBCs of some of their relatives. 
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Materials and Methods 
Design of the study and ethical considerations  
Blood was donated by healthy volunteers, patients and their relatives after 
written informed consent, using venipuncture and EDTA as anticoagulant. Control 
donors and patients had the same ethnic background. Patients were clinically 
diagnosed with PKAN (118), which could be confirmed by mutational analysis for 
some patients (Sup. Figure 7.1). Family trees are shown in Figure 7.1A (family A and 
O) and Sup. Figure 7.1 for other PKAN patients and their family members (family 
C, N, UL, U), for which a complete set of analyses could not be obtained. 
RBCs were isolated from 5-10 ml blood and separated from platelets and white 
blood cells using Ficoll (GE Healthcare, Waukesha, WI, USA) density centrifu-
gation. The study was performed following the guidelines of the local medical 
ethical committees and in accordance with the declaration of Helsinki. As a part 
of the EMINA project, funded by E-Rare (40-41905-98-9005), this study was 
approved by the ethics committee of the Ludwig-Maximillius-Universität, Münich. 
Cell counts and classification
Cells were resuspended in Ringer solution (125 mM NaCl, 5 mM KCl, 1 mM MgSO4, 
2.5 mM CaCl2, 5 mM glucose, 32 mM HEPES, pH7.4), poured into Lab-Tek cham-
bered cover glass (Thermo Fisher Scientific, Rochester NY, USA), and random 
field pictures were taken for each sample. Counting and classification were 
performed on at least 400 cells by two independent operators, using the clas-
sifiers discocyte, echinocyte, acanthocyte and otherwise misshapen cell (Figure 
7.1B). All microscopy was performed using a TCS SP5 confocal laser scanning 
microscope (Leica Microsystems, Mannheim, Germany) equipped with an HCX 
Plan-Apochromat 63X NA 1.2 water immersion lens. 
Plasma microparticle analysis
Microparticle (MP) purification from plasma and analysis was performed as previ-
ously described (82). MPs were stained with monoclonal anti-Glycophorin A-PE 
(clone KC16, Beckman Coulter, Fullerton, CA, USA) at a 1:100 dilution to specifi-
cally identify RBC-derived MPs.
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MP formation in vitro
RBCs were suspended in Ringer to a hematocrit of 4% and incubated for 4 or 24 
hours at 37°C in a humidified incubator. MPs were isolated from the supernatant 
by centrifugation at 21,000xg for 30 minutes (30). Counting and staining of MPs 
was performed as described previously (82), with staining for Band 3, using the 
K2N6B antiserum (30) at 1:500 dilution. 
Immunofluorescence
RBCs were fixed and stained as described previously (175). For blocking purposes, 
1% BSA was used. Primary antibodies and dilutions were mouse anti-stomatin 
(GARP-50) at a 1:100 dilution, mouse anti-band 3 N-terminal domain (B3-136, 
Sigma-Aldrich, St. Louis MO, USA) at a 1:100 dilution and mouse anti-ß-spectrin 
(Acris, Herford, Germany) at a 1:50 dilution. The secondary antibody was goat 
anti-mouse Alexa 488 (Invitrogen, Carlsbad CA, USA) at a 1:1000 dilution. As 
internal controls, RBCs of one healthy control donor were stained with a rabbit 
antibody against the membrane domain of band 3 (IVF12, dilution 1:100 (133)) and 
these RBCs were mixed 1:1 with all patient, relative and all other healthy control 
samples. RBCs were imaged by confocal microscopy as described above. Image 
analysis was carried out using ImageJ version 1.45J. Cells were categorized by 
shape and total cell-associated fluorescence was calculated by adding the signals 
from all the planes composing the Z-stacks. From these data the mean fluo-
rescence intensity (MFI) was measured per cell. In order to adjust for variance 
between different slides, the fluorescence of each sample was related to the 
same internal control.
RBC membrane preparation and immunoblot analysis 
RBC membranes were obtained by lysing one volume of packed RBCs in 10 
volumes of ice-cold lysis buffer (5 mM Na2HPO4, pH 8.0 with protease inhibi-
tors (cocktail tablet;  Roche, Basel, Switzerland), 3 mM benzamidine and 1 mM 
Na3VO4) for 10 min on ice. The membrane fraction was washed repeatedly by 
centrifugation at 21,000xg for 10 min to remove free hemoglobin and solubi-
lized 1:1 with Laemmli buffer (Bio-Rad Laboratories, Hercules CA, USA) supple-
mented with 100 mM ß-mercaptoethanol for SDS-PAGE. SDS-PAGE was carried 
out according to Laemmli (148) on 10% polyacrylamide gels. Proteins were trans-
ferred to PVDF membranes using the iBlot system (Invitrogen, Carlsbad CA, 
USA). These membranes were blocked with Odyssey Blocking Buffer (LI-COR, 
Lincoln NE, USA) and probed with 1:2000 mouse anti-band 3 N-terminal domain 
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(BIII-136, Sigma-Aldrich, St. Louis MO, USA), 1:5000 mouse anti-ß-spectrin 
(Acris, Herford, Germany), or 1:10000 anti-ß-actin (Sigma-Aldrich). As secondary 
antibodies 1:10000 goat anti-rabbit IgG-Alexa Fluor 680 (Invitrogen, Carlsbad 
CA, USA), and/or goat anti-mouse IgG-IRDye 800 (LI-COR, Lincoln NE, USA) 
were used. The blots were scanned with the Odyssey Infrared Imaging System 
(LI-COR, Lincoln NE, USA) and the images were analyzed using the Odyssey 
Software version 2.1. 
Microfluidics
RBC deformation within the microcapillaries was simulated with a microfluidic 
device with narrow, 7 µm width, channels as described previously (53). Flow of cells 
was observed through a UPLFLN 100X, NA 1.3 oil immersion objective (Olympus, 
The Netherlands) using an optical microscope (IX71, Olympus) equipped with a 
high-speed CMOS camera (Phantom high speed camera, Vision Research, UK). 
In each run, a sequence of approximately 20,000 images was recorded. 
Spleen-mimicking device 
RBC deformability was further assessed using a bead-sorting device that mimics 
the mechanical deformation that RBCs experience in the spleen, as described 
previously (78). RBCs from the donor of interest were labeled with CFSE diac-
etate (84). A 2% hematocrit suspension in Ringer with 1% BSA (6 ml), consisting 
of 5% labeled patient RBCs and 95% unlabeled RBCs from a healthy control 
donor, was passed through the bead-sorting device at a flow rate of 60 ml/h. 
Flow cytometry analysis of the upstream fraction, the retained fraction, and the 
downstream fraction was performed to determine the ratio of labeled versus 
unlabeled RBCs in each separate sample.
Percoll separation 
RBC fractionation according to cell density was performed using a discontin-
uous Percoll gradient consisting of six layers ranging from 40% Percoll to 80% 
Percoll, as described previously (24). The RBCs were combined into four frac-
tions: Fraction 1, 61% Percoll + 64.5% Percoll; Fraction 2, 67.5% Percoll; Fraction 
3, 71% Percoll; and Fraction 4, 80% Percoll. 
HbA1c and HbF measurements 
Red cell lysates were analyzed on an HA 8160 hemoglobin analyzer (Menarini 
Diagnostics, Italy) to determine the HbA1c and HbF concentrations.
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Results
Abnormally shaped red cells are present in the blood of PKAN 
patients and their relatives 
In order to acquire a better understanding of the morphological and functional 
characteristics of PKAN red blood cells, we performed a detailed morpholog-
ical analysis of red cells from patients with PKAN as well as from their family 
members without neurological symptoms. 
This analysis showed that the presence of acanthocytes was always accompa-
nied by that of echinocytes and other misshapen cells (Figure 7.1B; see also Sup. 
Figure 7.1). Although not all PKAN patients had acanthocytes, most patient’s 
blood samples contained a high percentage of morphologically abnormal RBCs. 
Furthermore, the blood of some relatives without neurological symptoms 
contained abnormally shaped red cells (e.g. family A in Figure 7.1B; see also family 
UL in Sup. Figure 7.1).  
In order to obtain more insight into the molecular cause(s) underlying these aber-
rant morphologies, we evaluated the distribution and organization of the integral 
membrane protein band 3, the cytoskeleton protein spectrin, and the raft-as-
sociated stomatin with confocal microscopy. The total fluorescence intensity of 
the various antibody stainings was measured per cell and the cells were catego-
rized by shape (Figure 7.2A). A quantitative analysis (see Materials and Methods) 
showed no differences in the amounts of band 3 in the RBCs of the controls, 
patients or relatives. However, the spectrin signal was decreased, whereas the 
stomatin signal was increased in the RBCs of PKAN patients and their relatives 
(Figure 7.2B). These changes were present in all red cells, independent of their 
shape. Immunoblots showed aberrant degradation of band 3 in some patients 
and their relatives  (Figure 7.2C family O; Sup. Figure 7.2 family N, C), but normal 
stomatin and spectrin staining patterns (Sup. Figure 7.3). Taken together, these 
data suggest perturbation in membrane protein organization, rather than protein 
abundance, in the RBCs of PKAN patients.
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FIGURE 7.1 Pedigree and RBC morphology of the subjects in this study. (A) Patients who are clin-
ically diagnosed with PKAN are indicated in grey, the healthy relatives are indicated in white. (B) Repre-
sentative pictures of blood films used for classification of cell shape. (C) Cells are classified in disco-
cyte, echinocyte, acanthocyte or otherwise misshapen. The graph depicts the percentages of different 
cell morphologies in PKAN patients (marked with an asterisk) and their unaffected family members, 
compared to healthy donors (control 1+2) (see also Sup. Figure 7.1 for other PKAN families).
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FIGURE 7.2 Quantitative and qualitative analysis of the main components of the membrane- 
cytoskeleton complex. (A) Confocal microscopy was used to categorize the red blood cells by their 
cell shape in discocyte versus misshapen cells. Immunofluorescence staining of band 3, spectrin and 
stomatin showed that the distribution of these proteins is similar in healthy looking cells and misshapen 
cells. (B) Quantitative image analysis of at least 25 cells was used to determine the mean fluorescent 
values of antibodies against band 3, ß-spectrin and stomatin in relation to the control samples (dotted 
black line at 100%). Error bars represent the standard error. The grey dotted line depicts the standard 
error of the controls.  (C) Band 3 in membrane fractions. Western blot staining with an antibody against 
the N-terminal domain of Band 3 (see also Sup. Figure 7.2). Aberrant degradation patterns are seen in 
the 40 and 70 kDa area.
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Increased numbers of RBC-derived microparticles are present in 
PKAN patients with acanthocytes
Since altered membrane organization has been described to favor MP formation 
during physiological aging and in various hereditary red cell disorders (107), we 
evaluated the amount of RBC-derived MPs in the blood of PKAN patients. The 
numbers of these MPs in the plasma were increased in all members of family A, 
but not in family O (Figure 7.3A). Analysis of the composition of MPs produced 
in vitro showed that the concentration of band 3 decreased for all MPs with time. 
Interestingly, the concentration of glycophorin A-positive vesicles increased 
for controls and O family with time, but decreased for family A (Figure 7.3B), 
suggesting an association between the number of MPs that are generated in vitro 
and their composition (Figure 7.2A). 
PKAN red cells are less resistant to deformation in a spleen-mim-
icking device 
One of the main functional features of RBCs is their capacity to deform in the 
microcirculation and in the narrow sinusoidal space of the spleen (78, 234). We 
used microfluidics technology to simulate the physiological conditions that RBCs 
encounter within the microcapillaries, and to analyze deformability at the single 
cell level (53). We found no major changes in red cell PKAN deformability and 
relaxation compared to healthy red cells, notwithstanding their morphological 
abnormalities (Figure 7.4A). Within the narrow channels, acanthocytes were only 
discernible by minor irregularities, but upon exiting the channels, they imme-
diately relaxed back into their typical shape with thorn-like protrusions (Figure 
7.4A). However, the ability of PKAN RBCs to undergo a more extreme defor-
mation stress, as analyzed with a spleen-mimicking device, was severely reduced 
compared to healthy controls (Figure 7.4B). RBCs from patient A3 and from his 
parents were much more retained than control red cells. The RBCs of patient 
O3 were also more fragile than healthy red cells (Figure 7.4B); analysis of the 
retained and downstream samples indicated that a considerable number of the 
patients' cells was lost, suggesting a high susceptibility to mechanical stress 
leading to cell lysis. 
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FIGURE 7.3 Microparticle formation by PKAN RBCs as characterized by flow cytometry. (A) The 
amount of RBC MPs in plasma. (B) Membrane composition of in vitro generated MPs. Band 3 and glyco-
phorin A (GpA) was measured on MPs collected after 4 and 24h incubation of the RBCs in Ringer solu-
tion at 37 °C.
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FIGURE 7.4 Deformability and fragility studies of RBCs. (A) RBC deformability and relaxation 
capacity was studied with a microfluidic device (53). Scale bar 10 µm. (B) Deformability and fragility 
were also measured with a spleen-mimicking device (78). The cells of interest were stained with CFSE, 
mixed with RBCs of a control donor, and passed through a bed of metal beads (78, 84). Retention was 
measured by the number of cells that did not pass through the bead layer. The percentages of CFSE-pos-
itive cells in the retained and downstream sample were compared to that in the upstream sample (set at 
5%, depicted as a dotted line in panel B).   
A
B
0,00%
2,00%
4,00%
6,00%
8,00%
Ctrl 1 O1 O2 O3 A1 A2 A3
%
 o
f c
el
ls 
of
 in
te
re
st
Retained
Downstream 
129
7.  Red cell structure and function in neuroacanthocytosis
0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
C
tr
ls O
1
O
2
O
3* A1 A2 A3
*
A4 A
5 A6 C
1
C
2
C
3* U
L1
U
L2
U
L3
*
U
L4 U
1
U
2
U
3* U
4 N
1
N
2
N
3*
FIGURE 7.5 Measurements of fetal hemoglobin (HbF) in red cells of PKAN patients and their 
relatives. Dark green patients; light green controls (Ctrls) and family members. The control value is the 
mean of 6 control samples. The error bar depicts the standard deviation.
Hemoglobin composition indicates altered RBC homeostasis in 
PKAN patients 
Since altered MP formation and increased retention in the spleen could affect RBC 
lifespan, we measured HbA1c in PKAN and healthy red cells as an indirect, inde-
pendent parameter of red cell survival (210, 251). Routine hematological param-
eters, including reticulocyte counts and HbA1c values of PKAN patients and their 
relatives were within in the normal range. This provided no indications for a signif-
icant reduction in RBC lifespan. However, the RBCs of several PKAN patients and 
their family members contained increased HbF levels (Figure 7.5A). These findings 
may indicate alterations in erythropoiesis in patients with PKAN (222).
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Discussion
Here we report an extensive morphological and functional description of the red 
cells of patients with PKAN and their relatives, which presents a unique opportu-
nity to investigate the pathophysiology of this rare neurodegenerative disorder.
Our data suggest that the acanthocytic shape is only one of the various possible 
abnormal morphologies of RBCs in patients with PKAN. The presence of 
increased levels of misshapen red blood cells in the blood of relatives without any 
neurological symptoms indicates that perturbation of membrane organization 
may not be limited to the homozygous state of the disease. Together with the 
immunofluorescence and immunoblot data, this suggests that the membrane 
organization of RBCs may be more sensitive to the presence of pathological NA 
proteins than that of neuronal cells. An extensive morphological analysis of the 
red cells of patients with other forms of NA and their relatives is required to test 
the general applicability of this conclusion. At present, we cannot exclude that 
the misshapen red cells represent a stage before the acanthocytes, and that the 
transition occurs as a consequence of aging and/or stress experienced during 
their life (27). However, this theory is not supported by the HbA1c levels, which 
were not significantly different for acanthocyte-rich fractions. Instead, our 
finding that HbF is increased in RBCs from patients with NA may suggest that 
acanthocytes are already formed during erythropoiesis. Increased HbF levels 
have been associated with altered erythropoiesis (199, 210). Indeed, a mild hemo-
lytic anemia is described in many NA patients (206), which could induce stress 
erythropoiesis resulting in increased HbF (185). Thus, our data may imply that 
especially erythropoiesis is sensitive to pantothenate kinase-associated alter-
ations in coenzyme A synthesis.
The decreased spectrin content in PKAN RBCs as detected by our immuno-
fluorescence analysis may be due to a PKAN-related reduction in the spectrin 
content or to a reduced accessibility of epitopes for the anti-spectrin antibody. 
Discrepancies between immune assays and other semi-quantitative methods 
have been noted before in molecular studies on red blood cells and acanthocy-
tosis (27, 71). The immunoblots showed no indications for degradation, but any 
breakdown products may have been degraded and removed from the cells (27, 
192). An altered epitope accessibility may be related to changes in phosphoryla-
tion-sensitive protein-protein interactions underlying abnormal cell morphology 
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(71, 96). The available data do not enable us to distinguish between an innate 
lower spectrin content in newly matured red blood cells and a loss of spectrin 
during their stay in the circulation. Since these alterations were not associated 
with the number of acanthocytes, it is likely that all red cells in PKAN patients 
present abnormal features, which result in abnormally shaped red cells and acan-
thocytes only in a fraction of the cells. 
The changes in staining for the raft marker stomatin, possibly in close associa-
tion with altered microparticle generation (Salzer et al., 2002), constitute other 
indications for a perturbation of the membrane organization in PKAN red blood 
cells. Since misshapen red cells are generally associated with decreased red cell 
deformability (182), we analyzed the deformation of PKAN red cells in a micro-
fluidic device. The deformability of discocytes and misshapen cells from PKAN 
patients was similar to that of red cells from healthy controls. However, the 
decreased deformability and/or the increased fragility of PKAN red cells in the 
spleen-mimicking device suggest an anomaly in the intrinsic membrane deform-
ability of PKAN red cells (Figure 7.4B) This fragility could explain the slight hemo-
lytic anemia in NA patients (206).
In conclusion, we report for the first time an extensive characterization of red 
cells from PKAN patients and family members. We showed increased numbers 
of misshapen red cells together with acanthocytes in PKAN subjects, but also 
in some of their relatives without neurological symptoms. The morphological 
abnormalities were associated with indications for perturbation in cytoskeleton 
and lipid bilayer organization, possibly underlying altered microparticle formation 
and reduced deformability in the spleen. 
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<< Page 132: SUP. FIGURE 7.1 Pedigrees and red cell morphology of other PKAN families. (A) 
Patients that are clinically diagnosed with PKAN are indicated in grey, the healthy relatives are indicated 
in white. PKAN diagnosis could be confirmed by mutation analysis for patient N3 and N4. (B) The graph 
depicts the percentages of various RBC categories in PKAN patients (marked with an asterisk) and their 
family members, compared to healthy donors (control 1, 2 and 3)
SUP. FIGURE 7.2 Band 3 in membrane fractions of several PKAN patients. Western blot staining 
with antibody against N-terminal domain of Band 3, as described in the Material and Methods section. 
Aberrant degradation patterns were found between the 35 and the 70 kDa area.
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8.  Summary and general discussion
The RBC constitutes a prototypic example of the intricate relationship between 
cell structure and function. The RBC’s structure is optimal for its main function: 
efficient oxygen delivery and CO2 removal. It lacks organelles and a nucleus, 
thereby providing more space for the oxygen-carrying protein hemoglobin. 
Furthermore, its typical biconcave, flexible shape does not only maximize the 
surface/volume ratio for gas exchange, but also makes it capable of withstanding 
the mechanical stress it experiences during the many times it travels the circula-
tory system. Often, RBCs have been oversimplified as a ‘bag of hemoglobin’, while 
in reality they are much more complex. Their membrane-cytoskeleton build-up 
enables the cell to resist fragmentation while undergoing extensive deforma-
tion in the microcapillaries and the spleen. Furthermore, RBCs contain important 
enzymes and substrates for several metabolic pathways and antioxidant defense 
mechanisms. These pathways are elegantly controlled by interactions between 
the integral membrane protein band 3 with other membrane and cytoskeletal 
proteins, and with key enzymes of various metabolic pathways. These interac-
tions are regulated by the binding of deoxyhemoglobin to band 3, and thereby 
by the physiological changes in oxygen concentration that the RBCs experience 
during their passage through the circulation.
Mutations in the main RBC proteins are associated with altered morphology, 
decreased stability, and/or increased removal, and many of these mutations 
lead to anemia. It is generally thought that mutations in membrane proteins that 
affect horizontal or lateral interactions lead to elliptocytosis and membrane 
fragmentation, while mutations in proteins involved in vertical interactions are 
thought to induce vesiculation-associated membrane loss, and the concomi-
tant appearance of spherocytes (62). Even though spherocytes and elliptocytes 
are the most common pathological RBC shapes, there is a wide variety of other 
malformations (Figure 1.6). A critical review of the literature does not reveal a 
clear association between RBC morphology, the affected protein and functional 
changes. Moreover, there is only a limited number of data on the effect of a 
disturbance of membrane protein interactions on RBC metabolism. Thus, there is 
an unmet need for a molecular framework that explains the effect of alterations 
in a membrane protein on the interaction with its partners, and the concomi-
tant effects on RBC morphology and function. Such a framework would be of 
great benefit for understanding the causes of anemia and the side effects of 
RBC transfusion products. Furthermore, this may generate new insights in the 
role of RBC vesiculation.
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The main aim of the research described in this thesis was to gain a better under-
standing of the structural features that determine the function and morphology 
of the red blood cell in health and disease. 
Chapter 1 provides a general introduction to RBCs and their structure-function 
relationship in health, as well as in pathological and transfusion-related circum-
stances. 
Red cell survival after transfusion 
In chapter 2, we review the available data on aging-associated and storage-asso-
ciated alterations in RBC deformability. During storage, RBCs undergo various 
metabolic, structural and morphological changes, the so-called storage lesions. 
The consequences of these changes for RBC survival after transfusion are mostly 
unknown. Strikingly, it still has not been determined which changes acquired 
during storage are responsible for the disappearance of up to 30 percent of the 
transfused RBCs within the first hours after transfusion in the patient. Since the 
changes in most metabolic parameters such as 2,3-DPG, ATP, and pH are rapidly 
reversible, the metabolic events underlying these parameters are not likely to 
contribute to most adverse transfusion effects. The storage-associated morpho-
logical changes suggest that alterations in membrane structure are more likely 
to cause a decrease in transfusion efficacy and an increase in harmful effects. 
The last few years have witnessed a strong increase in proteomic and biochem-
ical data on RBC biology during blood bank storage. Especially the data on stor-
age-related exposure of removal signals such as PS and band 3-derived senes-
cent cell antigens support the theory that physiological aging-related changes in 
the RBC membrane are major, functionally relevant quality determinants of RBC 
concentrates. 
The review, together with preliminary data from our own laboratory, support the 
theory that changes in the RBC membrane during blood bank processing and 
especially in the first two weeks of storage are responsible for the accompanying 
changes in deformability. After two to three weeks of storage, functionally rele-
vant molecular changes are likely to become irreversible, since they comprise 
progressive proteolysis and vesicle formation. Uncovering the triggering events 
and the underlying signaling pathways will be instrumental in understanding and 
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preventing the untimely disappearance of a considerable fraction of the trans-
fused RBCs within the first hours after transfusion. 
In our perspective, the most fruitful approach to elucidate the basis for reduced 
RBC survival after transfusion starts with investigating the effects of signal-
ing-based manipulation of RBCs in vitro on physiological relevant parameters. 
These parameters should be informative on the activation of, and recognition 
and removal by the immune system, on deformability in the capillaries and in 
the spleen, and on the susceptibility to osmotic stress, as this may be critical 
during passage of transfused RBCs through the kidneys. Proteomic and metab-
olomic information will be important in assessing the accompanying changes in 
membrane structure and homeostasis. The main challenge consists of the devel-
opment of biologically relevant read-out systems, and the more consequent 
correlation in blood bank research between quality control in the blood bag and 
quality control in the patient.
Relevant read-out systems of physiological 
indicators of RBC survival
In chapters 3 and 4 we present the data of our research on two physiologically 
relevant parameters for red cell survival after transfusion, deformability and 
exposure of removal signals. During its passage through the circulation, the RBC 
encounters deformation-associated mechanical stress in the capillaries and in 
the spleen, and osmotic stress during its passage through the kidney. Therefore, 
we used a microfluidic device to test the deformation capacity in capillary-mim-
icking circumstances, and we assessed the effects of osmotic stress on the expo-
sure of the removal signal phosphatidylserine (PS).
Deformability, the combined result of properties of the membrane-cytoskeleton 
complex, the surface area-to-volume ratio, and the hemoglobin content, is a crit-
ical determinant of capillary blood flow (183). During blood bank storage as well 
as in many pathophysiological conditions, RBC morphology changes, and these 
changes have been suggested to be associated with decreased deformability and 
removal (20, 94, 98, 235). While various techniques provide information on the 
rheological properties of stored RBCs, their clinical significance is controversial. 
We developed a microfluidic approach for evaluating RBC deformability in a phys-
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iologically meaningful and clinically significant manner. Unlike other techniques, 
our method enables a high-throughput determination of changes in deformation 
capacity to provide statistically significant data, while providing morphological 
information at the single-cell level. In addition, the visual aspect of this method 
makes it possible to study subpopulations within one sample, making it an attrac-
tive method to study red cell pathologies. By parallelization of several microchan-
nels, sufficient throughput can be generated for off-line analysis, for example 
with flow cytometry. In chapter 3, we use this technique to demonstrate that high 
temporal resolution imaging of RBCs at the exit zone of narrow channels provides 
comprehensive information on their capacity to deform and subsequently relax 
to a discoid shape. A simultaneous detection of a deformed and relaxing RBC can 
be performed, thereby correlating deformation behavior to the morphology of 
mechanically unstressed RBCs. Our data show that, under conditions that closely 
mimic capillary dimensions and flow, the capacity to deform and the capacity to 
relax are not affected during storage in the blood bank. Our data also show that 
altered cell morphology by itself does not necessarily affect deformability.
During storage in blood bags, RBCs undergo a series of structural changes 
that include the exposure of phosphatidylserine (PS), a potent removal signal 
in vivo. In chapter 4, we postulate that, during blood bank storage, the suscep-
tibility to stress-induced PS exposure increases, thereby rendering a consider-
able fraction of the RBCs susceptible to rapid removal after transfusion. There-
fore, we exposed RBCs of different storage times to various near-physiological 
stress conditions, such as hyperosmotic shock and energy depletion. The effect 
of these treatments on PS exposure was measured by flow cytometric anal-
ysis of annexin V binding. We show that during storage under blood bank condi-
tions, RBCs become increasingly susceptible to loss of phospholipid asymmetry. 
These effects are most prominent when induced by hyperosmotic shock, such as 
RBCs experience in vivo in the kidneys. Particularly the RBCs of higher densities 
become increasingly susceptible with storage time. These cells have a smaller 
volume and an increased HbA1c content, as is typical of aged RBCs. We conclude 
that during blood processing and storage in the blood bank, some RBCs become 
damaged and thereby acquire an increased susceptibility to stress-induced PS 
exposure. This increased susceptibility may be responsible for the rapid disap-
pearance of a considerable fraction of the RBCs during the first 24 hours after 
transfusion. The RBCs that are rapidly cleared from the circulation after trans-
fusion are the most likely cause of unwanted transfusion reactions, especially 
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in patients who depend on frequent transfusions. Elucidation of the molecular 
cause of this increased susceptibility to PS exposure and removal may lead to the 
development of methods to prevent their generation, or to remove them from 
the blood bag before transfusion.
During its time in the circulation, as well as during storage in the blood bank, RBCs 
lose membrane surface due to continuous vesiculation (38, 252). In general, vesi-
cles are associated with various physiological processes involving intercellular 
communication, hemostasis, and immunity (99, 127). In the last few years, the 
interest in the ins and outs of RBC vesiculation has increased, since vesiculation 
plays a role in all stages of the RBC’s life, constitutes one of the RBC storage 
lesions, and is involved in RBC pathologies. Therefore, the formation of vesicles, 
their quantity and their composition constitute a relevant biomarker for RBC 
homeostasis, both in vivo and in vitro. In chapter 5, we give an overview of the 
available data on the vesicle composition of RBCs and the hypotheses that have 
been proposed for the vesicle generation process. We combine these data into 
a new model and postulate some experimental approaches to confirm and/or 
enhance this theory. In our model, a disturbance of the band 3-ankyrin anchoring 
complexes leads to increased compression and rigidity of the spectrin cytoskel-
eton, leading to buckling of the phospholipid bilayer, which then results in vesicle 
formation. The predictions of this model on size and protein composition of vesi-
cles are confirmed by the available data, especially data of vesicles that are gener-
ated during aging in vivo and in blood bank storage conditions. Manipulation of 
the lipid composition of the RBC membrane may be instrumental in improving 
RBC quality, for example, in blood bank conditions. Also, manipulation of protein 
modification, including but possibly not restricted to prevention of oxidation 
and/or proteolysis, may result in a more robust RBC. A more detailed, molec-
ular elucidation of the vesicle composition is necessary to falsify our hypotheses.
Regulation of red blood cell homeostasis 
through structural changes
During their passage through the circulation, human red blood cells encounter 
severe conditions. Yet, they survive for 120 days, and also adapt to their surround-
ings by subtle regulation of membrane organization and metabolism. RBC homeo-
stasis depends heavily on interactions between the integral membrane protein 
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band 3 with other membrane and cytoskeletal proteins, and with key enzymes of 
various metabolic pathways. These interactions are regulated by the binding of 
deoxyhemoglobin to band 3, and by a signaling network revolving around Lyn and 
Syk kinase-mediated phosphorylation of band 3. 
Triggered by the data discussed in chapter 2, we investigated the effects of signal-
ing-based manipulation of RBCs in vitro on physiologically relevant parameters in 
chapter 6. After an initial screening of a number of compounds, we determined 
the effects of the band 3-affecting reagents DIDS, NEM, PP2 and orthovana-
date on a number of morphological and functional RBC characteristics, protein 
localization at the plasma membrane, and generation and composition of vesi-
cles. We show that band 3-centered manipulation of the interaction between 
the lipid bilayer and the cytoskeleton has various effects on: 1) morphology as 
shown by high resolution microscopy and quantitative image analysis; 2) orga-
nization of membrane proteins as indicated by immunofluorescence confocal 
microscopy and quantitative as well as qualitative analysis of vesicle genera-
tion; (3) membrane lipid organization as indicated by flow cytometric analysis of 
phosphatidylserine exposure; 4) deformability as assessed in capillary-mimicking 
circumstances using a microfluidics system; 5) deformability as determined using 
a spleen-mimicking bead-sorting device; 6)  metabolic activity as indicated by 
metabolomic analysis. 
Changes in organization of the membrane-cytoskeleton proteins are not neces-
sarily accompanied by changes in cell morphology, and vice versa, indicating the 
absence of a consistent correlation between cell morphology and membrane 
organization. Furthermore, in our experience, changes in morphology, deforma-
bility, and PS exposure are not always correlated, as has been commonly surmised, 
based on pathological conditions such as HE and HS. 
Conclusions on the effect of a change in membrane organization on deforma-
bility are likely to depend on the degree and type of mechanical stress employed 
during analysis. Because different techniques yield different data on RBC 
deformability, we propose a critical appraisal on the biological relevance on 
the commonly used methods to measure deformability. Since the bead-sorting 
device and the microfluidic device measure deformability under physiological 
circumstances-mimicking conditions, these seem to be more biologically rele-
vant than the standard ektacytometry or micropipette aspiration methods. 
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Furthermore, it remains to be established if and how the method of analysis itself 
contributes to the observed effects. For example, high shear stress, as expe-
rienced in the spleen-mimicking device and in the ektacytometer, may induce 
vesiculation and thereby reduce deformability in susceptible RBCs that display a 
normal deformability in the less stressful conditions of the microfluidic system.
Overall our data show that there is a complex relationship between red cell 
morphology, membrane organization and deformability. The data demonstrate 
that RBCs have a relatively high resistance to disturbance of membrane organi-
zation in vitro, which may reflect their capacity to withstand mechanical, oxida-
tive and osmotic stress in vivo. Furthermore, they show that the main current 
theories in which disturbances in horizontal or vertical linkage between the lipid 
bilayer and the cytoskeleton are directly linked to changes in cell morphology 
require a re-evaluation, since they are insufficient to explain all structural and 
functional observations.
One of the main conclusions we draw from our metabolomics data is the signif-
icant influence of donor variability on the metabolome of the red blood cell. 
Our data suggest large differences between individuals in the susceptibility of 
the main metabolic pathways of the RBC to disturbance of band 3 conforma-
tion. This may be due to genetic variability in the characteristics of key enzymes 
in the various metabolomic pathways and/or membrane transporters, or to the 
variability in the natural history of the red blood cells. These interindividual differ-
ences could well influence other RBC homeostatic processes, such as suscepti-
bility to oxidative damage.
Neuroacanthocytosis
Neuroacanthocytosis (NA) is a family of rare hereditary neurodegenerative 
disorders, which includes chorea-acanthocytosis (ChAc), McLeod syndrome 
(MLS), Huntington’ s disease-like 2 (HDL2) and panthothenate kinase-associ-
ated neurodegeneration (PKAN). Patients affected by these progressive, fatal 
disorders suffer from devastating movement disorders as well as a variety of 
other symptoms, caused by neurodegeneration of the basal ganglia.  One of the 
biological hallmarks of NA is the presence of acanthocytes in the blood, RBCs 
with thorny protrusions. The association of acanthocytosis and neurodegenera-
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tion of the basal ganglia suggests a common pathogenic pathway. Therefore, a 
key to the understanding of underlying mechanisms of these disorders may be 
found in the RBCs of NA patients. 
Changes in the structure and function of band 3, as well as abnormalities in a 
band 3-regulating signaling network occupy a central position in our knowledge 
on the RBCs from NA patients. However, the relation between the disease-
causing mutations, the abnormal RBC shape, the structural changes and their 
effects on the function of the acanthocytic red cells remains mainly unknown.
In chapter 7 we measure the earlier described physiologically relevant parame-
ters (deformability, vesiculation and PS exposure) in RBCs from PKAN patients. In 
a large collaborative study to elucidate the molecular mechanisms underlying the 
aberrant red cell morphology and the corresponding functional consequences, 
we analyzed the RBCs of several PKAN families. PKAN has been recently included 
in NA as a recessive NBIA disorder (neurodegeneration with brain iron accumula-
tion), displaying clinical manifestations similar to those of NA, but characterized 
by the accumulation of iron in the basal ganglia. In comparison with ChAc and 
MLS, only limited data are available on the characteristics of the RBCs of PKAN 
patients. 
We performed a qualitative and semi-quantitative morphological, immunoflu-
orescent, biochemical and functional analysis of the RBCs of several patients 
with PKAN and, for the first time, also of the RBCs of their family members. We 
show that the blood of patients with PKAN contains not only variable numbers of 
acanthocytes, but also a wide range of other misshapen RBCs. Immunofluores-
cent and immunoblot analyses suggest an altered membrane organization, rather 
than quantitative changes in protein expression. Strikingly, these changes are not 
limited to the red blood cells of PKAN patients, but are also present in the RBCs 
of heterozygous carriers without neurological problems. Moreover, changes are 
not only present in acanthocytes, but also in other RBCs, including discocytes. 
The morphological abnormalities were associated with perturbations in cyto-
skeleton and lipid bilayer organization, possibly underlying altered microparticle 
formation and reduced deformability in the spleen. Furthermore, we found that 
fetal hemoglobin (HbF) is increased in RBCs from patients. Since increased HbF 
levels have been associated with altered erythropoiesis, this suggests that acan-
thocytes are already formed during erythropoiesis. 
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These morphological, molecular and functional characteristics of red cells in 
patients with PKAN and their family members offer new tools for diagnosis and 
present a window on the pathophysiology of neuroacanthocytosis.
Future directions
As ‘simple’ as the red cell is, it still requires considerable scrutiny before its most 
fundamental characteristics are fully understood. Various mechanisms have 
been postulated for the generation of abnormally shaped RBCs. These theo-
ries center around a weakening of the linkage between the cytoskeleton and the 
lipid bilayer. Current theories on disturbance of the horizontal or vertical linkages 
seem to be insufficient to explain all structural and functional observations. Our 
data in chapter 5 show that the structure-morphology linkage is more complex. 
Moreover, the homeostasis of red cells is a refined process, with more regula-
tory systems than may be expected at first sight. Phosphorylation seems to be of 
great importance in an active signal transduction network in the RBC membrane, 
regulating membrane organization, and thereby RBC homeostasis (70, 95, 197, 
208). Therefore, it may be worthwhile to invest in phosphoproteomic analyses in 
order to establish a better picture of these signaling pathways. On top of that, 
metabolomic analysis may turn out to be instrumental in the identification of 
players in the signaling routes that regulate the RBC’s homeostasis, and of the 
interaction between the RBC and its organism-wide environment, both in healthy 
and in pathological circumstances. Especially metabolomics analysis of patient 
RBCs and plasma in comparison with healthy controls could lead to new insights.
Chemical reagents that interact with membrane proteins or that inhibit kinases 
or phosphatases have a low specificity. Finding a more specific method to manip-
ulate the interaction of membrane proteins could help in a better understanding 
of fundamental RBC processes. For this goal two strategies could be used. First, 
protein-protein interactions could be disturbed by means of specific peptides. 
For this, recently developed methods to introduce peptides and proteins into 
RBCs could be used (93), instead of the more artificial ghost resealing tech-
niques used so far (8, 19). Second, genetically encoded tools may be used to 
study dynamic signaling processes in living cells. Innovative techniques, such as 
inducible protein dimerization tools, can be applied to activate specific signaling 
proteins in cells on demand with a chemical or light-induced stimulus (79, 198, 
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200). Since RBCs do not have a genetic machinery which can be exploited for 
such a strategy, this approach should be applied to red cell progenitor cells or to 
iPS cells, which then can be differentiated in vitro. 
The latter strategy may also be of interest in the research on the pathophysi-
ology of NA. There are several indications that, in NA patients, critical processes 
may be altered during erythropoiesis, resulting in the appearance of acantho-
cytes and other misshapen RBCs in the circulation. Therefore, studying the 
different steps of erythroblast maturations instead of RBCs may be a worthwhile 
strategy. Furthermore, since patient material is very rare, it might be worthwhile 
to invest in the generation of induced pluripotent stem (iPS) cells, in order to 
have an unlimited source of research material. Human patient-specific iPS cells 
are believed to be an ideal cell model of neurodegenerative diseases. Since iPS 
cells behave similar to embryonic stem cells, these cells do not only provide a 
nearly unlimited cell source for pathophysiological studies, but also allow direct 
studies of all major cell types affected in NA, such as brain cells (astrocytes and 
neurons) and peripheral cells (RBCs, myocytes). Moreover, the generated cell 
model would eventually also be suitable for high-throughput drug screening for 
innovative NA treatment approaches.
Furthermore, in order to understand the molecular mechanisms underlying 
RBC-mediated pathology, we need to employ more physiologically relevant 
tools. The spleen-mimicking and capillary-mimicking devices are good first steps, 
revealing for example functional changes even if the morphology is unaffected. 
Nevertheless, they can be improved. With our current microfluidic system, 
RBCs pass only once through a capillary constriction. This single passage may 
be insufficient to reveal how differences in membrane protein composition and 
protein-protein interaction affect the function of RBCs in the constantly recur-
ring shear stress in vivo. Moreover, we do not know if and how deformability of 
RBCs is influenced by differences in oxygen pressure such as the cells encounter 
in the circulation. In order to address these issues, the microfluidics system 
could be expanded with an oxygen level control unit and a loop. To make the 
system resembling the situation in vivo even more, the walls of the device could 
be coated with vascular endothelial cells. Abnormal interactions between RBCs 
and endothelial cells are crucial in causing vascular pathology in several diseases 
(230). So, by refining the microfluidic set-up, a full range of conditions that a RBC 
encounters in the circulation, could be simulated.
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Finally, the spleen plays a vital role in RBC ageing, vesiculation and clearance (35, 
176, 252). The red pulp macrophages are phagocytically very active and seem to 
play a role in the removal of old and damaged RBCs (49, 176). Therefore, adding 
red pulp macrophages to the bead compartment of the spleen-mimicking device, 
would make the device a better resemblance to the situation in vivo. That way, not 
only mechanical retention can be observed, but the role of cell-cell interaction 
and phagocytosis can be studied as well.
Conclusion
In this thesis, we introduce several physiologically relevant read-out systems and 
new techniques to study RBC characteristics, which can be helpful in assessing 
the survival of transfused or pathologically disturbed RBCs. Furthermore, we 
provide some new insights into the effects of changes in plasma membrane 
organization on red cell morphology and function. Although we are just discov-
ering the complexity of the red blood cell, these and other new techniques and 
approaches will help to understand the fundamental structural characteristics 
that shape red blood cell function.
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De rode bloedcel (RBC) is een duidelijk voorbeeld van een cel waarbij structuur 
en functie perfect op elkaar afgestemd zijn. Haar belangrijkste functie is het effi-
ciënt leveren van zuurstof aan de organen en het verwijderen van CO2. De rode 
bloedcel heeft geen organellen of een celkern, waardoor er meer ruimte is voor 
hemoglobine, het molecuul dat zuurstof bindt en vervoert. Bovendien zorgt de 
typische biconcave, flexibele vorm niet alleen voor een optimale oppervlakte/
volume ratio voor gaswisseling, maar maakt die ook dat de cel bestand is tegen 
de mechanische krachten in de bloedsomloop.
Rode bloedcellen worden vaak ten onrechte voorgesteld als een ‘zak met 
hemoglobine’. In werkelijkheid zijn ze echter zeer complex georganiseerd. Het 
membraan-cytoskelet zorgt ervoor dat de cel niet fragmenteert wanneer ze 
wordt vervormd in de microcapillairen en milt. Verder bevatten rode bloedcellen 
belangrijke enzymen en substraten voor meerdere metabole routes en bescher-
mingsmechanismen tegen oxidatieve schade.  Deze processen worden elegant 
gestuurd door interacties van het integrale membraaneiwit band 3 met andere 
membraan- en cytoskeleteiwitten (zie figuur 1.1) en met sleutelenzymen van de 
verschillende metabole routes. Deze interacties worden op hun beurt geregu-
leerd door de binding van deoxyhemoglobine aan band 3 en dus door de fysi-
ologische veranderingen in zuurstofconcentratie die  de rode bloedcel ervaart 
tijdens de circulatie door het lichaam.
Veranderingen in de belangrijkste rode bloedceleiwitten zijn geassocieerd met 
veranderde morfologie, verminderde stabiliteit en/of verhoogde verwijdering 
van cellen uit de circulatie en leiden dan ook vaak tot anemie. Er is een breed 
scala aan malformaties van de rode bloedcel (figuur 1.6), waarbij sferocyten 
en elliptocyten het meest voorkomen. Er is nog geen duidelijk verband aange-
toond tussen de RBC morfologie, de aangedane eiwitten en functionele veran-
deringen. Bovendien is op dit moment maar weinig kennis over het effect van 
verstoringen van membraaneiwit-interacties op het metabolisme van de rode 
bloedcel. Er is dus een behoefte aan een moleculair raamwerk dat het effect van 
veranderingen in een membraaneiwit op de interactie met zijn partners, en de 
bijkomende effecten op RBC morfologie en functie verklaart. Zo'n raamwerk zou 
van groot nut zijn voor het begrijpen van de oorzaak van anemie en de effecten 
van bloedtransfusie. 
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Het belangrijkste doel van het in dit proefschrift beschreven onderzoek was een 
beter begrip te krijgen van de structurele kenmerken die de functie en morfol-
ogie van de rode bloedcel in gezondheid en ziekte bepalen. Hoofdstuk 1 geeft 
een algemene inleiding over de rode bloedcel en hoe structuur en functie aan 
elkaar gerelateerd zijn.
 
Overleving van de rode bloedcel
na transfusie
In hoofdstuk 2 worden de in de literatuur beschreven veranderingen in vervorm-
baarheid van de RBC als gevolg van veroudering en opslag in de bloed-
bank besproken.  Tijdens opslag in de bloedbank ondergaan rode bloedcellen 
verscheidene metabole, structurele en morfologische veranderingen.   Opval-
lend genoeg is het niet bekend welke van deze veranderingen verantwoordelijk 
zijn voor het verdwijnen van een aanzienlijk percentage van de getransfundeerde 
cellen in de patiënt binnen de eerste uren na transfusie. Aangezien veranderingen 
in de meeste metabole parameters zoals 2,3-DPG, ATP en pH reversibel zijn, zijn 
veranderingen daarin waarschijnlijk niet verantwoordelijk voor de snelle verwi-
jdering van deze cellen. De morfologische veranderingen tijdens de opslag die 
gepaard gaan met veranderingen in de membraanstructuur zouden wél kunnen 
leiden tot een afname in transfusie effectiviteit en een toename van de schade-
lijke bijeffecten. 
De afgelopen jaren is er een sterke toename geweest van data over de staat van 
de rode bloedcel tijdens opslag in de bloedbank.  Onderzoek naar het ontstaan 
van verwijderingssignalen zoals fosfatidylserine en band 3-afgeleide verouder-
ingsantigenen bevestigt de theorie dat veranderingen die gerelateerd zijn aan 
fysiologische veroudering in de RBC membraan relevante determinanten zijn 
voor de kwaliteit van transfusie-RBC’s.
Ons literatuuronderzoek ondersteunt de theorie dat veranderingen in de RBC 
membraan tijdens bewaren in de bloedbank, met name in de eerste twee weken 
van opslag, verantwoordelijk zijn voor veranderingen in vervormbaarheid.  Na 
twee tot drie weken worden de relevante moleculaire veranderingen waarschijn-
lijk irreversibel, omdat ze een gevolg zijn van progressieve proteolyse en vorming 
van vesikels. Het aan het licht brengen van de omstandigheden die dit activeren, 
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alsook de onderliggende signaalroutes, zal het begrip én op termijn het voor-
komen bevorderen van het vroegtijdig verdwijnen van een aanzienlijk deel van de 
getransfundeerde rode bloedcellen.
Om de verminderde RBC overleving na transfusie op te helderen is het zinvol 
de effecten van manipulatie van signaleringsprocessen in de cel in vitro op fysi-
ologisch relevante parameters te onderzoeken. Deze parameters moeten infor-
matief zijn over de activatie van, en herkenning en verwijdering door het immu-
unsysteem, over de vervormbaarheid van de cellen in de capillairen en de milt, 
en over de gevoeligheid voor osmotische stress. Informatie uit de proteomica en 
metabolomica zal belangrijke bijdragen leveren aan  het vaststellen van de bijbe-
horende veranderingen in de membraanstructuur en homeostase van de cel. 
Relevante indicatoren voor RBC overleving
In hoofdstuk 3 en 4 presenteren we de gegevens van ons onderzoek naar twee 
fysiologisch relevante parameters voor de rode bloedcel overleving na transfusie: 
vervormbaarheid en het verschijnen van verwijderingssignalen. Tijdens de bloed-
somloop, ervaart de RBC extreme mechanische stress als gevolg van vervorming 
in de capillairen en in de milt, alsook osmotische stress tijdens de passage door 
de nieren. Daarom hebben we een opstelling gemaakt met op capillairen lijkende 
microkanalen, waarmee we in vitro de vervormingscapaciteit van cellen konden 
testen. Daarnaast onderzochten we de effecten van osmotische stress op het 
verwijderingssignaal fosfatidylserine.
Vervormbaarheid
Goede vervormbaarheid is belangrijk voor een succesvolle passage door de 
capillairen en de milt. Deze wordt bepaald door drie factoren: de eigenschappen 
van het membraan-cytoskelet complex, de oppervlakte/volume-verhouding van 
de cel en het hemoglobinegehalte. Tijdens het bewaren van rode bloedcellen in 
de bloedbank en bij veel rode-bloedcelaandoeningen verandert de morfologie 
van de cel. In de literatuur wordt verondersteld dat deze veranderingen gepaard 
gaan met een verminderde vervormbaarheid en verhoogde verwijdering uit 
de circulatie.  Terwijl verschillende technieken informatie geven over de reolo-
gische eigenschappen van de RBC, is de klinische betekenis van deze informatie 
twijfelachtig.  Daarom ontwikkelden wij een opstelling met microkanalen om 
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RBC vervormbaarheid te bestuderen onder voor de kliniek relevante omstan-
digheden. In tegenstelling tot andere technieken levert onze methode statistisch 
relevante gegevens op basis van analyse van grote hoeveelheden cellen, waarbij 
ook analyse van individuele cellen mogelijk is. Door het visuele aspect van deze 
methode is het mogelijk om subpopulaties te analyseren. Hierdoor is het ook 
een aantrekkelijke methode om ziektebeelden van de rode bloedcel te bestud-
eren. In hoofdstuk 3 passen we deze techniek toe op rode bloedcellen uit trans-
fusie-eenheden. Daarvoor hebben we monsters genomen van verschillende 
bewaartijden en geanalyseerd in een proefopstelling die de capillaire afmetingen 
en stroming in het lichaam nabootst. Onze resultaten laten zien dat het vermogen 
van de cellen om te vervormen én het vermogen om daarna weer te ontspannen 
niet aangetast worden tijdens de opslag in de bloedbank. Onze gegevens tonen 
ook aan dat een verandering in celmorfologie op zich niet gerelateerd is met de 
vervormbaarheid.
Omdat verschillende technieken voor het meten van vervormbaarheid verschil-
lende uitkomsten opleveren, zou er kritisch moeten worden gekeken naar de 
biologische relevantie van de tot nu toe gangbare methodes om vervormbaar-
heid te meten. Aangezien de opstelling met microkanalen, evenals een milt-na-
bootsende techniek, de vervormbaarheid onder fysiologische omstandigheden 
simuleren, lijken deze meer relevant dan de standaard ektacytometrie- of de 
micropipet-methoden. 
Fosfatidylserine 
Tijdens de opslag in bloedzakken ondergaan rode bloedcellen veranderingen. 
Een hiervan is het verlies van de asymmetrische verdeling van fosfolipiden in 
de membraan en het verschijnen van fosfatidylserine aan de buitenkant van het 
celmembraan. Fosfatidylserine is een krachtig verwijderingssignaal in vivo. In 
hoofdstuk 4 veronderstellen we dat tijdens de opslag in de bloedbank de gevoe-
ligheid voor het stress-geïnduceerde verschijnen van fosfatidylserine toeneemt, 
wat ertoe leidt dat een aanzienlijk deel van de rode bloedcellen gevoelig wordt 
voor snelle verwijdering.  Om dit te testen hebben we rode bloedcellen van 
verschillende bewaartijden blootgesteld aan enkele stressomstandigheden die 
de fysiologie nabootsen, zoals een hyperosmotische shock en glucosetekort. Het 
effect van deze behandelingen op de verschijning van fosfatidylserine werd 
gemeten door flowcytometrische analyse van annexine V binding. We tonen aan 
dat tijdens bewaren onder bloedbankomstandigheden rode bloedcellen in toen-
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emende mate vatbaar worden voor verlies van fosfolipidenasymmetrie.  Deze 
effecten zijn het meest uitgesproken na een hyperosmotische shock, zoals de 
rode bloedcellen ook ervaren in de nieren. Met name oudere rode bloedcellen 
worden gevoeliger met de bewaartijd. We concluderen dat tijdens de verwerking 
van bloed en de opslag van rode bloedcellen in de bloedbank, sommige rode 
bloedcellen beschadigd raken en daardoor een verhoogde gevoeligheid verw-
erven voor het laten verschijnen van fosfatidylserine aan de buitenkant.  Deze 
verhoogde gevoeligheid kan de reden zijn voor het snelle verdwijnen van een 
aanzienlijk deel van de rode bloedcellen gedurende de eerste uren na trans-
fusie. Rode bloedcellen die snel na transfusie worden verwijderd uit de circulatie 
zijn de meest waarschijnlijke oorzaak van ongewenste transfusiereacties. Dit is 
voornamelijk een probleem bij patiënten die transfusie-afhankelijk zijn.  Ophel-
dering van de moleculaire oorzaak van deze verhoogde gevoeligheid kan leiden 
tot de ontwikkeling van methoden om dit te voorkómen, of om de cellen met een 
verhoogde gevoeligheid uit de bloedzak te verwijderen vóór transfusie.
Vorming van vesikels 
Zowel in de bloedsomloop als tijdens de opslag in de bloedbank verliezen rode 
bloedcellen membraanoppervlak door de vorming van vesikels. In het algemeen 
worden vesikels geassocieerd met verschillende fysiologische processen waar-
onder intercellulaire communicatie, hemostase en reacties van het immuunsys-
teem. In de afgelopen jaren is de interesse in vorming van vesikels door de RBC 
toegenomen, omdat dit proces een rol speelt in alle stadia van het leven van de 
RBC. Bovendien speelt vesikelvorming een negatieve rol bij bloedtransfusies en 
bij RBC pathologieën. Daarom is de vorming van vesikels, zowel wat betreft de 
hoeveelheid als de samenstelling, een relevante biomarker voor RBC homeo-
stase in vivo en in vitro. In hoofdstuk 5 geven we een overzicht van de beschik-
bare gegevens over de samenstelling van RBC vesikels en de hypotheses voor de 
manier waarop ze gevormd worden. Aan de hand hiervan stellen we een nieuw 
model voor, alsook enkele experimentele benaderingen waarmee dit kan worden 
getoetst. In ons model leidt een verstoring van de band 3-ankyrine complexen 
tot meer compressie en stijfheid van het spectrinecytoskelet, hetgeen leidt tot 
het kromtrekken van de fosfolipide bilaag. Dit resulteert in vesikelvorming (Figuur 
5.3). Van dit model afgeleide aannames over de grootte en eiwitsamenstelling 
van vesikels worden bevestigd door de in de literatuur beschikbare gegevens. 
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Regulering van de homeostase van de RBC
door middel van  veranderingen in de 
structuur
Ondanks de zware omstandigheden die rode bloedcellen ervaren tijdens hun 
tocht door het lichaam, bedraagt hun levensduur toch 120 dagen. Ze passen zich 
aan hun omgeving aan door subtiele regulatie van membraan-organisatie en 
metabolisme.  Naar aanleiding van de bevindingen in hoofdstuk 2 onderzoeken 
we in hoofdstuk 6 de effecten van manipulaties van signaleringsroutes op fysi-
ologisch relevante parameters in vitro. Na een eerste screening van een aantal 
chemische stoffen, bepaalden we het effect van reagentia die de structuur van 
het membraaneiwit band 3 beïnvloeden. Onze resultaten tonen aan dat manipu-
latie van de interactie tussen de lipide bilaag en het cytoskelet via band 3 effecten 
heeft op: 1) celmorfologie; 2) organisatie van membraaneiwitten; (3) organisatie 
van membraanlipiden; 4) vervormbaarheid; 5) metabolisme. Ook concluderen we 
dat veranderingen in de organisatie van de eiwitten in het cytoskelet-membraan 
complex niet noodzakelijkerwijs gepaard gaan met veranderingen in celmorfol-
ogie en vice versa. Er is dus geen consistent, eenduidig verband tussen celmor-
fologie en membraanorganisatie. Bovendien blijken veranderingen in morfologie, 
vervormbaarheid en fosfatidylserine-expressie niet altijd gecorreleerd te zijn. Dit 
weerspreekt het heersende beeld, dat vooral berust op waarnemingen bij pathol-
ogische rode bloedcelaandoeningen zoals elliptocytose en sferocytose.
Uit onze studie blijkt ook dat er een complexe relatie bestaat tussen morfol-
ogie, membraan-organisatie en vervormbaarheid. RBCs hebben een grote weer-
stand tegen verstoring van membraanorganisatie in vitro. Dit kan hun vermogen 
weerspiegelen om mechanische, oxidatieve en osmotische stress te weerstaan 
in vivo. Bovendien zien we dat de belangrijkste huidige theorieën, die stellen dat 
verstoringen in horizontale of verticale verbindingen tussen de lipide bilaag en 
het cytoskelet rechtstreeks verband houden met specifieke veranderingen in de 
celmorfologie, een herevaluatie vereisen, omdat ze niet alle structurele en func-
tionele observaties kunnen verklaren.
Een van de belangrijkste conclusies die we trekken uit onze metabole data is de 
aanmerkelijke invloed van donor variabiliteit op het metaboloom van de rode 
bloedcel.  Onze gegevens suggereren dat grote interindividuele verschillen 
bestaan in de gevoeligheid van de belangrijkste metabole routes van de RBC voor 
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verstoring van de band 3 conformatie. Dit kan het gevolg zijn van genetische vari-
abiliteit in de eigenschappen van sleutelenzymen in de diverse metabole paden 
en/of membraan transport eiwitten. Deze interindividuele verschillen zouden ook 
andere processen om de homeostase te bewaken kunnen beïnvloeden, zoals het 
voorkomen van oxidatieve schade.
Neuroacanthocytose
Neuroacanthocytose (NA) is de aanduiding voor een groep zeldzame erfe-
lijke neurodegeneratieve aandoeningen, waar chorea-acanthocytosis (ChAc), 
McLeod syndroom (MLS), ‘Huntingtons disease-like 2’ (HDL2) en pantothenaat-ki-
nase geassocieerde neurodegeneratie (PKAN) onder vallen. Patiënten met deze 
progressieve, fatale aandoeningen lijden aan ernstige bewegingsstoornissen 
alsmede een verscheidenheid aan andere symptomen, veroorzaakt door neuro-
degeneratie van de basale ganglia. Een van de biologische kenmerken van NA is de 
aanwezigheid van acanthocyten in het bloed. Dit zijn rode bloedcellen met opval-
lende, doornachtige uitsteeksels. De combinatie van acanthocytose en neurode-
generatie suggereert een gemeenschappelijke pathogene route. Daarom kunnen 
rode bloedcellen van NA patiënten een sleutelrol spelen in het begrijpen van de 
onderliggende moleculaire oorzaken van de ziekteverschijnselen.
Onze huidige kennis over de rode bloedcellen van NA patiënten betreft vooral 
veranderingen in de structuur en functie van band 3, alsmede afwijkingen in een 
met band 3 geassocieerd signaleringsnetwerk. Echter, over de relatie tussen de 
mutaties die de ziekte veroorzaken, de abnormale RBC morfologie, structurele 
veranderingen en hun mogelijke  effecten op de functie van de acanthocyt is nog 
heel weinig bekend. 
In hoofdstuk 7 meten we de eerder beschreven fysiologisch relevante parame-
ters (vervormbaarheid, vorming van vesikels en verschijning van fosfatidylserine) 
in de rode bloedcellen van leden van verschillende PKAN families.  In vergeli-
jking met ChAc en MLS is er slechts beperkte informatie beschikbaar over de 
kenmerken van de rode bloedcellen van PKAN patiënten.
We hebben kwalitatieve en semi-kwantitatieve morfologische, immunofluo-
rescente, biochemische en functionele analyses uitgevoerd op de rode bloed-
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cellen van verschillende patiënten met PKAN én, voor het eerst, ook op de rode 
bloedcellen van hun familieleden. Onze resultaten laten zien dat het bloed van 
patiënten met PKAN niet alleen variabele aantallen acanthocyten bevat, maar 
ook een breed scala aan andere misvormde rode bloedcellen. Immunofluores-
centie- en immunoblot-analyses suggereren een verandering in de membraan 
organisatie, maar geen kwantitatieve veranderingen in eiwitexpressie. Opvallend 
is dat deze veranderingen niet beperkt zijn tot de rode bloedcellen van patiënten, 
maar ook aanwezig zijn in de rode bloedcellen van heterozygote dragers die 
geen neurologische problemen hebben.  Bovendien zijn de veranderingen niet 
alleen aanwezig in acanthocyten, maar ook in andere rode bloedcellen, waar-
onder de normale discocyten. De morfologische abnormaliteiten gaan gepaard 
met verstoringen van de organisatie van het cytoskelet en de lipide bilaag. Dit zou 
de veranderde vorming van vesikels en verminderde vervormbaarheid in de milt 
kunnen verklaren. Bovendien vonden we dat het foetaal hemoglobine (HbF) is 
verhoogd bij enkele patiënten. Aangezien toegenomen HbF niveaus een gevolg 
zijn van veranderde erythropoiese, kan dit betekenen dat acanthocyten al tijdens 
de erytropoiese in het beenmerg gevormd worden.
Deze morfologische, moleculaire en functionele eigenschappen van rode bloed-
cellen van patiënten met PKAN en hun familieleden bieden nieuwe aanknoping-
spunten voor diagnose en inzichten in de pathofysiologie van neuroacanthocytose.
Conclusie
In dit proefschrift introduceren we een aantal fysiologisch relevante parame-
ters en nieuwe technieken om de rode bloedcel te bestuderen. Deze kunnen een 
belangrijke rol spelen bij het  inschatten van de overleving van getransfundeerde 
of pathologische RBCs. Bovendien presenteren we een aantal nieuwe inzichten in 
de effecten van veranderingen in de organisatie van de celmembraan op morfol-
ogie en functie. Het lijkt erop dat we pas net beginnen te ontdekken hoe complex 
de rode bloedcel is. De in dit proefschrift beschreven technieken en daarmee 
geproduceerde resultaten kunnen helpen om de structurele kenmerken te begri-
jpen die de functie van rode bloedcellen vorm geven.
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